Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,gap junction channel activity (GO:0005243),0.8959303688817084,1.9265858625305194,0.0,0.0029658949592625064,0.003,2/22,0.29%,GJC1;GJD3
prerank,wide pore channel activity (GO:0022829),0.8912143945368395,1.9244249672305174,0.0,0.001977263306175004,0.004,2/23,0.29%,GJC1;GJD3
prerank,fibroblast growth factor receptor binding (GO:0005104),0.8817250041719267,1.8889534439886955,0.0,0.003624982727987508,0.01,3/21,2.34%,FGF22;FGF18;FGF1
prerank,CXCR chemokine receptor binding (GO:0045236),0.9512542665943216,1.8212514147860994,0.0,0.0415225294296751,0.128,1/11,0.05%,CXCL12
prerank,cytokine activity (GO:0005125),0.7248322284472066,1.8177606563195716,0.0,0.03776572914794258,0.148,13/131,8.68%,CXCL12;BMP5;WNT4;FAM3C;WNT2B;CX3CL1;IL16;TGFB2;KITLG;IL1A;CCL25;SLURP1;IL18
prerank,growth factor activity (GO:0008083),0.7355820401589886,1.7963498814648151,0.0,0.05585768839944387,0.235,8/74,8.15%,FGF22;FGF18;FGF1;VEGFC;AREG;PDGFB;NRG3;ARTN
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.7346061126314927,-1.7939355029010615,0.0031645569620253164,0.36383588702486935,0.276,6/12,13.97%,TENT2;TENT4B;MTPAP;TENT5A;TENT4A;PAPOLG
prerank,chemokine receptor binding (GO:0042379),0.788273144482229,1.772765022791428,0.0023837902264600714,0.08473985597892875,0.373,2/35,1.82%,CXCL12;CX3CL1
prerank,chemokine activity (GO:0008009),0.7955446564282131,1.7699838155411176,0.0012121212121212121,0.07847263746382048,0.392,2/31,1.82%,CXCL12;CX3CL1
prerank,metallocarboxypeptidase activity (GO:0004181),0.7932041367714914,1.711958813153415,0.0012391573729863693,0.22178303417596298,0.791,5/26,5.39%,ACE2;VASH2;CPD;CPE;FOLH1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.8574891217051759,1.7003187941280322,0.004310344827586207,0.239446586377793,0.847,1/13,0.10%,BMP5
prerank,triglyceride lipase activity (GO:0004806),0.7856335651211229,1.6886162765547714,0.014360313315926894,0.26045950278614377,0.889,3/20,6.94%,LCAT;LIPE;CEL
prerank,BMP receptor binding (GO:0070700),0.857489180826139,1.682838645768721,0.0043541364296081275,0.25704422980275055,0.906,1/12,0.10%,BMP5
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.7011496878000083,-1.6747216895224755,0.009036144578313253,0.6963964829014692,0.71,3/11,15.95%,SLC17A5;SLC2A9;SLC5A3
prerank,O-acyltransferase activity (GO:0008374),0.7391904786014071,1.6587671663225583,0.006105006105006105,0.330811360840818,0.963,5/30,8.02%,LCAT;MOGAT3;SOAT1;GPAM;PLA2G4A
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.6880600104849803,1.6524705626529101,0.00437636761487965,0.3303442052245239,0.969,8/60,6.15%,MUSK;ROR2;DDR1;DDR2;EPHB2;NRP1;CRIM1;AXL
prerank,intracellular chloride channel activity (GO:0061778),-0.6164809869045986,-1.635852390553886,0.007042253521126761,0.5139572845365633,0.842,5/16,10.85%,ANO6;TTYH2;ANO3;ANO10;TTYH3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.6164809869045986,-1.635852390553886,0.007042253521126761,0.5139572845365633,0.842,5/16,10.85%,ANO6;TTYH2;ANO3;ANO10;TTYH3
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.7938459863934799,1.633874137221179,0.01747311827956989,0.38886178354775086,0.987,4/15,6.67%,ALDH1A2;ALDH1L1;ALDH1A1;ALDH7A1
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.6679529631692056,1.6191396452951297,0.009750812567713976,0.42776855839529854,0.996,7/60,6.38%,MUSK;ROR2;DDR1;DDR2;EPHB2;AXL;ACVR1
prerank,receptor ligand activity (GO:0048018),0.6426985277969409,1.6186393066512896,0.0,0.4047574297346479,0.996,23/245,8.68%,FGF22;FGF18;BMP5;WNT4;FAM3C;WNT2B;CX3CL1;DAND5;FGF1;IL16;VEGFC;TGFB2;GAS6;AREG;PDGFB;KITLG;SEMA6D;IL1A;NRG3;CCL25;ARTN;SLURP1;IL18
prerank,frizzled binding (GO:0005109),0.7056606936712027,1.617099443972406,0.01800720288115246,0.38864208762484254,0.996,4/34,6.24%,WNT4;WNT2B;DVL1;SDCBP
prerank,DNA polymerase activity (GO:0034061),0.7386870748747095,1.6165194205471707,0.023106546854942234,0.3704246704384173,0.996,6/22,6.74%,POLG;POLE4;POLE2;POLA1;POLD3;POLB
prerank,tropomyosin binding (GO:0005523),0.7891169427283964,1.6111317062649628,0.013831258644536652,0.3725164068833708,0.998,4/16,4.80%,NEBL;TMOD1;S100A6;TMOD3
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.7416002474527782,1.6090285983357244,0.020752269779507133,0.36259242819428295,0.998,6/21,6.74%,POLG;POLE4;POLE2;POLA1;POLD3;POLB
prerank,serine-type peptidase activity (GO:0008236),0.6474479940613314,1.607627173621643,0.001026694045174538,0.3506496722291718,0.998,3/96,1.02%,GZMK;TYSND1;CD5L
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.6619408614785582,-1.6064152673924295,0.012269938650306749,0.5373095019272712,0.909,7/12,21.71%,CNOT2;CNOT1;CNOT7;PAN2;CNOT6L;CNOT8;NOCT
prerank,carboxypeptidase activity (GO:0004180),0.7168898026354913,1.5995252550302765,0.00936768149882904,0.3676420229938002,0.999,8/35,11.60%,ACE2;VASH2;CPD;CPE;FOLH1;AGBL3;CTSZ;MINDY2
prerank,sodium channel regulator activity (GO:0017080),0.690058273843051,1.5990699452916588,0.018648018648018648,0.35331223702214615,0.999,6/37,9.16%,SGK3;SGK2;NEDD4;GPD1L;CAMK2D;PTPN3
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.7934014600470443,1.5814203217832072,0.01977401129943503,0.4060507925560989,1.0,4/13,6.67%,ALDH1A2;ALDH1L1;ALDH1A1;ALDH7A1
prerank,growth factor receptor binding (GO:0070851),0.6396206859544515,1.5750000542500808,0.0,0.4150731971193528,1.0,18/95,12.68%,FGF22;FGF18;GLMN;FGF1;GRB2;VEGFC;AREG;PDGFB;PTPRJ;SDCBP;IL1RAP;CNOT9;ATXN2;SNX1;FRS2;ERN1;ERAP1;TGFA
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.7123486270971081,1.5744237005236703,0.027227722772277228,0.4020069229350995,1.0,8/27,10.15%,POLR2D;POLR1C;POLR1D;POLR3H;POLR2A;POLR1A;CRCP;POLR3A
prerank,phosphatidate phosphatase activity (GO:0008195),-0.6392016931579101,-1.5645493082830384,0.03939393939393939,0.6456610105942763,0.959,7/13,17.68%,PLPPR1;LPIN2;LPIN1;PLPPR4;PLPP3;PLPPR5;PLPP4
prerank,death receptor activity (GO:0005035),0.8117354635999701,1.5633726035858522,0.03172205438066465,0.429454528446546,1.0,2/11,3.43%,TNFRSF11A;TNFRSF25
prerank,G protein-coupled receptor binding (GO:0001664),0.6160116018744439,1.5547727838408605,0.00101010101010101,0.44631605524901996,1.0,21/132,13.76%,CXCL12;WNT4;S1PR1;WNT2B;DVL1;HOMER2;FLNA;ARHGEF12;REEP2;ARRB2;SDCBP;PSMC5;USP33;CCL25;USP20;GNAQ;TULP3;GNAI3;LRP6;PDCD6IP;BICD1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.7450178321634312,1.5465557176777114,0.033602150537634407,0.4627784768102598,1.0,5/18,6.51%,ALDH1A2;ALDH6A1;AKR1B1;FAR1;ALDH1A1
prerank,voltage-gated anion channel activity (GO:0008308),-0.6037968758730689,-1.5443669435608502,0.027237354085603113,0.6569300440715099,0.975,9/15,15.85%,ANO6;VDAC2;VDAC1;CLCN4;CLCN6;VDAC3;CLCN3;GPR89B;GPR89A
prerank,solute:anion antiporter activity (GO:0140323),0.7876242043671777,1.5385052822828262,0.03428571428571429,0.4799328305585103,1.0,3/14,6.52%,SLC4A3;SLC7A11;SLC26A11
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.47303670833539313,-1.536943646252221,0.03680981595092025,0.6073922168420186,0.982,17/33,20.11%,PRKN;TCERG1;ARIH2;DCUN1D1;SIAH1;RNF19A;RNF14;RNF185;RNF217;ANKIB1;TRAF6;DCUN1D3;RNF180;RNF144A;AUP1;RPS3;TOLLIP
prerank,cytochrome-c oxidase activity (GO:0004129),-0.6132196887002553,-1.5359689161588161,0.04044117647058824,0.5440742315682303,0.982,10/15,29.65%,CYB5A;COX10;COX7A2L;COX6B1;COX8A;NDUFA4;COX4I1;COX6A1;COX5A;COX15
prerank,5'-3' RNA polymerase activity (GO:0034062),0.6952320547449432,1.5337817695279863,0.038366336633663366,0.4848002468827839,1.0,8/27,10.15%,POLR2D;POLR1C;POLR1D;POLR3H;POLR2A;POLR1A;CRCP;POLR3A
prerank,retinoid binding (GO:0005501),0.7265824208041463,1.532514984256462,0.04046997389033943,0.47502253004107375,1.0,1/22,0.31%,ALDH1A2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.6624008976372038,1.5144599675597008,0.02733485193621868,0.5372631486499346,1.0,4/38,10.43%,TFPI2;SERPINI1;ANXA2;FURIN
prerank,cytokine receptor binding (GO:0005126),0.6129258622430552,1.510289451409509,0.012409513960703205,0.5392279502125833,1.0,16/83,13.58%,CXCL12;VEGFC;TGFB2;LIFR;SMAD3;KITLG;SPRED2;SDCBP;CCL25;IL1RAP;IL18;PXDN;ERAP1;SH2B3;SYK;SPRED1
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.7780934875276754,1.5090424155309825,0.05116959064327485,0.5295770221705387,1.0,5/12,8.80%,SLC9A9;SLC9A1;LETM1;SLC9A7;SLC9A6
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.48965144623592655,-1.50722353812922,0.04864864864864865,0.60601089148297,0.998,10/27,19.54%,ITPR2;SLC11A1;ITPR1;TMEM165;MAGT1;SLC11A2;ZDHHC13;MRS2;ATP2B4;SLC12A2
prerank,MHC class I protein binding (GO:0042288),0.7578808720895187,1.5029739782095481,0.04664723032069971,0.5417167063431356,1.0,4/13,11.74%,TUBB4B;ATP5F1A;TAP1;DERL1
prerank,bHLH transcription factor binding (GO:0043425),0.727868516367749,1.502389712051954,0.045992115637319315,0.5298024995651025,1.0,4/19,5.09%,ISL1;SP1;PSMD9;SMAD3
prerank,translation elongation factor activity (GO:0003746),-0.5843729574707557,-1.4930091519355932,0.059233449477351915,0.6146068578682672,0.999,11/14,33.10%,EEFSEC;EEF1A1;GFM2;GTPBP2;EEF2;GTPBP1;GFM1;EEF1B2;EIF5A;EIF5AL1;TSFM
prerank,neurexin family protein binding (GO:0042043),0.7834515599926156,1.4850193034253685,0.06677018633540373,0.5919368649037503,1.0,3/10,6.94%,SYTL2;CPE;CEL
prerank,syntaxin-1 binding (GO:0017075),0.6889075437073351,1.4845052111541113,0.05263157894736842,0.5793875802919306,1.0,6/22,10.33%,STXBP2;LRRK2;VAMP3;DAPK1;VAMP2;STXBP5
prerank,lipase activity (GO:0016298),0.6298545527527046,1.4845041457026018,0.04611923509561305,0.5652561758945666,1.0,7/43,10.19%,LCAT;SMPD3;LIPE;LIPA;CEL;ABHD6;ABHD16A
prerank,MHC protein binding (GO:0042287),0.7003838292657398,1.4820294354668215,0.058365758754863814,0.5623901775134905,1.0,7/20,16.95%,TUBB4B;ATP5F1A;TAP1;DERL1;ATP5F1B;CD81;TAPBP
prerank,potassium channel regulator activity (GO:0015459),0.6271605842389727,1.4729349365342637,0.03455964325529543,0.588994550902224,1.0,6/49,7.48%,SGK3;SGK2;AKAP9;FLNA;YWHAE;DLG1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.5683977287107875,-1.4673230452337709,0.072992700729927,0.6790213211524305,0.999,6/14,24.65%,TIMP2;SPOCK1;SPOCK2;BST2;TIMP3;RECK
prerank,ribosomal large subunit binding (GO:0043023),0.7592218440980752,1.4591108327167015,0.05263157894736842,0.638431358882461,1.0,4/11,5.00%,EIF6;NMD3;MALSU1;RBM3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.7169505836448818,1.451580151082966,0.09103641456582633,0.6583847417716948,1.0,3/14,6.57%,PYCR2;ALDH1L1;MTHFR
prerank,metalloexopeptidase activity (GO:0008235),0.6188465339793924,1.4465207668462101,0.045657015590200446,0.6677776976756908,1.0,10/51,12.65%,ACE2;VASH2;CPD;METAP1;CPE;FOLH1;LNPEP;AGBL3;XPNPEP1;ERAP1
prerank,rRNA binding (GO:0019843),0.6171089608080255,1.439087917979656,0.06053811659192825,0.6891604010660816,1.0,6/42,5.41%,ANG;CAVIN1;SBDS;GTF3A;EMG1;RPLP0
prerank,carboxylic ester hydrolase activity (GO:0052689),0.5818263231261523,1.4389307125514377,0.037267080745341616,0.6756679454069898,1.0,13/85,10.21%,LCAT;PLA2G7;NDST3;LIPE;PLA2G6;TARS2;LIPA;CEL;ABHD6;PLA2G4A;AARS1;ABHD16A;PNPLA6
prerank,syntaxin binding (GO:0019905),0.5978305302163378,1.4371738272558179,0.04427645788336933,0.6704334938866247,1.0,19/61,13.23%,STXBP2;VAMP1;LRRK2;NAPG;VAMP3;STX7;TMED9;SNAP47;SYT12;STX16;DAPK1;VAMP2;CACNA1A;STXBP5;ABL1;STXBP5L;VPS11;ABCA1;NAPA
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.7256584380574247,1.433744759119057,0.08207934336525308,0.6726847493937982,1.0,1/15,0.61%,SLC4A3
prerank,pyridoxal phosphate binding (GO:0030170),0.6640630995997185,1.4322013712829493,0.08781127129750983,0.6670162068840757,1.0,4/20,10.40%,CBS;PDXK;PSAT1;SRR
prerank,peptidoglycan binding (GO:0042834),-0.6245500743868133,-1.4318266711186847,0.05571847507331378,0.7931093062984258,0.999,5/10,20.03%,NLRP3;HK1;RNASE7;TLR2;NOD1
prerank,acetyltransferase activity (GO:0016407),0.6314598654267057,1.4315302586352834,0.08124253285543608,0.6567365998577228,1.0,9/31,13.16%,LCAT;ACAT1;ELP3;EP300;NAA16;GTF2B;KAT2B;ESCO1;NAA15
prerank,insulin-like growth factor I binding (GO:0031994),0.7212716657866841,1.429147252317212,0.09214501510574018,0.65451146119876,1.0,5/13,13.60%,IGFBP3;IGFBP2;ITGA6;IGF1R;INSR
prerank,BMP binding (GO:0036122),-0.6051103714535753,-1.4286748386359687,0.08814589665653495,0.7502346626638474,0.999,3/11,27.26%,BMPR2;ENG;GREM2
prerank,potassium ion antiporter activity (GO:0022821),0.7057166545284701,1.421352981154316,0.09288824383164006,0.6788054778060245,1.0,5/15,8.80%,SLC24A5;SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,transcription corepressor binding (GO:0001222),0.649850012020049,1.4209639908115141,0.06575682382133995,0.6683689228500472,1.0,10/27,9.64%,RORA;EHMT1;USP11;THAP7;ZBTB7A;ESR1;EHMT2;WIZ;EZH2;CTBP1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.4656790369036736,-1.4187474245093097,0.0825242718446602,0.7463674480917043,0.999,14/27,20.11%,PRKN;ARIH2;DCUN1D1;SIAH1;RNF19A;RNF14;RNF217;ANKIB1;TRAF6;DCUN1D3;RNF180;RNF144A;AUP1;TOLLIP
prerank,R-SMAD binding (GO:0070412),0.6794666974976621,1.4178671170764001,0.09175531914893617,0.6703275690666509,1.0,10/18,16.49%,RGCC;SMAD6;PMEPA1;JUN;SMAD3;LDLRAD4;PPM1A;DDX5;SMAD4;DROSHA
prerank,potassium:proton antiporter activity (GO:0015386),0.7607757442070681,1.4171806716799176,0.08580343213728549,0.6615159868203041,1.0,4/10,8.80%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,C2H2 zinc finger domain binding (GO:0070742),0.7391199882026379,1.4150948271718145,0.07580174927113703,0.6593661764893766,1.0,4/11,13.68%,THAP7;EHMT2;ZXDC;SRRM2
prerank,sodium:proton antiporter activity (GO:0015385),0.7449986193330621,1.4124600121777904,0.0852359208523592,0.6591492091102215,1.0,4/11,8.80%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,metal ion:proton antiporter activity (GO:0051139),0.7161552369019631,1.4065799684655225,0.09855072463768116,0.6750212155339284,1.0,5/13,8.80%,SLC9A9;SLC9A1;LETM1;SLC9A7;SLC9A6
prerank,myosin II binding (GO:0045159),0.7465762067047874,1.4053134834278513,0.09131736526946108,0.6694170786741999,1.0,4/10,11.92%,LLGL2;LLGL1;STXBP5;STXBP5L
prerank,chloride channel regulator activity (GO:0017081),0.7044473991286598,1.3998888679444947,0.1006993006993007,0.6821239492867285,1.0,2/14,4.76%,SGK3;STX7
prerank,transcription coregulator binding (GO:0001221),0.5940207150784977,1.3986702465059115,0.06423034330011074,0.6762711284096176,1.0,22/50,16.07%,RORA;EHMT1;USP11;THAP7;RELA;AR;ZBTB7A;SMAD3;ESR1;EHMT2;WIZ;CDK9;EZH2;CTBP1;UBE2I;LCOR;PPARD;CHD6;CTCF;SMAD4;NEK6;LMO2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.4263444162787989,-1.3941053259618101,0.06535947712418301,0.8185004320928383,1.0,19/29,48.59%,SLC25A13;SLC38A7;SLC1A1;SLC25A30;SLC26A2;SLC1A5;SLC25A11;SLC25A14;SLC25A12;SLC25A22;SLC25A21;SLC1A4;SLC13A3;SLC26A8;SLC26A6;SLC25A10;SLC46A1;SLC1A6;SLC19A1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.6184791981464979,-1.3936630948114304,0.05970149253731343,0.7724383672619677,1.0,4/10,7.60%,NCF2;NCF1;CYBA;CYBB
prerank,MAP kinase phosphatase activity (GO:0033549),0.7208614220684366,1.3906998516750824,0.09347181008902077,0.7016195263005366,1.0,3/12,8.29%,DUSP3;DUSP16;DUSP10
prerank,nuclease activity (GO:0004518),0.5812910716177566,1.389983985952483,0.06792873051224944,0.6944605022818808,1.0,9/52,7.41%,ANG;DFFB;RNASE6;RNASEH2A;WRN;ISG20L2;REXO5;RNASE4;MRE11
prerank,Hsp70 protein binding (GO:0030544),0.6155747649574238,1.3856723884935243,0.09427207637231504,0.7021082249017788,1.0,6/31,4.00%,DNAJB1;SACS;PPID;DNAJC18;DNAJC8;HIKESHI
prerank,sterol transfer activity (GO:0120015),0.6608927433510147,1.384778215251236,0.1117092866756393,0.6955982799731035,1.0,6/17,16.25%,OSBP;STARD5;ABCG1;ABCA1;GRAMD1B;OSBPL2
prerank,insulin-like growth factor binding (GO:0005520),0.6812059082325869,1.384232698876131,0.11627906976744186,0.687535159919235,1.0,5/15,13.60%,IGFBP3;IGFBP2;ITGA6;IGF1R;INSR
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.7258914007614574,1.3809925021757883,0.10043668122270742,0.6919561891914178,1.0,3/11,4.81%,ROR2;SASH1;MAP3K11
prerank,ribonuclease activity (GO:0004540),0.5776614829030424,1.371522551600066,0.09110867178924259,0.7248647280437567,1.0,14/56,12.18%,ANG;RNASE6;ZC3H12D;RNASEH2A;SMG6;EXOSC5;PPP1R8;EXOSC7;RNASE4;AGO2;ZC3H12B;CPSF3;RNASE3;ERN1
prerank,exopeptidase activity (GO:0008238),0.5821571352196317,1.3693384793844672,0.09080841638981174,0.7245277578183381,1.0,9/50,12.65%,ACE2;METAP1;CPE;FOLH1;DPP3;LNPEP;CTSZ;XPNPEP1;ERAP1
prerank,FAD binding (GO:0071949),0.6289914604769983,1.360680618074015,0.1092964824120603,0.7528155418357694,1.0,6/24,12.19%,NQO2;KDM1B;QSOX1;MTHFR;MICAL2;AIFM1
prerank,phosphatase inhibitor activity (GO:0019212),0.6481717786867697,1.3559326201400907,0.1276005547850208,0.7642935252327833,1.0,8/20,15.82%,URI1;CABIN1;STYX;BOD1L1;SET;ENSA;PPME1;PPP1R9B
prerank,clathrin adaptor activity (GO:0035615),0.6749207305613578,1.3551447118685682,0.13623595505617977,0.7575323242346966,1.0,5/15,8.83%,AP1M1;LDLRAP1;STON2;AP2A1;DAB2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.7291192924543142,1.3517822928129208,0.11838006230529595,0.7623140950627111,1.0,4/10,8.35%,EHMT1;SUV39H1;EHMT2;ASH1L
prerank,exonuclease activity (GO:0004527),0.5734785218277118,1.3498224467745656,0.103954802259887,0.7607390487396082,1.0,14/46,13.93%,POLG;RAD50;REXO2;EXOSC5;WRN;ISG20L2;REXO5;EXOSC7;MRE11;EXD2;XRN2;CPSF3;REV3L;APEX2
prerank,phosphate ion binding (GO:0042301),0.7123222426233091,1.3480290504724775,0.14176829268292682,0.7586271409653007,1.0,2/10,2.57%,RELA;ADSS1
prerank,DNA polymerase binding (GO:0070182),0.6553895103241998,1.3471486382379514,0.13306451612903225,0.7531598729457123,1.0,6/18,12.01%,SMARCA4;SMG6;CDK2AP1;POLG2;HSP90AA1;HMGB1
prerank,anion:anion antiporter activity (GO:0015301),0.6588880008361243,1.3468741385915088,0.13125845737483086,0.7448526074907358,1.0,2/17,6.52%,SLC4A3;SLC26A11
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.5284255706992346,-1.3455297157975536,0.12631578947368421,0.9595722661935746,1.0,5/15,16.90%,SLC1A2;SLC25A13;SLC38A7;SLC17A6;SLC1A1
prerank,transcription coactivator binding (GO:0001223),0.6390875326172598,1.3425582855014737,0.12928759894459102,0.7551168566282341,1.0,6/20,8.29%,RORA;RELA;AR;SMAD3;ESR1;CDK9
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.6586351213649331,1.3406102676507348,0.13438735177865613,0.7541428713700071,1.0,2/17,1.44%,AK4;AK3
prerank,galactosyltransferase activity (GO:0008378),0.6990118816642426,1.337752299433611,0.14350453172205438,0.7582563649509658,1.0,3/11,9.77%,B4GALT3;B4GALT5;B4GALT1
prerank,protein tyrosine kinase activity (GO:0004713),0.5393868087570328,1.3346254631040946,0.06960081883316274,0.7634380382287996,1.0,19/108,13.79%,MUSK;ROR2;DDR1;DDR2;DYRK2;EPHB2;BTK;YES1;AXL;LYN;EPHA5;IGF1R;ABL1;HIPK2;SYK;CLK1;INSR;CAMKK2;FYN
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.4705743636072571,-1.3306424637530547,0.128,0.9845681129202617,1.0,11/19,29.89%,GRIK1;GABRA2;GABRA3;GRIK4;GRIK2;GABRA5;GABRA4;GABRG1;GRIK5;GRIK3;GABRA1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.430441048752187,-1.3271442385861907,0.11931818181818182,0.9523847409500557,1.0,12/28,29.89%,GRIK1;GABRA2;GABRA3;GRIK4;GRIK2;GABRA5;GABRA4;CHRNA7;GABRG1;GRIK5;GRIK3;GABRA1
prerank,GABA receptor binding (GO:0050811),-0.5659411604921487,-1.325914823718814,0.15963855421686746,0.9128413549752077,1.0,10/11,41.40%,PLCL2;TRAK2;TRAK1;GABARAP;GABARAPL2;JAKMIP1;GABARAPL1;LHFPL4;AKAP5;SHISA7
prerank,heme binding (GO:0020037),0.5434081752825317,1.3245489621839128,0.10554371002132196,0.8001796289299178,1.0,4/65,4.82%,FLVCR2;CBS;EIF2AK1;HMOX2
prerank,hyaluronic acid binding (GO:0005540),0.6972979614939251,1.3243489662446457,0.15763546798029557,0.7915682872256016,1.0,2/10,9.66%,CHODL;CD44
prerank,double-stranded RNA binding (GO:0003725),0.5420762008349967,1.3219841636570535,0.0967741935483871,0.792859594342384,1.0,18/70,12.21%,TUBB4B;EIF2AK2;ILF3;ZNF346;DDX60;TLR7;EIF4B;MSN;MBNL1;RFTN1;SIDT1;RC3H2;TLR3;AGO2;MTDH;ADAR;PRKRA;ZFR
prerank,nuclear import signal receptor activity (GO:0061608),0.6481172721176756,1.3151203565192655,0.14788732394366197,0.8147347543840763,1.0,6/15,9.84%,KPNB1;HIKESHI;RANBP6;IPO9;KPNA6;IPO5
prerank,1-phosphatidylinositol binding (GO:0005545),0.6472797591976703,1.3149849311511081,0.15438108484005564,0.8061617063892386,1.0,5/15,8.37%,ZFYVE9;EEA1;SNX10;EPB41;WDFY1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.63016597174186,1.31220449679416,0.15704697986577182,0.809678215657843,1.0,4/19,8.02%,GAS6;ABI1;NRG3;PAK2
prerank,cGMP binding (GO:0030553),-0.5593372365283148,-1.3096927046531348,0.14613180515759314,0.947641321792568,1.0,2/11,9.11%,PDE10A;PDE11A
prerank,dynactin binding (GO:0034452),0.6691786229647881,1.3054378069245416,0.17293233082706766,0.831406265858153,1.0,5/12,13.76%,SNX5;BBS4;BICDL1;MAPT;BICD1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.6591326308433072,1.304831006647489,0.17086834733893558,0.824975090207171,1.0,3/13,6.84%,SLC66A1;SLC7A2;SLC7A7
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.6680246878367857,1.3045538340777125,0.17908309455587393,0.8171255532692789,1.0,1/12,0.90%,NQO2
prerank,phospholipase C activity (GO:0004629),-0.4436294811327426,-1.3029777228341195,0.1324200913242009,0.9382134079391765,1.0,6/25,14.72%,PLCG2;PLCL1;CHRM3;PLCB2;PLCE1;PLCG1
prerank,estrogen receptor binding (GO:0030331),0.5691468396339994,1.2977707743987117,0.14028776978417265,0.8385616203279723,1.0,7/32,7.95%,ISL1;PPID;RERG;WBP2;PADI2;ESR1;NCOA1
prerank,fatty acid synthase activity (GO:0004312),-0.5677672397940338,-1.297722795875031,0.1544943820224719,0.922881716300188,1.0,8/10,40.69%,ELOVL6;ELOVL7;ELOVL5;ELOVL4;CBR4;ELOVL1;OXSM;MCAT
prerank,nuclear receptor binding (GO:0016922),0.5213564053400899,1.2976839960456972,0.10183299389002037,0.8300509289890623,1.0,32/111,13.71%,ISL1;ZNHIT3;SMARCA4;BRD8;PPID;RERG;ZBTB7A;WBP2;PADI2;PRKCB;EP300;SMAD3;BUD31;TACC2;HMGN3;ESR1;KDM3A;NCOA1;PRPF6;JMJD1C;NCOR1;NCOA3;ACTN4;GTF2B;NCOR2;KDM4C;TCF7L2;LCOR;RXRA;PPARGC1B;GTF2H1;DDX5
prerank,acid-thiol ligase activity (GO:0016878),-0.5291487563151172,-1.2939042885339795,0.16828478964401294,0.9039810153495836,1.0,6/13,35.31%,ACSS1;ACSL1;ACSS2;AASDH;ACSS3;AACS
prerank,acetylation-dependent protein binding (GO:0140033),0.6181356698362326,1.2936055711598855,0.16796875,0.8308934131881139,1.0,8/20,15.29%,THAP7;SMARCA4;ZMYND8;DPF2;BRD2;BRD7;BRD3;PHIP
prerank,lysine-acetylated histone binding (GO:0070577),0.6181356698362326,1.2936055711598855,0.16796875,0.8308934131881139,1.0,8/20,15.29%,THAP7;SMARCA4;ZMYND8;DPF2;BRD2;BRD7;BRD3;PHIP
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5555965598214295,-1.2923405009716862,0.1566265060240964,0.8759487313142269,1.0,8/11,25.69%,CASP4;PYCARD;CASP7;CASP8;CASP9;CASP2;CASP1;CASP3
prerank,leucine zipper domain binding (GO:0043522),0.6793808735360811,1.2916693094597438,0.1703125,0.8308276955127207,1.0,1/10,0.63%,PMF1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.6541851542661504,1.2908888919991646,0.1804949053857351,0.8257192799680116,1.0,4/13,7.50%,ITGB1BP1;GDI1;GDI2;RGS14
prerank,copper ion binding (GO:0005507),0.559528512670118,1.284322012529996,0.14009111617312073,0.8458892202669692,1.0,8/42,12.92%,ANG;COX17;ATP7A;IL1A;LACC1;LOXL3;PRNP;TP53
prerank,endopeptidase inhibitor activity (GO:0004866),0.5293365406533381,1.282915091097063,0.1099476439790576,0.843490640097726,1.0,8/82,11.35%,TFPI2;UBE2Z;UCHL5;SERPINI1;BIRC6;ANXA2;FURIN;PRNP
prerank,potassium ion leak channel activity (GO:0022841),0.6388101488699369,1.2822830060089425,0.17590027700831026,0.8379093739365977,1.0,4/15,12.84%,TMEM175;KCNK2;KCNK13;KCNK10
prerank,deoxyribonuclease activity (GO:0004536),0.6237298758298117,1.2801533426509337,0.18662952646239556,0.8390381145213012,1.0,3/14,7.85%,DFFB;MRE11;ERCC4
prerank,DNA secondary structure binding (GO:0000217),0.5686315740407253,1.2785657252097837,0.17575757575757575,0.8383404450870738,1.0,8/31,12.01%,BLM;RAD18;WRN;RBBP8;MAPT;RAD51B;ABL1;HMGB1
prerank,gated channel activity (GO:0022836),0.6448639531951936,1.2770875900885126,0.1752136752136752,0.8366105242781239,1.0,4/14,8.52%,TMEM266;TMC7;TMEM63B;PIEZO2
prerank,four-way junction DNA binding (GO:0000400),0.6129105124209266,1.2747869556576004,0.17938420348058903,0.8383596418182018,1.0,5/17,12.01%,BLM;WRN;RAD51B;ABL1;HMGB1
prerank,ion gated channel activity (GO:0022839),-0.4249329182089756,-1.2740617330853976,0.14678899082568808,0.9208063497579416,1.0,7/24,10.85%,ANO6;KCNT2;TTYH2;ANO3;TMEM63A;ANO10;TTYH3
prerank,protein kinase C binding (GO:0005080),0.5459483742925165,1.2730230722587643,0.149438202247191,0.8379306129876168,1.0,14/43,16.76%,IRS1;NELL1;HDAC9;PRKCB;SQSTM1;HDAC5;TWF2;GRK5;ABL1;PRKCSH;NELL2;PRKD2;PKN1;TOP2B
prerank,metallopeptidase activity (GO:0008237),0.5126557670314296,1.2706569865965447,0.11237113402061856,0.8401983119019815,1.0,11/113,9.26%,ACE2;ADAMTS12;NLN;ADAMTS2;ADAM15;METAP1;ADAM12;ADAMTSL3;NRDC;LNPEP;ADAMTS10
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.47856171073780035,-1.2693355815858385,0.15471698113207547,0.907393000683902,1.0,11/16,40.63%,SLC25A13;SLC38A7;SLC1A1;SLC25A30;SLC1A5;SLC25A11;SLC25A14;SLC25A12;SLC25A22;SLC1A4;SLC13A3
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.5141972872588428,1.2661328628229376,0.15918803418803418,0.8517244771284588,1.0,18/69,14.15%,MOGAT3;SOAT1;ELP3;CERS6;EP300;ZDHHC5;PLA2G4A;ZDHHC1;CERS4;NMT1;NAA16;GTF2B;KAT2B;ESCO1;ZDHHC6;NAA15;CERS5;ZDHHC20
prerank,transforming growth factor beta binding (GO:0050431),0.5871638153679851,1.2640690814282676,0.1874180865006553,0.8528535260533746,1.0,5/23,12.97%,CD36;THBS1;ACVR1;TGFBR2;TGFBR1
prerank,3'-5' exonuclease activity (GO:0008408),0.5385619172754681,1.26255165803571,0.17279821627647715,0.8513826169575089,1.0,11/45,12.46%,POLG;RAD50;REXO2;EXOSC5;WRN;EXOSC7;ERI3;MRE11;EXD2;XRN2;REV3L
prerank,phospholipase A2 activity (GO:0004623),0.5720332447792535,1.2608606914473055,0.20173267326732675,0.8510070017045464,1.0,3/26,8.02%,PLA2G7;PLA2G6;PLA2G4A
prerank,actin binding (GO:0003779),0.49576162693945447,1.2581592719536683,0.08157099697885196,0.8548574325290994,1.0,41/170,15.73%,ANG;SYNE2;VCL;VASH2;LRRK2;TLN2;VPS16;BCL7B;ADCY8;MAP1A;TMOD1;PDLIM2;IQGAP2;ALDOA;TPM1;CAPZB;PARVB;EZR;GIPC1;MAPT;ARPC1A;EPS8L1;SSH2;PHACTR2;TWF2;ADD1;MICAL2;ACTN4;EPS8;DBNL;TMSB4X;ABL1;MYO9B;FMN2;LIMA1;FLNB;DAG1;ABLIM1;MICAL3;MACF1;CAPZA1
prerank,NF-kappaB binding (GO:0051059),0.5685017661733933,1.2573467437178538,0.20418204182041821,0.8505819287152216,1.0,8/24,15.59%,CDK5RAP3;RELA;EP300;FAF1;MTDH;COMMD7;NPM1;HDAC2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.6616635448121044,1.2567160388612695,0.21428571428571427,0.8385229809608858,1.0,3/11,5.38%,BAG3;HSPH1;SIL1
prerank,adenyl nucleotide binding (GO:0030554),0.6616635448121044,1.2567160388612695,0.21428571428571427,0.8385229809608858,1.0,3/11,5.38%,BAG3;HSPH1;SIL1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5092246796615496,-1.2565496084295111,0.2116564417177914,0.9302421943031858,1.0,10/12,42.62%,XDH;CISD2;SDHB;CIAPIN1;ISCA1;ISCU;CISD1;FXN;ISCA2;FDX1
prerank,actinin binding (GO:0042805),0.589394755551939,1.2525281125507812,0.21355498721227623,0.8488766371622534,1.0,7/21,16.88%,RELA;CACNA1D;PPARG;PKD2;CACNA1C;DAG1;KCNA5
prerank,peptidase inhibitor activity (GO:0030414),-0.38692065053307034,-1.252195142274807,0.174496644295302,0.9173042893787464,1.0,5/33,6.27%,CST3;TIMP2;RENBP;CAST;SIMC1
prerank,endopeptidase activator activity (GO:0061133),-0.556332742535801,-1.2446982384695044,0.19540229885057472,0.9191572663059182,1.0,9/10,40.24%,PSMD14;VSIR;PSME1;PSME2;APH1A;PSENEN;NLRC4;APH1B;PSME3
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.5064041024064911,-1.2445375124234426,0.22033898305084745,0.8908571213014912,1.0,7/13,31.25%,DNA2;DNASE1L1;FAN1;ZGRF1;ENDOV;DICER1;SLX4
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.6747381547643153,1.2432391823489284,0.22929936305732485,0.8808539032145868,1.0,2/10,3.36%,SLCO4C1;SLCO1B1
prerank,carboxylic acid binding (GO:0031406),-0.37027011706671975,-1.242853449518525,0.12179487179487179,0.8704008300172961,1.0,14/38,23.83%,UBR1;SESN1;GRIN2B;GLUD1;GRIN3A;SESN3;GCLC;GLRA1;UBR2;CASTOR2;EPDR1;PHYH;GLRA2;GRIN1
prerank,telomeric DNA binding (GO:0042162),0.5564281823556335,1.2419665906969004,0.19520958083832335,0.8785667884552095,1.0,13/32,18.05%,BLM;RAD50;SMG6;WRN;TERF2;HNRNPA2B1;HMBOX1;TERF1;CTC1;HNRNPD;PURA;SMG7;NCL
prerank,mRNA 3'-UTR binding (GO:0003730),0.5151986646270158,1.2398764126242887,0.15641293013555788,0.8807046463206136,1.0,24/79,16.53%,ELAVL4;SECISBP2L;ELAVL2;RPL41;ILF3;CARHSP1;TARDBP;RBMS3;RNPS1;PUM2;HNRNPA2B1;LARP4B;PABPC4;FXR2;PUM1;ZFP36L1;TP53;RNF20;DDX5;RBMS1;HNRNPC;SERBP1;CELF2;CPEB2
prerank,GABA receptor activity (GO:0016917),-0.42897360883728564,-1.2392713388802086,0.21052631578947367,0.8587520384211627,1.0,9/21,29.89%,GABRB1;GABRA2;GABRA3;GABBR1;GABRA5;GABRA4;GABRB3;GABRG1;GABRA1
prerank,mannose binding (GO:0005537),0.6272766885132928,1.2372946784618293,0.23546511627906977,0.8849159540815141,1.0,1/12,0.77%,LMAN1
prerank,ephrin receptor binding (GO:0046875),0.5670108467407865,1.2370322594202077,0.24155844155844156,0.8788526870471411,1.0,8/21,13.79%,GRB2;PTPN1;LYN;ANKS1A;CBL;ABL1;ANKS1B;FYN
prerank,cyclic nucleotide binding (GO:0030551),-0.4386533653813822,-1.2351110411556459,0.17916666666666667,0.8496156235364203,1.0,7/21,20.91%,PDE4D;PDE10A;PDE4B;PDE11A;PDE4A;KCNH1;CNBD2
prerank,death receptor binding (GO:0005123),-0.4857102306447224,-1.2321842729731456,0.176056338028169,0.8369905000541069,1.0,9/15,33.37%,MADD;RIPK1;FEM1B;EDA;TMBIM1;BID;DAB2IP;BDNF;MYD88
prerank,phosphoric ester hydrolase activity (GO:0042578),0.518825557950784,1.2313682695368722,0.20112359550561798,0.8956840706209969,1.0,8/49,8.29%,SMPDL3A;DUSP3;PLCXD3;SMPD1;PLCXD2;PTPRJ;DUSP16;DUSP10
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.49313138778088556,1.2301725111690072,0.0970970970970971,0.8933532822281586,1.0,48/181,15.59%,ISL1;CDK5RAP3;PARP9;DMAP1;RELA;SMARCA4;SP1;BBS4;NFATC1;JUN;AR;EP300;SMAD3;SPEN;BUD31;TACC2;HDAC5;MEF2A;RBBP8;NCOA1;PTPRT;TAF4;NCOR1;NCOA3;FAF1;PPARG;MTDH;TAL1;ACTN4;COMMD7;NCOR2;TCF7L2;MIER3;MAPK14;HIPK2;TP53;CTDP1;RXRA;CREB1;RBPJ;PPARD;NCOA2;LDB2;LDB1;ARNT;NPM1;PIAS1;HDAC2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6477304538595771,1.2292923651415018,0.22522522522522523,0.889776460614664,1.0,1/11,4.60%,PADI2
prerank,lysine N-methyltransferase activity (GO:0016278),0.5775028307705498,1.2287809695977272,0.22572178477690288,0.8849993286842579,1.0,4/20,7.97%,EHMT1;EHMT2;SETD2;SETD3
prerank,GABA-A receptor activity (GO:0004890),-0.4491676076630118,-1.2277739101654292,0.17829457364341086,0.8296968454442288,1.0,8/18,29.89%,GABRB1;GABRA2;GABRA3;GABRA5;GABRA4;GABRB3;GABRG1;GABRA1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.5487061095462447,1.2267585585834446,0.2059186189889026,0.886457356369205,1.0,6/29,10.43%,GBA2;CTBS;PARG;ACER3;GANAB;GALC
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.42392293377586376,-1.221627396320427,0.1810344827586207,0.8294536426112125,1.0,7/23,23.33%,PLCG2;CHRM3;PLCB2;PLCE1;PLCG1;PLCB3;PLCH1
prerank,filamin binding (GO:0031005),0.6485350929122723,1.2213292948101238,0.27123695976154993,0.9014685930904883,1.0,3/11,13.07%,TMEM67;NEBL;FBLIM1
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5094429932681492,-1.2207657237980027,0.24550898203592814,0.8110725504451242,1.0,7/11,15.68%,ATP8A2;ABCA3;ATP11A;ATP10A;ABCB4;ATP8B1;ATP8A1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.5612965701768602,1.21615384805579,0.22791293213828426,0.9164306476729555,1.0,7/24,15.18%,CAMKK1;CAMK1D;CAMK2D;DAPK1;MAPKAPK2;CAMK2G;MKNK1
prerank,endonuclease activity (GO:0004519),0.5137558469552339,1.2145067783293388,0.22112211221122113,0.9165075252796999,1.0,9/49,12.18%,ANG;ZC3H12D;SMG6;MRE11;ERCC4;AGO2;ZC3H12B;CPSF3;ERN1
prerank,disordered domain specific binding (GO:0097718),0.5613068767874896,1.2141623880659609,0.25637755102040816,0.9108263419895156,1.0,10/23,16.61%,DFFB;HSP90AA1;NCOA3;TP53;FN1;FYN;CALM1;CLTC;RB1;KCNA1
prerank,SH2 domain binding (GO:0042169),-0.3832167118921943,-1.2126307038448374,0.21568627450980393,0.8185264948354618,1.0,11/31,14.22%,ARHGAP5;PAG1;PTK2;JAK2;NLK;SH3PXD2B;LAT2;INPPL1;CCDC88A;RACK1;LILRB1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5333590572676153,-1.211210777467572,0.24293785310734464,0.8029867434653276,1.0,9/10,35.84%,LAPTM5;IDE;DNAJC2;FAN1;DNAJB2;FAAP20;USP15;ANKRD13D;ANKRD13B
prerank,semaphorin receptor activity (GO:0017154),0.6258443211492685,1.2111340397176367,0.2692867540029112,0.9165671977032842,1.0,4/11,13.83%,PLXNA1;NRP1;PLXNC1;NRP2
prerank,calcium channel regulator activity (GO:0005246),0.5283257965005606,1.208519293165961,0.2361111111111111,0.9203561519545804,1.0,3/37,4.70%,SGK3;CACNG7;YWHAE
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.5303985290251289,1.2052065064829136,0.2505938242280285,0.9265262586397872,1.0,8/34,8.54%,EHMT1;SUV39H1;EHMT2;KMT2E;SETD2;KMT5B;SETD3;EZH2
prerank,myosin V binding (GO:0031489),-0.4755522828279832,-1.2041454134922547,0.2831541218637993,0.8070762632428452,1.0,6/15,10.31%,RAB10;RAB6B;RAB11A;RAB11B;RAB14;RAB27B
prerank,histone methyltransferase binding (GO:1990226),0.6276340161753151,1.1993121910490276,0.272863568215892,0.9444088312322299,1.0,5/11,13.20%,PRDM4;WIZ;CBX1;NOP56;LCOR
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3608428569199732,-1.1988617653876816,0.2,0.8056660466264699,1.0,8/35,4.90%,HCK;DYRK1A;PTK2;PTK2B;FGR;SLA;FES;CSK
prerank,ligand-gated ion channel activity (GO:0015276),-0.38140732098977875,-1.198670432056238,0.19745222929936307,0.7879714831196978,1.0,7/30,17.03%,GABRB1;GRIK1;GRIN2B;GRIN3A;GRIK4;GRIK2;ANXA6
prerank,anion transmembrane transporter activity (GO:0008509),0.6228242060333278,1.1975970022291313,0.27203647416413373,0.9448462556518712,1.0,4/12,15.52%,ABCC5;SLC26A11;SLCO2B1;ABCG2
prerank,cholesterol transfer activity (GO:0120020),0.574090160236903,1.1971720678415037,0.27544097693351427,0.9394544976967892,1.0,5/16,16.25%,STARD5;ABCG1;ABCA1;GRAMD1B;OSBPL2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.4311183508860643,-1.195552813849456,0.25210084033613445,0.7804690988844841,1.0,9/20,12.59%,USP9X;OTUD5;USP47;COPS2;UFSP2;SENP2;SENP3;COPS5;USP50
prerank,endopeptidase regulator activity (GO:0061135),-0.34287616095613527,-1.1953616485442,0.1875,0.7640689607048988,1.0,16/40,35.04%,PSMD14;CST3;RENBP;CAST;VSIR;ABCA2;TFPI;PSMF1;RECK;PSME1;PSME2;APH1A;CST7;PSENEN;NLRC4;PCSK1N
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5284976398899985,-1.1941778021784966,0.2627118644067797,0.7517604025511717,1.0,7/10,25.69%,CASP4;CASP7;CASP8;CASP9;CASP2;CASP1;CASP3
prerank,ligand-gated channel activity (GO:0022834),-0.3814180092137637,-1.1917397296463723,0.2111801242236025,0.7431356680063831,1.0,7/29,17.03%,GABRB1;GRIK1;GRIN2B;GRIN3A;GRIK4;GRIK2;ANXA6
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.5610740727530881,1.1912548902505116,0.25879396984924624,0.9564758673491233,1.0,3/22,4.12%,ELAVL4;ILF3;RBMS3
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.4509453128445412,-1.1908028438715283,0.23430962343096234,0.7307993031645657,1.0,6/17,13.22%,GRIK1;GRIN2B;PTK2B;GRIN3A;GRIK4;GRIK2
prerank,phosphoric diester hydrolase activity (GO:0008081),0.5146393948063492,1.1894638270078737,0.24061032863849766,0.9568951442238961,1.0,10/35,13.93%,SMPDL3A;PLCXD3;TDP2;SMPD3;SMPD1;PLCXD2;PLD4;PLCB4;GPCPD1;APEX2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.5280714560934565,-1.1883373035851543,0.24795640326975477,0.723564285812266,1.0,8/10,35.84%,LAPTM5;IDE;PML;FAN1;DNAJB2;FAAP20;ANKRD13D;ANKRD13B
prerank,glucose transmembrane transporter activity (GO:0005355),0.5869944909079737,1.1868093220114158,0.2782956058588549,0.9612558024922949,1.0,1/17,1.39%,SLC2A3
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.4803577213388968,1.1855757664256297,0.20374220374220375,0.9595164509040753,1.0,17/91,10.70%,WDR45;SVIL;LDLRAP1;SYTL2;SLC9A1;WDR45B;SDCBP;GSDMD;MAPT;MAPKAP1;SNX3;TWF2;MYO1G;KIF16B;SNX20;ANXA2;TULP3
prerank,retinoic acid receptor binding (GO:0042974),-0.42561084905376817,-1.184903137834527,0.22040816326530613,0.7193112550434366,1.0,4/17,4.84%,NSD1;CNOT1;TACC1;ASXL1
prerank,hexose transmembrane transporter activity (GO:0015149),0.6122434516537973,1.183389077350986,0.29428571428571426,0.9614618115576151,1.0,1/12,1.39%,SLC2A3
prerank,small GTPase binding (GO:0031267),0.4719303963381089,1.180934990318768,0.16096579476861167,0.9643614422236781,1.0,59/170,17.12%,LRRK2;FGD6;FGD3;UNC13D;FGD1;RAB3GAP1;EHD1;BRAF;RIN3;AP3M1;WASF1;FLNA;IQGAP2;RUSC2;MYO5A;STK19;EXOC5;EVI5;BICDL1;IFT20;USP33;RANBP9;PAK2;MAPKAP1;RAPGEF4;ARHGAP1;EPS8;AKAP13;HPS4;CYRIB;EXOC4;KIF3A;OCRL;RAF1;CDKL5;SORL1;ANKFY1;RABGAP1;MYO9B;ABCA1;BICD1;PEX5L;NDRG1;TRIP11;GGA1;OPTN;ARHGDIB;PDE6D;GOLGA5;IQGAP1;GGA3;GOLGA4;PKN1;PAK1;DNM1L;CYFIP1;HACE1;GCC2;RALBP1
prerank,peptide hormone receptor binding (GO:0051428),0.6113180940359083,1.1799375775651202,0.2848575712143928,0.9616620581315976,1.0,1/11,6.95%,PSMC5
prerank,DNA-binding transcription factor binding (GO:0140297),0.4730301798244138,1.1772772029836807,0.16349047141424272,0.9663050549219429,1.0,50/189,16.27%,ISL1;DMAP1;RELA;SP1;BBS4;ZMYND8;HCFC1;PSMD9;NFATC1;JUN;AR;TLE2;ZBTB7A;HDAC9;EP300;SMAD3;SPEN;HDAC5;PSMC5;CRTC1;TLE1;MEF2A;RBBP8;NBN;NCOR1;PPARG;MTDH;CTBP1;TAL1;TXLNG;TCF12;NOC2L;HMGB1;TCF7L2;MIER3;HIPK2;TP53;BCL2;CREB1;RBPJ;PPARD;LDB2;LDB1;NPM1;PIAS1;NEK6;HDAC2;LMO2;TLE4;MEF2C
prerank,mechanosensitive ion channel activity (GO:0008381),0.6123887720462714,1.173177315766074,0.29429429429429427,0.9769657995810695,1.0,3/12,8.52%,TMC7;TMEM63B;PIEZO2
prerank,5'-3' exonuclease activity (GO:0008409),0.5876917230364204,1.1723464662836944,0.29305555555555557,0.9737412352440814,1.0,5/14,11.07%,DCLRE1A;XRN1;MRE11;XRN2;CPSF3
prerank,tau-protein kinase activity (GO:0050321),-0.4092819629529967,-1.1721696977387153,0.264,0.7418458963842429,1.0,9/20,16.71%,SIK3;DYRK1A;GSK3B;TAOK2;PRKAA1;MARK1;MARK4;PHKG2;MARK3
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5396334039948147,1.1691314391241747,0.29411764705882354,0.9809041852684713,1.0,4/20,13.00%,MOGAT3;LCLAT1;AGPAT4;AGPAT5
prerank,low-density lipoprotein particle binding (GO:0030169),0.5689025231720797,1.168750174895313,0.28854314002828857,0.975739361935753,1.0,4/16,12.31%,CD36;THBS1;COLEC12;SORL1
prerank,ubiquitin binding (GO:0043130),0.47132675185211453,1.1681961235456622,0.2470960929250264,0.9715130647320274,1.0,16/73,10.09%,TSG101;UCHL3;FBXW7;UBXN1;RNF31;ILRUN;SMAD3;SQSTM1;UBXN7;BUB3;USP33;NEDD4;FAF1;USP5;ASCC2;PLAA
prerank,general transcription initiation factor binding (GO:0140296),0.5362510079597269,1.1661218528297197,0.2944038929440389,0.9735583158167612,1.0,7/25,12.00%,THAP7;RELA;AR;ESR1;PSMC5;GTF2B;YEATS2
prerank,GTPase binding (GO:0051020),0.4626077685431767,1.16010230528352,0.16950852557673018,0.9913422060966295,1.0,67/195,17.12%,LRRK2;FGD6;FGD3;UNC13D;FGD1;RAB3GAP1;EHD1;BRAF;RIN3;AP3M1;WASF1;FLNA;IQGAP2;RUSC2;MYO5A;FNBP1L;STK19;AMBRA1;EXOC5;EVI5;BICDL1;IFT20;HSP90AA1;USP33;RANBP9;PAK2;MAPKAP1;SPTBN1;RAPGEF4;ARHGAP1;ENO1;EPS8;AKAP13;HPS4;BNIP3;CYRIB;EXOC4;KIF3A;OCRL;RAF1;CDKL5;SORL1;ANKFY1;RABGAP1;MYO9B;ABCA1;BICD1;PEX5L;NDRG1;TRIP11;GGA1;OPTN;GNB1;ARHGDIB;BECN1;PDE6D;GOLGA5;IQGAP1;GGA3;GOLGA4;PKN1;PAK1;DNM1L;CYFIP1;HACE1;GCC2;RALBP1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.5383485426664141,1.1596710452452565,0.29234629861982436,0.9865503232915286,1.0,2/24,1.44%,AK4;AK3
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.5780361276773299,1.1562175386323243,0.3115727002967359,0.9945569813612358,1.0,3/14,5.56%,NUBPL;NDUFS1;NFU1
prerank,kinesin binding (GO:0019894),-0.3641494088271932,-1.1529281938627516,0.20725388601036268,0.7843803679997143,1.0,18/27,37.97%,SPAG9;MAPK8IP3;SNCA;AP1AR;IFT88;AP1G1;ARHGEF10;TOR1B;TTBK2;NEFH;KLC2;KIFAP3;TOR1A;CROCC;MAPK8IP1;ATCAY;PLEKHM2;RAB29
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.41493120113310433,-1.1526983865738958,0.26991150442477874,0.7705112006287573,1.0,10/21,17.83%,PDE4D;PDE10A;PDE8A;PDE4B;PDE8B;PDE1B;PDE11A;PDE1A;PDE4A;PDE3A
prerank,cell adhesion mediator activity (GO:0098631),-0.39730760106500174,-1.1520042898889542,0.28502415458937197,0.7584921518722152,1.0,9/24,17.90%,CNTN6;DSCAML1;NTNG1;JAM3;LRRC4C;SIRPA;CNTN2;EMB;BSG
prerank,death domain binding (GO:0070513),-0.4987376313875073,-1.151242641082917,0.3183183183183183,0.7471071335490206,1.0,7/11,24.70%,BCL2L1;MCL1;RIPK1;RACK1;IRGM;BAX;DAP
prerank,N-acyltransferase activity (GO:0016410),0.5060101139486322,1.1510788260640061,0.27455621301775146,1.0,1.0,8/32,13.35%,SIRT7;CERS6;EP300;CERS4;NMT1;NMT2;ESCO1;CERS5
prerank,leak channel activity (GO:0022840),0.5546801354029957,1.1500589818121607,0.29521276595744683,1.0,1.0,4/18,12.84%,TMEM175;KCNK2;KCNK13;KCNK10
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.5105965542369827,1.1495292888566,0.29594272076372313,1.0,1.0,14/34,16.37%,UBE2Z;UFC1;AKTIP;UBE2A;UBE2J2;BIRC6;UBE2Q2;UBE2I;UBE2W;UBE2F;UBE2H;UBE2D3;UBE2G1;UBE2E3
prerank,active ion transmembrane transporter activity (GO:0022853),0.5028625320185287,1.1489924878302367,0.28771929824561404,0.9983353561283164,1.0,4/37,3.36%,SLCO4C1;UQCRH;UQCRC1;SLCO1B1
prerank,histone deacetylase binding (GO:0042826),0.46668976447357846,1.1486586427813863,0.28868120456905505,0.9933432963455711,1.0,27/88,16.76%,THAP7;RELA;SP1;TFAP4;YWHAE;HDAC9;HDAC5;HSP90AA1;MEF2A;MAPK8;PKN2;NACC1;NCOR1;PHF6;TAL1;KAT2B;PRDM1;NCOR2;MIER3;TP53;LCOR;AKAP8L;HDAC2;PKN1;MEF2C;YWHAB;TOP2B
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.5055774062700851,-1.147724373323562,0.3011049723756906,0.7435288953512297,1.0,4/10,9.28%,PIK3CG;PIK3CA;PIK3C3;PIK3C2B
prerank,glutathione transferase activity (GO:0004364),0.5286911105355074,1.14621308891359,0.3147208121827411,0.9967583296320642,1.0,1/23,0.99%,MGST3
prerank,RNA polymerase core enzyme binding (GO:0043175),0.4962660793602333,1.1461556933399988,0.30787878787878786,0.9907077795589858,1.0,11/33,14.60%,URI1;RPRD1B;CTR9;SPTY2D1;RPRD2;RPRD1A;AGO2;NCOA3;GTF2B;UVSSA;RECQL5
prerank,protein serine/threonine kinase activity (GO:0004674),0.4538901053413193,1.1459290477262767,0.13513513513513514,0.9853710108030956,1.0,75/335,13.98%,SGK3;SGK2;PLK1;CAMKK1;LRRK2;PRKCZ;RPS6KB2;RIOK3;IRAK4;MINK1;EIF2AK2;DYRK2;NEK3;CAMK1D;BRAF;BMPR1A;PIK3R4;MAP3K11;CDK7;PRKCB;PRKCA;PRKACA;CDK2;PRKDC;SQSTM1;STK19;MAPK1;MAP3K20;CDK6;ACVR1;STK11;IKBKB;CDC42BPB;MAPK8;PKN2;PAK2;RPS6KA5;CDK9;RPS6KC1;CAMK2D;MAP3K9;CSNK1G1;MAST2;IRAK2;GRK5;DAPK1;CHEK2;BRD2;KALRN;NEK7;CDK5;MAST3;TAOK1;TGFBR2;ULK2;BMP2K;MTOR;RAF1;ERN1;CDKL5;MAPK14;SRPK2;HIPK2;MAPKAPK2;TGFBR1;NRBP1;MAST4;ACVR1B;CDK8;SYK;CAMK2G;CLK1;PRKD2;CSNK1A1;MAP3K8
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.33169056974558647,-1.1451318062458167,0.20161290322580644,0.7381867426254499,1.0,11/42,19.67%,CCNT2;CCNT1;CCNY;CCNH;CCNL1;CCNC;CCNYL1;CDKN1B;CCNG2;CCNK;CNPPD1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.6087316758810651,1.1445706003777674,0.3302034428794992,0.9846954344687278,1.0,5/11,15.16%,RAD50;TERF2;HNRNPA2B1;TERF1;CTC1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.5436778413606991,1.144165249224095,0.30434782608695654,0.9801706644000355,1.0,6/20,11.66%,AK4;AK3;MPP1;DLG1;AK2;MAGI3
prerank,alpha-actinin binding (GO:0051393),0.5297697177243496,1.1431506188123868,0.3184634448574969,0.9780159193003859,1.0,8/24,16.88%,CACNA1D;PDLIM2;PPARG;PALLD;PKD2;CACNA1C;DAG1;KCNA5
prerank,transition metal ion binding (GO:0046914),0.45513526097496687,1.1426967957214036,0.119,0.9737422612213055,1.0,75/397,13.41%,ACE2;ANG;SMPDL3A;FNTB;NQO2;BLM;PDXK;KDM1B;UBA5;KPNB1;COX17;TARS1;TDP2;DYRK2;ZMYND8;SMPD1;ENPP5;RASSF1;EEA1;KDM5A;GALNT1;WRN;ATP7A;SMAD3;RBAK;NFU1;TRAF7;ACER3;CHORDC1;DPP3;IL1A;KDM3A;MNAT1;USP33;GALNT3;LACC1;KDM5B;LNPEP;WDFY1;PTPN1;ALOX5;RCHY1;LIMS1;TAB3;EXD2;PPARG;B4GALT1;RNF11;LOXL3;MT1F;MT1M;MT1H;MT1X;MT1A;MT1E;MT1G;MT1B;GTF2B;SEC24B;CZIB;GDA;SEC24D;PTGR2;PRNP;ZMYND11;ABL1;KDM4C;ESCO1;XPNPEP1;ERAP1;CYLD;TP53;DUSP12;RXRA;S100B
prerank,lipoprotein particle binding (GO:0071813),0.5383211850327184,1.1423404315507288,0.3220108695652174,0.9691389338070481,1.0,5/20,12.31%,CD36;THBS1;MAPT;COLEC12;SORL1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.5432057191913018,1.1421701127748851,0.3312020460358056,0.9640224208606473,1.0,9/21,15.39%,WASF1;AKAP9;AKAP1;PRKACA;ARFGEF1;EZR;WASF2;PRRC1;AKAP8L
prerank,protein phosphatase regulator activity (GO:0019888),0.479954239536019,1.1392780505935693,0.30558598028477546,0.9696063784777885,1.0,18/53,15.88%,EIF2AK2;IGBP1;CABIN1;PPP2R2A;BOD1L1;SET;PPP4R1;RCAN2;RCAN3;PPP1R16B;PPP2R3A;SHOC2;PPP2R5C;CALM1;ENSA;PPME1;PPP1R9B;PPP2R2D
prerank,transcription cis-regulatory region binding (GO:0000976),0.45466022514297183,1.1351107102657747,0.13,0.9796871690782074,1.0,82/406,16.97%,ISL1;BRCA1;RORA;ZBTB8A;RELA;IRF1;SP1;SMAD6;SUV39H1;ZFP90;CASZ1;TFAP4;SOX13;ZBTB5;BBX;RUNX1;MAX;JUN;AR;KDM5A;ELK3;TRPS1;SMAD3;ARID5B;TEAD1;RBAK;HDAC5;NR3C1;JUND;MEF2A;TFCP2;CUX1;DRGX;AGO2;TAF4;NCOR1;PPARG;SETX;TAL1;ENO1;CDC5L;DEAF1;ACTN4;ZBTB46;TCF12;ZNF568;FOXN3;ARID4B;XRN2;NR5A1;PSPC1;CREB3L2;NR2C2;SOX11;HMGB1;ZFP69;TCF7L2;ATF6;SOX6;BRD7;TP53;RXRA;NFX1;RREB1;RFX3;TBL1XR1;CTCF;ARNT;SNAPC3;NPAS3;SMAD4;NPM1;SMARCA2;CIC;FOXK1;HNRNPL;MEF2C;RB1;TFDP2;STAT6;TBL1X;NFYA
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.5118574299102612,1.1330250518334888,0.3215590742996346,0.9821764699408719,1.0,4/27,8.80%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.49186165446436414,-1.1326536143600918,0.3113207547169811,0.7589293955419922,1.0,8/12,29.89%,GABRB1;GABRA2;GABRA3;GABRA5;GABRA4;GABRB3;GABRG1;GABRA1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.5558406750654264,1.1324170511575675,0.3412587412587413,0.9788667474613924,1.0,3/15,10.11%,SOCS4;SOCS7;SOCS5
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.4956654182060411,1.1310532155260689,0.3099273607748184,0.978429204341977,1.0,11/33,14.60%,URI1;RPRD1B;CTR9;AR;RPRD2;RPRD1A;AGO2;NCOA3;GTF2B;UVSSA;RECQL5
prerank,chemoattractant activity (GO:0042056),0.5150613276877433,1.1298114445632088,0.3361963190184049,0.9774366854088986,1.0,3/26,5.17%,CX3CL1;VEGFC;PDGFB
prerank,ferrous iron binding (GO:0008198),0.5281449987352859,1.129704850899519,0.33376455368693403,0.9722283221538032,1.0,9/21,17.72%,FECH;FTO;EGLN3;EGLN2;EGLN1;TET2;ALKBH1;FTH1;FTL
prerank,MAP kinase kinase activity (GO:0004708),0.5660623083899414,1.1284497768889605,0.3650568181818182,0.971553747445882,1.0,8/15,16.92%,LRRK2;MAP2K6;MAP3K9;MAP2K5;MAPK14;MAP2K2;MAP2K1;MAP2K4
prerank,single-stranded RNA binding (GO:0003727),0.48545652434849823,1.1275424769032742,0.3235294117647059,0.9693308669510894,1.0,9/43,12.21%,POLR2D;ILF3;DDX60;TLR7;EIF4B;AGO2;U2AF2;RBM7;ZFR
prerank,histone deacetylase activity (GO:0004407),0.5418438108260047,1.1260363847003916,0.3410553410553411,0.9694845948570843,1.0,4/19,6.16%,SIRT7;HDAC9;HDAC11;HDAC5
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.4490048202054132,1.1247400858602192,0.098,0.9688645741361628,1.0,75/597,13.22%,POU2F3;ISL1;GLIS1;BRCA1;ZIC4;SP8;RELA;IRF1;SP1;SMAD6;SUV39H1;TFAP4;SOX13;TGIF1;CLOCK;BBX;RUNX1;MAX;NFATC1;JUN;AR;ZBTB7A;ORC4;KDM5A;ELK3;IRF3;BCL6;POLA1;SMAD3;ARID5B;TEAD1;ESR1;HDAC5;NR3C1;JUND;PRDM4;TFCP2;CUX1;DRGX;KDM5B;LIN28B;MAFG;NCOR1;ORC2;PPARG;NR6A1;MBNL2;TAL1;HMBOX1;HIVEP1;HOXC4;TCF12;ZNF568;ARID4B;ZSCAN29;NR5A1;PSPC1;CREB3L2;NR2C2;SOX11;PRDM1;GMEB2;ABL1;HMGB1;BACH2;TCF7L2;ATF6;SOX6;MLH3;BRD7;TP53;MAF;NR1D2;KLF13;RXRA
prerank,microtubule binding (GO:0008017),0.44897367670080773,1.1237956791441708,0.246,0.9668928028832986,1.0,56/222,16.87%,TOGARAM2;PLK1;MID1;VASH2;LRRK2;SBDS;EML3;ALMS1;NDEL1;MDM1;MAP1A;CCDC61;MAPRE1;KIF13A;MTUS1;REEP2;TUBGCP6;KIF20B;CAMSAP3;POLB;EZR;DCTN1;CCDC66;RGS14;MAPT;TUBGCP2;MAST2;KIF26B;KIF16B;APC;CDK5;FBXW11;PRNP;KIF3A;EML4;EML1;STARD9;EML2;TERF1;NDRG1;MAP6;RMDN1;KIF21A;CLASP1;PEX14;MACF1;MAP4K4;KIF1B;CLIP1;VAPB;LRPPRC;CEP290;DNM1L;CEP295;KIF2A;HOOK2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.5610305135770257,1.1227253802812691,0.35988620199146515,0.9654427484245275,1.0,2/14,4.09%,MTMR11;MTMR1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.45997085875033034,1.1222964309952186,0.29830148619957536,0.9618075091741721,1.0,12/72,10.70%,SVIL;LDLRAP1;SYTL2;SLC9A1;SDCBP;GSDMD;MAPKAP1;TWF2;MYO1G;SNX20;ANXA2;TULP3
prerank,nucleoside-diphosphatase activity (GO:0017110),0.580110191376588,1.1218789562699272,0.3684210526315789,0.9580709845145885,1.0,3/12,10.09%,NUDT5;ENTPD1;CANT1
prerank,receptor tyrosine kinase binding (GO:0030971),0.46957143177041966,1.1203036208411044,0.32397408207343414,0.9584594794126733,1.0,15/56,15.70%,DUSP3;GAS6;IRS1;SQSTM1;PITPNM1;NRG3;PTPN1;NCK1;SOCS5;CBL;FRS2;SH2B3;TP53;SH2B2;PIK3R1
prerank,E-box binding (GO:0070888),0.4960088071926617,1.120148995552186,0.3558926487747958,0.9538952202765744,1.0,5/34,9.73%,TFAP4;CLOCK;MAX;PPARG;TAL1
prerank,alkali metal ion binding (GO:0031420),0.5587742079196854,1.1201182723031455,0.33578792341678937,0.9488565969040953,1.0,2/13,3.78%,PDXK;ACAT1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.44989637367194574,1.1200581489648254,0.23146292585170342,0.9439625110845593,1.0,40/188,16.27%,BRCA1;RELA;IRF1;SP1;SMAD6;SUV39H1;TFAP4;SOX13;RUNX1;JUN;AR;KDM5A;SMAD3;ARID5B;HDAC5;JUND;NCOR1;PPARG;TAL1;TCF12;ZNF568;ARID4B;PSPC1;CREB3L2;SOX11;HMGB1;TCF7L2;ATF6;SOX6;BRD7;TP53;RXRA;RFX3;TBL1XR1;CTCF;SMAD4;SMARCA2;FOXK1;HNRNPL;MEF2C
prerank,mitogen-activated protein kinase binding (GO:0051019),0.4992268602579771,1.116387609568685,0.3459196102314251,0.9522637539346203,1.0,8/29,12.92%,CDK5RAP3;NFATC1;PTPRJ;DUSP16;DUSP10;ABL1;MAPK14;MAPKAPK2
prerank,pseudouridine synthase activity (GO:0009982),-0.45146617421347246,-1.1159813252571884,0.34105960264900664,0.7926201286676451,1.0,7/13,35.40%,PUS7;TRUB2;TRUB1;DKC1;PUS1;RPUSD4;PUS3
prerank,organic anion transmembrane transporter activity (GO:0008514),0.45404456613881466,1.1158832004122046,0.2907801418439716,0.9490653522479789,1.0,22/134,16.20%,SLC4A3;SLC25A24;SLC66A1;SLCO4C1;SLC35D1;CD36;SFXN5;SLCO1B1;SLC7A2;SLC38A2;ABCC5;SLC7A8;SLC25A2;SLC25A32;SLC38A9;SLC27A1;SLCO2B1;SLC15A4;SLC38A6;ABCG2;SLC25A1;SLC35A3
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.37768457869397176,-1.1152499866423533,0.27876106194690264,0.7569447846535952,1.0,8/22,38.02%,CHRM3;HTR4;HTR1F;HTR7;HTR2B;HRH2;HRH1;HTR2A
prerank,serotonin receptor activity (GO:0099589),-0.37768457869397176,-1.1152499866423533,0.27876106194690264,0.7569447846535952,1.0,8/22,38.02%,CHRM3;HTR4;HTR1F;HTR7;HTR2B;HRH2;HRH1;HTR2A
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.37768457869397176,-1.1152499866423533,0.27876106194690264,0.7569447846535952,1.0,8/22,38.02%,CHRM3;HTR4;HTR1F;HTR7;HTR2B;HRH2;HRH1;HTR2A
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.5439505937188986,1.1150376701414837,0.35075653370013754,0.9471248162237491,1.0,2/16,4.09%,MTMR11;MTMR1
prerank,zinc ion binding (GO:0008270),0.44432498918991137,1.113911572356868,0.211,0.9460164255149409,1.0,59/293,14.33%,ACE2;SMPDL3A;FNTB;NQO2;BLM;PDXK;KDM1B;UBA5;KPNB1;TARS1;ZMYND8;SMPD1;ENPP5;RASSF1;EEA1;KDM5A;SMAD3;RBAK;TRAF7;ACER3;CHORDC1;DPP3;MNAT1;USP33;KDM5B;LNPEP;WDFY1;PTPN1;RCHY1;LIMS1;TAB3;PPARG;RNF11;MT1F;MT1M;MT1H;MT1X;MT1A;MT1E;MT1G;MT1B;GTF2B;SEC24B;CZIB;GDA;SEC24D;PTGR2;ZMYND11;KDM4C;ESCO1;ERAP1;CYLD;TP53;DUSP12;RXRA;S100B;ZDHHC20;TET2;GRIN2A
prerank,amino acid transmembrane transporter activity (GO:0015171),0.4724133415398703,1.1125234746867132,0.33953997809419495,0.9461411963325529,1.0,7/47,12.25%,SLC66A1;SLC7A2;SLC38A2;SLC7A11;SLC7A7;SLC7A8;SLC38A9
prerank,hydro-lyase activity (GO:0016836),0.47900840339016293,1.1122549117627611,0.3470319634703196,0.9423152899649914,1.0,7/41,14.15%,CBS;HACD1;PCBD2;ECHS1;ENO1;HSD17B4;HACD4
prerank,calcium channel inhibitor activity (GO:0019855),-0.4553939259246596,-1.1096524553077884,0.32075471698113206,0.760380516042304,1.0,4/11,21.06%,CALM2;ITPR1;FKBP1A;MCUB
prerank,vitamin D receptor binding (GO:0042809),-0.45768709119591355,-1.1082024668094783,0.3298245614035088,0.7526759683575092,1.0,10/14,33.89%,MED13;MED17;SNW1;MED12;THRAP3;MED4;MED30;TAF11;TAF7;MED24
prerank,DNA binding (GO:0003677),0.4412169438600289,1.1060797062441523,0.134,0.960022804473545,1.0,120/694,15.41%,POU2F3;POLR2D;ANG;POLG;BRCA1;C1D;RORA;MPG;BANF1;ZIC4;BLM;TSG101;RELA;IRF1;SMARCA4;SP1;RAD50;ILF3;PSIP1;HLX;NUPR1;TIGD2;TFAP4;TDP2;SOX13;CLOCK;DDX60;ZEB2;SSBP1;MAX;XRCC4;TARDBP;POLR2A;RAD18;JUN;ZBTB7A;KDM5A;IRF3;BCL6;POLA1;WRN;DCLRE1A;EP300;SMAD3;ARID5B;TEAD1;PRKDC;LIN9;RC3H2;SPTY2D1;RBM5;IKZF1;POLG2;BRCA2;BCLAF3;XRN1;MEF2A;RBBP8;MRE11;HP1BP3;MAPT;MECP2;ERCC4;TFCP2;CUX1;RTF2;NBN;KDM5B;CDK9;ZDHHC1;TAF4;PPARG;NR6A1;GLYR1;SETX;HMBOX1;RNF11;CDC5L;PARP4;RAD51B;CHD8;NR5A1;RBM6;ZNF711;NR2C2;ZMYND11;TSHZ2;HIVEP2;DNMT3A;ABL1;HMGB1;AIFM1;MAU2;TCF7L2;ZMYM6;ATF6;SOX6;RNF138;TP53;BCL2;RXRA;FUBP3;TERF1;SP4;COLEC11;CARF;RFX3;RBPJ;PPARD;RBMS1;RAD23B;CTCF;ARNT;SNAPC3;CTC1;SMAD4;ZBTB18;TRIM26;SMARCA2;CRLF3
prerank,endodeoxyribonuclease activity (GO:0004520),0.5307377794933752,1.1052505697752089,0.3514246947082768,0.9579789758023407,1.0,4/20,7.85%,RAD50;RBBP8;MRE11;ERCC4
prerank,transmitter-gated ion channel activity (GO:0022824),-0.35304764478015166,-1.1009242783182984,0.3333333333333333,0.7599421880981805,1.0,14/29,29.89%,GABRB1;GRIK1;GABRA2;GABRA3;GRIK4;GRIK2;GABRA5;GLRA2;GABRA4;GABRB3;GABRG1;GRIK5;GRIK3;GABRA1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.49877192120304475,1.1008377046866578,0.35786802030456855,0.9683875187758182,1.0,7/26,15.82%,CABIN1;PPP1R8;BOD1L1;SET;ENSA;PPME1;PPP1R9B
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.38433805155991047,-1.099648138906968,0.3253588516746411,0.7516339374170696,1.0,8/23,11.08%,PDE4D;PDE10A;PDE8A;PDE4B;PDE8B;PDE1B;PDE11A;PDE1A
prerank,adrenergic receptor binding (GO:0031690),-0.41864778574810063,-1.0989846631216043,0.28321678321678323,0.7424968752950214,1.0,6/16,14.68%,PDE4D;GRK2;ARRDC3;SAV1;APLP1;DLG4
prerank,double-stranded DNA binding (GO:0003690),0.4378962269133286,1.0985748656211352,0.17,0.9714516560955836,1.0,63/531,13.42%,POU2F3;ISL1;GLIS1;ZIC4;SP8;SP1;RAD50;PSIP1;TFAP4;TGIF1;CLOCK;DDX60;BBX;MAX;TARDBP;NFATC1;JUN;ZBTB7A;ELK3;IRF3;BCL6;TERF2;TEAD1;PRKDC;ESR1;NR3C1;JUND;POLG2;PRDM4;RBBP8;MRE11;MAPT;MECP2;TFCP2;CUX1;DRGX;KDM5B;LIN28B;MAFG;PPARG;NR6A1;MBNL2;HMBOX1;HIVEP1;HOXC4;TCF12;RAD51B;ZSCAN29;NR5A1;NR2C2;ZMYND11;PRDM1;GMEB2;ABL1;HMGB1;BACH2;MAU2;ATF6;MAF;NR1D2;KLF13;RXRA;TERF1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.5023856866926295,1.097801461572155,0.3650190114068441,0.9692504579391573,1.0,7/23,15.24%,WDR45;WDR45B;MAPKAP1;SNX3;KIF16B;SNX14;HIP1
prerank,RNA binding (GO:0003723),0.4357468901036734,1.0969471265392978,0.068,0.967515879042517,1.0,271/1321,13.88%,TUBB4B;POLR2D;ANG;WDR6;COL14A1;SNRPD2;SNRPD1;BRCA1;CAVIN1;C1D;HABP4;RPL18;NSUN6;ATP5F1A;BOP1;UTP3;DENR;PELP1;SBDS;SECISBP2L;EIF4A3;ELAVL2;MRPS31;BICC1;MRPS30;SART1;RPS23;CCDC9;TBCA;ZC3H12D;EIF2AK2;HNRNPUL2;EIF3C;HNRNPM;MRPL37;EIF1AX;RPL41;ILF3;RPL31;PSIP1;LSM7;ZNF346;KPNB1;ATXN2L;DDX42;PDAP1;UTP18;EMG1;EIF4ENIF1;SMG6;NOA1;FAM98A;PPHLN1;PEF1;NMD3;RPS17;GRB2;FARSA;EIF3E;DDX49;TCP1;TFB2M;SYNCRIP;TUT4;PRPF38A;ALDH6A1;DDX60;CSTF3;DHX38;CSDE1;TLR7;SLIRP;DHX57;SAP18;SSBP1;ANKHD1;UBFD1;RPL4;TARDBP;MAPRE1;SARNP;EIF4B;CSTF2;MSN;POLR2A;FAM120C;RBMS3;MBNL1;RFTN1;SIDT1;JUN;SCG3;ZRANB2;MRPS21;UTP20;FRG1;FLNA;RNPS1;PYM1;YWHAE;ALDOA;RBM3;MSI1;PRPF3;RBM15;SPEN;AKAP1;CTNNA1;MYO5A;PRPF40A;RPLP0;PRKDC;DCP1B;ETF1;NOC3L;U2AF1;PUM2;GDI2;TNRC6B;R3HDM1;CS;NOL7;PTCD1;MAP3K20;RPS15A;RPL38;RC3H2;RBM5;ISG20L2;PRPF40B;METTL3;NUDT5;PPP1R8;EXOSC7;G3BP2;PDIA4;SUGP2;ERI3;HSP90AA1;LUC7L;EZR;NCOA5;MEX3C;API5;HNRNPA2B1;XRN1;MRPS35;MRPS28;PTBP3;MRPL1;SUMO2;RRP36;RRP1B;THOC5;HNRNPA3;UCHL5;POP1;HSPA9;MAPT;NUP98;GLRX3;GPKOW;TRNAU1AP;MECP2;LARP4B;TLR3;PABPC4;SRSF5;PKN2;AGO2;SPTBN1;PRPF6;FCF1;AARS1;PTPN1;LIN28B;TWF2;YTHDF1;TRA2A;UBTF;ADD1;ACIN1;SNRNP70;FXR2;PHF6;PUM1;GANAB;SNRPD3;DDX10;MTDH;MBNL2;SETX;RBFOX3;PRRC2C;IPO5;SCAF11;ENO1;FUS;APOBEC1;CDC5L;ZC3H12B;GTF2E2;SREK1;ANXA2;DDX23;ZC3H7A;DHX16;ACTN4;U2AF2;AFF2;ADAR;EIF1;YTHDC2;UBE2I;UTP6;NOC2L;ATXN2;XRN2;ARF1;DIAPH1;PRKRA;DCP1A;CPSF3;SF1;RBM7;RCAN3;RBM6;ZC3H13;PSPC1;QKI;SCAF4;SF3B2;LSM14A;SUCLG1;SNTB2;TMSB4X;HEATR1;TASOR;HMGB1;EIF3A;ZFP36L1;NOP56;SRSF9;ZFR;RPL21;RPS6;SRPRA;SRSF11;NOL8;SRPK2;DHX8;SAMD4A;EIF2S1;MSI2;RBM27;CCT3;NAA15;HNRNPH3;FUBP3;RTN4;PPARGC1B;NFX1;RPGR;DHX32;HNRNPH1;TRIM56;SRRM2;DDX5;MYEF2;FLNB;PCBP3
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.43274267319630366,-1.0965346979077646,0.3161290322580645,0.7383537213163215,1.0,2/14,8.30%,KCNJ2;KCND3
prerank,NADP binding (GO:0050661),-0.34202873803273376,-1.0965136251230325,0.25806451612903225,0.7278207040075877,1.0,11/32,21.77%,DPYD;KCNAB1;PGD;ME3;ME1;CAT;QDPR;HMGCR;CRYZL1;LBR;DUS2
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.41406202816803783,-1.0962778969245048,0.336996336996337,0.7082695100966456,1.0,5/16,9.39%,PTPRC;PTPRK;PTPRZ1;PTPN6;PTPRG
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.41406202816803783,-1.0962778969245048,0.336996336996337,0.7082695100966456,1.0,5/16,9.39%,PTPRC;PTPRK;PTPRZ1;PTPN6;PTPRG
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4694565350253359,1.0959003425657128,0.34933035714285715,0.9663799888956484,1.0,11/44,9.33%,EHMT1;SUV39H1;SETD1A;EHMT2;KMT2E;SETD2;KMT5B;SETD3;ASH1L;EZH2;KMT5C
prerank,steroid hydroxylase activity (GO:0008395),-0.4001836387177903,-1.0958123028766853,0.30677290836653387,0.6993526405579493,1.0,9/16,54.39%,CYP27A1;CYP7B1;CH25H;CYP2R1;CYP39A1;CYP2A6;CYP2U1;CYP1A1;CYP46A1
prerank,sterol binding (GO:0032934),0.46356581825632176,1.0951251002279514,0.3555070883315158,0.9642618828388952,1.0,15/56,16.25%,RORA;INSIG1;OSBP;INSIG2;SOAT1;SIDT1;STARD5;ABCG1;ABCA1;OSBPL1A;SCARB2;GRAMD1B;ERLIN1;CD81;OSBPL2
prerank,voltage-gated chloride channel activity (GO:0005247),-0.4767464999087119,-1.0938059383935899,0.37359550561797755,0.6948327183440556,1.0,4/10,14.89%,ANO6;CLCN4;CLCN6;CLCN3
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.46611434074572394,1.0932659287727042,0.3756967670011148,0.9658193465849159,1.0,11/46,17.14%,MGAT3;PIGP;B3GALNT1;B3GNT2;MGAT4B;EXT1;PIGQ;MGAT4A;LARGE1;B3GALT1;EXT2
prerank,acylglycerol lipase activity (GO:0047372),0.5680078836812416,1.0916503671720492,0.39477726574500765,0.9670383716349177,1.0,3/11,10.19%,LIPE;ABHD6;ABHD16A
prerank,water transmembrane transporter activity (GO:0005372),-0.4673304685972796,-1.0911344708954367,0.3567073170731707,0.6917260394233276,1.0,1/11,9.54%,AQP4
prerank,deubiquitinase activity (GO:0101005),0.4400081348389154,1.0902632369736638,0.3437826541274817,0.9671009115195226,1.0,26/88,15.42%,USP11;UCHL3;USP32;USP24;DESI2;USP19;MINDY3;USP34;USP29;MINDY4;USP33;USP1;UCHL5;USP48;USP20;USP5;USP46;TANK;MINDY2;USP3;CYLD;USP37;ATXN3;USP45;OTUD7A;VCPIP1
prerank,damaged DNA binding (GO:0003684),0.4700330760121282,1.090183041783228,0.3717217787913341,0.9626703797267682,1.0,7/44,8.16%,MPG;RAD18;DCLRE1A;EP300;RBBP8;ERCC4;NBN
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.43193115745326827,1.088512057856644,0.29429429429429427,0.9638724584194474,1.0,52/269,13.32%,CBS;BRCA1;MID1;WFS1;VCL;CDK5RAP3;PARP9;TSG101;RELA;FBXW7;SMAD6;GLMN;UBXN1;UQCRC1;RNF31;TCP1;PRKAR2A;POLR2A;RAD18;JUN;YWHAE;SMAD3;PRKACA;SQSTM1;AMBRA1;ARRB2;UBE2A;UBE2J2;UBXN7;CKB;HSP90AA1;RNF34;SUMO3;SUMO2;HSPA9;SLF1;SYT11;CHEK2;FAF1;APC;HGS;TANK;TRAF2;DERL1;CUL4A;CAMLG;UBE2W;TP53;RNF20;BCL2;ACVR1B;RTN4
prerank,O-methyltransferase activity (GO:0008171),-0.4836775144801617,-1.087982505278219,0.3816155988857939,0.6898122110807808,1.0,7/10,43.72%,COQ3;CMTR1;MEPCE;FTSJ3;CMTR2;BCDIN3D;ASMT
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.5605408825374562,1.0864866706520224,0.40147058823529413,0.9664882237314548,1.0,5/12,13.30%,CDK7;MAPK1;CDK6;CDK9;CDK8
prerank,retinoid X receptor binding (GO:0046965),-0.4554742658570877,-1.083774868129871,0.35542168674698793,0.6910079262447543,1.0,2/11,2.44%,NSD1;TACC1
prerank,kinase activator activity (GO:0019209),0.48367656232864015,1.083614680820592,0.37129300118623965,0.9719013309582002,1.0,2/30,6.79%,RGCC;STK11
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.4335380423569913,1.0828363005213535,0.31,0.9698333925684585,1.0,24/254,11.42%,POU2F3;RELA;IRF1;SP1;CASZ1;TFAP4;CLOCK;RUNX1;NFATC1;JUN;AR;ELK3;IRF3;SMAD3;ESR1;NR3C1;PRDM4;MEF2A;TFCP2;CDC5L;HOXC4;TCF12;NR2C2;SOX11
prerank,histone acetyltransferase activity (GO:0004402),0.4840793409052123,1.08276201440323,0.37349397590361444,0.9654673985173132,1.0,9/30,13.26%,SRCAP;CLOCK;EP300;BRCA2;TADA2A;NCOA3;EPC2;KAT2B;EPC1
prerank,thyroid hormone receptor binding (GO:0046966),0.48923598505668253,1.0818247013821567,0.3722627737226277,0.9641277114002619,1.0,9/28,15.07%,ZNHIT3;BRD8;HMGN3;JMJD1C;NCOR1;NCOA3;GTF2B;GTF2H1;TRIP12
prerank,cAMP binding (GO:0030552),-0.46636810907797455,-1.0817670451617993,0.39943342776203966,0.6868535094485355,1.0,3/11,4.82%,PDE4D;PDE10A;PDE4B
prerank,magnesium ion binding (GO:0000287),0.4323636555029823,1.0802331002776828,0.34826883910386963,0.964838897000401,1.0,22/135,12.74%,PLK1;LRRK2;PDXK;EYA2;TDP2;DYRK2;WRN;NT5C3A;MAP3K20;NUDT5;STK11;HPRT1;CDC42BPB;MAST2;PI4K2A;EXD2;SRR;TKT;IDH2;ABL1;ERN1;SRPK2
prerank,RNA polymerase II complex binding (GO:0000993),0.4733701390590311,1.0800604055833878,0.373639661426844,0.9608427095934059,1.0,10/32,14.60%,URI1;RPRD1B;CTR9;RPRD2;RPRD1A;AGO2;NCOA3;GTF2B;UVSSA;RECQL5
prerank,endopeptidase activity (GO:0004175),0.4261411978089011,1.0785908662137427,0.306,0.9615533570118567,1.0,33/257,13.81%,ACE2;TYSND1;ADAMTS12;NLN;CD5L;USP11;ADAMTS2;CTSC;USP24;USP34;PSMB8;ADAMTSL3;USP29;NRDC;USP33;USP1;USP48;TPP2;USP20;ADAMTS10;USP5;USP46;PROC;F3;CTSZ;FURIN;PARL;ADAM10;PSMA2;NAPSA;PCSK6;USP37;HTRA2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5758344955611736,1.0760368938072196,0.41809672386895474,0.9613960006166311,1.0,2/10,8.29%,DUSP16;DUSP10
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5758344955611736,1.0760368938072196,0.41809672386895474,0.9613960006166311,1.0,2/10,8.29%,DUSP16;DUSP10
prerank,omega peptidase activity (GO:0008242),0.4305104519983541,1.070765142140075,0.37293388429752067,0.9748503109233981,1.0,25/89,15.42%,USP11;UCHL3;USP32;USP24;DESI2;USP19;MINDY3;USP34;USP29;USP33;ASRGL1;USP1;UCHL5;USP48;USP20;USP5;USP46;TANK;USP3;CYLD;USP37;ATXN3;USP45;OTUD7A;VCPIP1
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.2979130009393631,-1.0699770609805703,0.32231404958677684,0.7056471069921598,1.0,12/42,17.90%,CNTN6;RAB10;STXBP6;DSCAML1;NTNG1;JAM3;LRRC4C;BAIAP2;SIRPA;CNTN2;EMB;BSG
prerank,thiol-dependent deubiquitinase (GO:0004843),0.43299565171238585,1.0699248117153113,0.372507869884575,0.9730823451059922,1.0,24/83,15.42%,USP11;UCHL3;USP32;USP24;DESI2;USP19;MINDY3;USP34;USP29;USP33;USP1;UCHL5;USP48;USP20;USP5;USP46;TANK;USP3;CYLD;USP37;ATXN3;USP45;OTUD7A;VCPIP1
prerank,microtubule minus-end binding (GO:0051011),0.5387889680826649,1.0695161289118065,0.3746312684365782,0.970083472073154,1.0,5/13,16.42%,TUBGCP6;CAMSAP3;TUBGCP2;MACF1;CEP290
prerank,carbohydrate kinase activity (GO:0019200),-0.4535101041406321,-1.0685608826535413,0.39118457300275483,0.7000582982400791,1.0,9/11,45.02%,NAGK;HK3;HK1;GNE;FGGY;POMK;XYLB;GALK1;KHK
prerank,serine-type endopeptidase activity (GO:0004252),0.43487780387579894,1.067595627913759,0.38590956887486855,0.971942286779445,1.0,11/80,17.13%,TYSND1;CD5L;PROC;F3;FURIN;PARL;PCSK6;HTRA2;RHBDD1;KLK2;PCSK5
prerank,protein phosphorylated amino acid binding (GO:0045309),0.45112266747138063,1.0663227446723713,0.3875878220140515,0.9717709896221189,1.0,14/42,16.50%,FBXW7;LDLRAP1;GRB2;IRS1;YWHAE;YES1;NEDD4;PTPN3;ABL1;VAV2;SYK;VAV1;PIK3R1;YWHAB
prerank,protein kinase C activity (GO:0004697),0.533338435380274,1.0656883333299452,0.4053295932678822,0.9694495149497682,1.0,3/14,5.26%,PRKCZ;PRKCB;PRKCA
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.423724159267863,-1.064908540912156,0.39570552147239263,0.7000002201531215,1.0,6/13,42.67%,SREBF2;ECI1;EBP;IDI1;MIF;ECH1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5341536472468947,1.0642306930559056,0.42334739803094235,0.9699189044105937,1.0,1/15,5.58%,CMKLR1
prerank,histone methyltransferase activity (GO:0042054),0.46673661898333896,1.062409729299114,0.40930787589498807,0.971687481885258,1.0,7/32,8.54%,EHMT1;SUV39H1;EHMT2;KMT2E;SETD2;KMT5B;EZH2
prerank,cadherin binding (GO:0045296),0.4183333434425629,1.0615412952474317,0.321,0.9702581103562375,1.0,91/315,17.06%,NUDC;DNAJB1;VCL;BAG3;ATXN2L;CLIC1;EHD4;CHMP5;EIF3E;ITGA6;SNX5;EHD1;HCFC1;UBFD1;MAPRE1;FLNA;YWHAE;TMOD3;CEMIP2;ALDOA;CTNNA1;FNBP1L;CAPZB;PTPRJ;MRTFB;ABI1;PACSIN2;ACVR1;MB21D2;EZR;GIPC1;PI4KA;MRE11;DLG1;EPS8L1;PKN2;PAK2;SPTBN1;PTPN1;PTPRT;NCK1;TWF2;ARHGAP1;ADD1;TXNDC9;APC;PDXDC1;ENO1;CDH11;ANXA2;CD2AP;DBNL;SNX1;CBL;PFKP;NOP56;CDH20;TBC1D10A;SH3GLB1;RTN4;WASF2;PTPRO;DOCK9;LIMA1;CDH18;FLNB;NDRG1;IST1;EPS15;CLINT1;PKP4;PPME1;HNRNPK;MACF1;STK24;CAPZA1;IQGAP1;SERBP1;VAPB;EPN2;TRIM25;YWHAB;RDX;TMPO;SPTAN1;MYO1B;PPFIBP1;CTNNA2;SNX9;GCN1;HSPA5
prerank,RNA methyltransferase activity (GO:0008173),0.5087551178386222,1.061529941957325,0.41336971350613916,0.9659722155987366,1.0,3/19,6.37%,METTL8;TGS1;METTL3
prerank,LRR domain binding (GO:0030275),0.5302759118731533,1.0613357635188108,0.4247159090909091,0.9622885565614273,1.0,2/14,9.12%,PMF1;ZXDC
prerank,N-methyltransferase activity (GO:0008170),0.49485205673840627,1.0611845085994762,0.40848806366047746,0.9585371829428561,1.0,3/20,7.97%,TRMO;TFB2M;SETD3
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4689194894821164,1.0594443824539703,0.3983739837398374,0.9599830156666727,1.0,7/37,8.31%,NARS2;TARS1;FARSA;WARS2;HARS1;TARS2;AARS1
prerank,tubulin binding (GO:0015631),0.42179101798599394,1.058531349528801,0.35435435435435436,0.9586143784852427,1.0,67/296,16.45%,TOGARAM2;PLK1;BRCA1;MID1;VASH2;LRRK2;SBDS;EML3;TBCA;ALMS1;NDEL1;MDM1;BBS4;MAP1A;STMN2;CCDC61;KIF13A;ALDOA;MTUS1;REEP2;TUBGCP6;KIF20B;DIXDC1;POLB;BRCA2;EZR;DCTN1;CCDC66;SETD2;RGS14;MAPT;TUBGCP2;MAST2;ARL4C;KIF26B;PHF6;KIF16B;APC;DIP2B;CDK5;TAOK1;TTLL4;PRNP;KIF3A;EML4;EML1;STARD9;EML2;RABGAP1;TERF1;FYN;NDRG1;MAP6;RMDN1;KIF21A;DAG1;CLASP1;ARL8A;PEX14;MAP4K4;KIF1B;CLIP1;PAK1;VAPB;LRPPRC;DNM1L;CEP295
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5421295849130153,1.0573371615909468,0.42835595776772245,0.9583451373150911,1.0,4/12,18.89%,B3GALNT1;B3GNT2;B3GALT1;B3GALT5
prerank,NAD+ binding (GO:0070403),0.5271858310932674,1.0570382905131028,0.4232424677187948,0.9551893685107674,1.0,2/12,3.29%,PARP9;HPGD
prerank,acyl-CoA hydrolase activity (GO:0047617),0.5067150685336559,1.0561071984983577,0.4183535762483131,0.953991193139449,1.0,4/17,12.94%,PLA2G6;ACOT9;ACOT13;ABCD1
prerank,solute:proton symporter activity (GO:0015295),-0.4011108840459899,-1.0536159942465362,0.3879310344827586,0.7178569265836963,1.0,7/16,17.82%,SLC36A1;SLC17A5;SLC2A13;SLC2A9;SLC11A2;CTNS;SLC15A2
prerank,RNA polymerase binding (GO:0070063),0.5024712150190517,1.0534342296670305,0.42779291553133514,0.9585568841729777,1.0,5/18,10.50%,BRCA1;STOM;NEDD4;PKN2;YTHDC2
prerank,ribosome binding (GO:0043022),0.4534449736705426,1.0531202838853329,0.4152823920265781,0.955406869669211,1.0,10/46,13.16%,EIF6;SBDS;EIF3C;PYM1;ETF1;YTHDF1;SEC61A1;NAA16;EIF2S1;NAA15
prerank,voltage-gated ion channel activity (GO:0005244),-0.42279734288215653,-1.052794300590898,0.3650190114068441,0.7108534548338621,1.0,7/14,15.85%,ANO6;CACNA1E;VDAC2;VDAC1;VDAC3;GPR89B;GPR89A
prerank,ubiquitin protein ligase binding (GO:0031625),0.4173112701014134,1.0514157920958318,0.3843843843843844,0.9566715055619458,1.0,48/254,13.32%,CBS;BRCA1;MID1;WFS1;VCL;TSG101;RELA;FBXW7;SMAD6;GLMN;UBXN1;UQCRC1;RNF31;TCP1;PRKAR2A;POLR2A;RAD18;JUN;YWHAE;SMAD3;PRKACA;SQSTM1;AMBRA1;ARRB2;UBE2A;UBE2J2;UBXN7;CKB;HSP90AA1;RNF34;SUMO2;HSPA9;SLF1;SYT11;CHEK2;FAF1;APC;TANK;TRAF2;DERL1;CUL4A;CAMLG;UBE2W;TP53;RNF20;BCL2;ACVR1B;RTN4
prerank,poly(A) binding (GO:0008143),0.49626742596341905,1.0512461610242907,0.4126778783958603,0.9531414523885303,1.0,4/21,7.94%,ELAVL4;EIF4A3;RBMS3;PABPC4
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5448844090518832,1.0508347078773332,0.4400606980273141,0.9504421054756199,1.0,1/11,0.90%,SLC25A24
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.4588950072133462,1.0502487135681662,0.4182692307692308,0.9482888353783181,1.0,11/32,16.47%,P4HTM;FTO;EGLN3;EGLN2;EGLN1;KDM4B;KDM4C;TET2;ALKBH5;ALKBH1;TET3
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.5379283770283422,1.0494089067983037,0.43854748603351956,0.9469436622932935,1.0,1/14,1.44%,AK4
prerank,androgen receptor binding (GO:0050681),0.47908936333887986,1.0479378248328433,0.4161490683229814,0.947426309646526,1.0,8/25,13.71%,SMARCA4;ZBTB7A;PRKCB;EP300;KDM3A;PRPF6;KDM4C;DDX5
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.4911947243665779,1.0478559473032205,0.417201540436457,0.9437904389800355,1.0,5/24,8.17%,OSBP;GOLPH3;GSDMD;PLA2G4A;SNX3
prerank,ubiquitin-protein transferase activity (GO:0004842),0.417095639236981,1.0473425072027678,0.364,0.9414592163180749,1.0,87/346,16.71%,TRIM55;NEURL1B;BRCA1;KLHL42;FBXO17;UBE2Z;RNF182;RNF31;RLIM;SH3RF3;FBXO21;FBXO3;PELI1;GID4;CDC23;AKTIP;TRAF7;RNF145;RC3H2;NHLRC1;UBE2A;RNF166;BIRC3;UBE2J2;CBLL1;FBXO9;RNF115;RNF34;PPIL2;MEX3C;NEDD4;BFAR;HECW1;RNF146;BIRC6;RCHY1;AREL1;RNF38;RNF216;FBXO11;UBE2Q2;RNF11;RFWD3;TRIM3;TRIM5;RNF157;CDC42;MYLIP;ASB2;TRAF2;FBXW11;RNF150;CBL;TRIM44;RNF144B;CUL4A;UBE3A;UBE2W;UBE3C;MIB1;VPS11;UBR5;RNF138;NHLRC3;HECTD1;RNF20;NFX1;TRIM56;UBE2H;TRIM59;RNF24;RNF135;RSPRY1;UBE2D3;DTX3;MSL2;TRIP12;TRIM26;RNF214;KCMF1;ZNRF3;UBE2G1;UBE2E3;TRIM25;UBR3;CNOT4;HACE1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.4427282867661067,-1.0463468238163336,0.41812865497076024,0.7168991737653346,1.0,8/11,21.96%,UBE4B;UBE4A;AMFR;UBE2K;RBX1;STUB1;ANAPC11;UBOX5
prerank,poly-purine tract binding (GO:0070717),0.47183662954834715,1.044310262244405,0.4430693069306931,0.9471538765310121,1.0,5/27,7.94%,ELAVL4;EIF4A3;RBMS3;ATXN1;PABPC4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5533632853032642,1.0431584283241548,0.45454545454545453,0.9468660175136252,1.0,3/10,11.13%,LACC1;APOBEC1;GDA
prerank,mRNA binding (GO:0003729),0.41983845482041826,1.0430943884454809,0.3847695390781563,0.9431788084328997,1.0,65/249,16.59%,ELAVL4;DENR;SECISBP2L;EIF4A3;ELAVL2;ZC3H12D;HNRNPM;RPL41;EIF4ENIF1;CARHSP1;SYNCRIP;CSTF3;TARDBP;CSTF2;RBMS3;RNPS1;RBM15;DCP1B;ETF1;PUM2;RC3H2;RBM5;METTL3;PPP1R8;G3BP2;LUC7L;HNRNPA2B1;PTBP3;THOC5;NUP98;LARP4B;PABPC4;SRSF5;AGO2;YTHDF1;SNRNP70;FXR2;PUM1;RBFOX3;ZC3H12B;DCP1A;SF1;QKI;LSM14A;EIF3A;ZFP36L1;SAMD4A;TP53;RNF20;FUBP3;SRRM2;DDX5;MYEF2;PCBP3;UNK;RBMS1;G3BP1;HNRNPC;HNRNPK;SERBP1;HNRNPL;NSRP1;CELF2;CPEB2;YTHDF3
prerank,protein homodimerization activity (GO:0042803),0.41497932910194657,1.0420656691979568,0.352,0.9425477540389071,1.0,122/590,15.90%,ANG;CBS;MID1;BANF1;NQO2;LRRK2;BLM;PDXK;TSG101;RELA;UBA5;SP1;EIF2AK1;TPD52L1;ADCY8;TFAP4;TMEM266;TPD52;SSBP1;TGFB2;ZNF318;BMPR1A;MTMR1;EEA1;PIP4K2A;FLNA;IRF3;PADI2;S100A6;RABEP1;MAP3K11;TPM1;WRN;SMAD3;TERF2;PDGFB;PANK1;FECH;HARS1;TARS2;NFS1;ABCB7;KIF20B;SPPL3;ACVR1;NUDT5;ABCD2;GLCE;HSP90AA1;IKBKB;CCDC66;TAP1;TENM4;BNIP3L;CAMK2D;MAP3K9;PTPRT;ADD1;RCHY1;IRAK2;CHEK2;FXR2;PIP4K2B;EXD2;CNOT9;ABCG1;NR6A1;ENO1;SMCHD1;NADK2;CANT1;DGKD;ACTN4;SRR;TKT;CACYBP;TRIM5;ST6GAL1;HPS4;BNIP3;ABCD3;PRKRA;SNX1;ZBTB38;VPS4B;ERN1;XPNPEP1;MFSD1;ERP29;SOX6;ADAM10;SH3GLB1;MYO9B;ABCD1;HSD17B4;NRBP1;BCL2;LRP6;RPE;PDCD6IP;CAMK2G;S100B;TERF1;PTPRO;PKD2;MIGA1;TBC1D22A;FZD9;LDB1;TIMM9;SCARB2;ARNT;ATG7;SMAD4;NPM1;HIP1;ABCG2;EXT1;GOLGA5;TPST2;INPP5F;PDGFC
prerank,protein phosphatase 2A binding (GO:0051721),0.4851452203973682,1.041476165556639,0.42111801242236024,0.9405209143421104,1.0,9/23,17.95%,ADCY8;IGBP1;BOD1L1;MAPT;TP53;ENSA;PPME1;MFHAS1;SMG7
prerank,CCR chemokine receptor binding (GO:0048020),0.4660907581745047,1.0392002996275427,0.4400977995110024,0.9439160028750726,1.0,2/28,7.28%,CX3CL1;CCL25
prerank,CARD domain binding (GO:0050700),-0.4075581444538661,-1.0388312637785575,0.4409722222222222,0.7255990194599121,1.0,8/14,23.46%,CASP4;CARD11;IRGM;CARD16;NOD1;CARD9;BCL10;CASP1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.5300675334405545,1.0367843856605936,0.44807121661721067,0.9473830818267549,1.0,1/12,0.90%,SLC25A24
prerank,FMN binding (GO:0010181),-0.4496914743973379,-1.0355895457775666,0.41002949852507375,0.7243624118468404,1.0,6/11,49.61%,POR;DUS2;MTRR;NDOR1;PNPO;NOS1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.40615766606953363,-1.0351379396794573,0.4416961130742049,0.7169710709863654,1.0,4/14,7.60%,NCF2;NCF1;CYBA;CYBB
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5128773775768279,1.0339412360552678,0.4430727023319616,0.9524002802651513,1.0,5/14,13.77%,DESI2;MINDY3;MINDY4;MINDY2;ATXN3
prerank,regulatory RNA binding (GO:0061980),0.4482618647046727,1.0335951816076525,0.43283582089552236,0.9495708558617302,1.0,8/38,10.19%,ZNF346;TUT4;TLR7;PUM2;HNRNPA2B1;AGO2;PUM1;ZC3H7A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.4511208290657054,-1.0332469471093617,0.42,0.7131714117900864,1.0,4/10,33.63%,DPYSL3;DPYSL5;OPLAH;CRMP1
prerank,ubiquitin protein ligase activity (GO:0061630),0.4123014379281232,1.0320511842538425,0.40540540540540543,0.9506164121413994,1.0,55/228,15.66%,TRIM55;NEURL1B;FBXO17;RLIM;SH3RF3;PELI1;GID4;RNF145;RC3H2;NHLRC1;RNF166;BIRC3;CBLL1;RNF115;RNF34;PPIL2;MEX3C;NEDD4;BFAR;HECW1;RCHY1;AREL1;RNF38;RNF216;RNF11;RFWD3;TRIM3;TRIM5;RNF157;CDC42;MYLIP;ASB2;RNF150;CBL;TRIM44;RNF144B;UBE3A;UBE3C;VPS11;UBR5;RNF138;NHLRC3;HECTD1;NFX1;TRIM56;TRIM59;RNF24;RNF135;UBE2D3;DTX3;MSL2;TRIP12;TRIM26;KCMF1;ZNRF3
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.38495749708670823,-1.0320393467844828,0.42745098039215684,0.7000684337510994,1.0,6/16,15.78%,ATP6V0A1;ATP6V1A;ATP6V1D;ATP6V0C;ATP6V0B;ATP6V1C1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.38495749708670823,-1.0320393467844828,0.42745098039215684,0.7000684337510994,1.0,6/16,15.78%,ATP6V0A1;ATP6V1A;ATP6V1D;ATP6V0C;ATP6V0B;ATP6V1C1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.4455302592834928,-1.0317232529013423,0.4754601226993865,0.6930169184733593,1.0,2/11,4.64%,RYR2;ITPR1
prerank,GTP binding (GO:0005525),0.4128862947440704,1.0306357563382704,0.43430290872617855,0.9512004174949125,1.0,24/172,10.95%,TUBB4B;LRRK2;ARL5A;NRAS;RHOF;ARL4A;ADSS1;SEPHS1;ARL6;ARF3;NOA1;RERG;RAP1A;MTG2;TUBA1A;RAP1B;RAB6A;ARL4C;KRAS;PIP4K2B;RAB2A;CDC42;RIT2;ARF1
prerank,sialyltransferase activity (GO:0008373),0.4737501881821078,1.0291914052914208,0.4278145695364238,0.9518498848919239,1.0,2/20,1.79%,ST8SIA5;ST8SIA4
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.41052657226977035,1.0276169730215645,0.43843843843843844,0.9528742031407335,1.0,56/232,15.66%,TRIM55;NEURL1B;FBXO17;RLIM;SH3RF3;PELI1;GID4;RNF145;RC3H2;NHLRC1;RNF166;BIRC3;CBLL1;RNF115;RNF34;PPIL2;MEX3C;NEDD4;BFAR;HECW1;RCHY1;AREL1;RNF38;RNF216;RNF11;RFWD3;TRIM3;TRIM5;RNF157;CDC42;MYLIP;ASB2;RNF150;CBL;TRIM44;RNF144B;UBE3A;UBE3C;VPS11;UBR5;RNF138;NHLRC3;HECTD1;NFX1;TRIM56;TRIM59;RNF24;RNF135;UBE2D3;DTX3;MSL2;TRIP12;TRIM26;PIAS1;KCMF1;ZNRF3
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.46710634002606716,1.0275887753129278,0.4468864468864469,0.9491945185510585,1.0,11/28,17.70%,LRRK2;PRKACA;MAP2K6;MAP3K9;MAP2K5;MAPK14;MAP2K2;RPS6KA2;MAP2K1;MAP2K4;RPS6KB1
prerank,sequence-specific DNA binding (GO:0043565),0.4114794531879591,1.0272633928337047,0.373,0.9465551821868364,1.0,72/590,15.19%,POU2F3;ISL1;GLIS1;RORA;ZIC4;SP8;SP1;HLX;TFAP4;SOX13;SMG6;TGIF1;CLOCK;ZEB2;BBX;MAX;NFATC1;JUN;ZBTB7A;ELK3;IRF3;BCL6;SMAD3;TERF2;TEAD1;ESR1;NR3C1;JUND;PRDM4;MEF2A;MAPT;MECP2;TFCP2;CUX1;DRGX;KDM5B;LIN28B;MAFG;PPARG;NR6A1;MBNL2;HMBOX1;HIVEP1;HOXC4;TCF12;ZSCAN29;NR5A1;ZNF711;NR2C2;ZBTB38;PRDM1;GMEB2;ABL1;BACH2;TCF7L2;ATF6;MAF;BCL2;NR1D2;KLF13;RXRA;TERF1;SP4;CREB1;RFX3;RBPJ;PPARD;CTCF;ARNT;CTC1;SMAD4;ZBTB18
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.4579223560247913,1.027181360142887,0.47147846332945287,0.9431431013285807,1.0,10/34,16.91%,DAPP1;IQGAP2;BTK;MAPKAP1;MYO1G;KIF16B;PLEKHB2;IQGAP1;ADAP2;MYO1B
prerank,neuropeptide binding (GO:0042923),0.49361415128015984,1.0271127481463183,0.43424657534246575,0.9397001119256153,1.0,2/18,12.31%,GPR149;SORL1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.43248819098723595,1.0261726767166595,0.44880174291938996,0.9388730615017211,1.0,10/53,15.51%,SLC66A1;SLC7A2;SLC38A2;SLC7A11;SLC7A7;SLC7A8;SLC25A2;SLC38A9;SLC15A4;SLC38A6
prerank,UDP-galactosyltransferase activity (GO:0035250),0.5526807154458967,1.0258902913158379,0.47213622291021673,0.9360637217405736,1.0,4/10,18.89%,B4GALT5;B4GALT1;B3GALT1;B3GALT5
prerank,Hsp90 protein binding (GO:0051879),0.4504632292736514,1.0258844681260844,0.4439140811455847,0.932498506250366,1.0,7/33,14.87%,PPID;USP19;CHORDC1;NR3C1;MAPT;ERN1;TSC1
prerank,guanyl ribonucleotide binding (GO:0032561),0.4086282612673643,1.0236229979988567,0.44879518072289154,0.9354560509408261,1.0,27/196,10.95%,TUBB4B;LRRK2;ARL5A;NRAS;RHOF;ARL4A;ADSS1;SEPHS1;ARL6;ARF3;NOA1;RAB8B;RAB12;RERG;RAP1A;MTG2;RAB5B;TUBA1A;RAP1B;RAB6A;ARL4C;KRAS;PIP4K2B;RAB2A;CDC42;RIT2;ARF1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.4591251840781147,1.0214749032133976,0.4794188861985472,0.9379268326980902,1.0,11/31,16.37%,UBE2Z;AKTIP;UBE2A;UBE2J2;BIRC6;UBE2Q2;UBE2W;UBE2H;UBE2D3;UBE2G1;UBE2E3
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.35539952623238524,-1.0208144542497661,0.4217391304347826,0.709586496994435,1.0,3/21,25.69%,GRM1;CHRNA7;CHRFAM7A
prerank,proton transmembrane transporter activity (GO:0015078),0.43344581797987014,1.0174412203352594,0.46206896551724136,0.9461354147466728,1.0,5/39,9.23%,UQCRH;UQCRC1;SLC9A1;SLC33A1;CLCN5
prerank,voltage-gated sodium channel activity (GO:0005248),0.4765283255303227,1.016189117385817,0.454661558109834,0.9464401247948355,1.0,1/22,0.39%,HCN3
prerank,calcium:sodium antiporter activity (GO:0005432),0.5408746301143453,1.016147416926832,0.4810126582278481,0.9430361093567174,1.0,1/10,1.09%,SLC24A5
prerank,ligand-gated cation channel activity (GO:0099094),-0.25249524109694194,-1.0148896641300127,0.43103448275862066,0.7153410140988081,1.0,6/75,2.51%,P2RX7;GRIK1;GRIN2B;KCNN2;PTK2B;GRIN3A
prerank,3'-5' DNA helicase activity (GO:0043138),0.4883423300839029,1.0130902484078692,0.4880450070323488,0.9484740255669404,1.0,2/16,4.94%,BLM;WRN
prerank,epidermal growth factor receptor binding (GO:0005154),0.46586705265902456,1.0107045741527485,0.45692883895131087,0.9516443335459683,1.0,7/25,15.24%,GRB2;AREG;CNOT9;ATXN2;SNX1;TGFA;HIP1
prerank,microtubule plus-end binding (GO:0051010),0.4785790717484555,1.0087043235000144,0.4712041884816754,0.9538208341026767,1.0,8/20,18.36%,MAPRE1;DCTN1;APC;FBXW11;CLASP1;CLIP1;CLASP2;MAPRE2
prerank,alanine transmembrane transporter activity (GO:0022858),-0.42067409948353063,-1.0081422627317607,0.4495114006514658,0.7218714274999,1.0,4/12,14.58%,SLC36A1;SLC38A7;SLC36A4;SLC3A2
prerank,miRNA binding (GO:0035198),0.4554210225385688,1.0065903345524123,0.4565483476132191,0.9567035932062409,1.0,7/30,10.19%,ZNF346;TUT4;PUM2;HNRNPA2B1;AGO2;PUM1;ZC3H7A
prerank,flavin adenine dinucleotide binding (GO:0050660),0.42710652778719066,1.0044634888421173,0.4834801762114537,0.9591398985538551,1.0,11/53,15.33%,NQO2;KDM1B;QSOX1;MTHFR;MICAL2;SDHA;ACADL;AIFM1;ETFA;ACOX3;MICAL3
prerank,GTPase regulator activity (GO:0030695),0.40118255859966767,1.0038606306006264,0.4974974974974975,0.9573611976867309,1.0,65/212,17.29%,LRRK2;LLGL2;ITGB1BP1;RAB3GAP1;LLGL1;SIPA1L3;GDI1;NF1;TBC1D15;JUN;NRP1;IQGAP2;DOCK1;TAGAP;EVI5;VAV3;IPO7;ALDH1A1;TBC1D17;ARFGEF1;ARHGAP22;RGS14;RGS3;RIC8B;TBC1D14;ADGRB3;ARHGAP1;TBC1D10B;RAP1GDS1;IPO5;GNAQ;STXBP5;ARHGAP35;SIPA1L2;ARHGAP39;TBC1D4;STXBP5L;OCRL;TBC1D12;TBC1D5;TBC1D10A;TBC1D13;RABGAP1;ARHGAP15;ARHGAP32;MYO9B;ARHGAP45;TBC1D22A;TBC1D8;LARS1;ARHGAP31;WASL;TBC1D1;PDE6D;IQGAP1;DNM1L;RP2;CPEB2;ARHGAP17;PREX1;RIN2;TBCK;RALBP1;RAPGEF2;NCKAP1L
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.40980348356428137,1.0026955020065131,0.4881565396498455,0.9571000763855618,1.0,27/100,17.07%,WDR45;OSBP;DAPP1;IQGAP2;WDR45B;BTK;RNF34;GOLPH3;GSDMD;MAPT;PLA2G4A;MAPKAP1;SNX3;MYO1G;KIF16B;SNX20;GAP43;ANKFY1;NCF4;SNX24;PLEKHB2;HIP1;SNX13;IQGAP1;ADAP2;MYO1B;PLEKHA5
prerank,protein tyrosine kinase binding (GO:1990782),0.41266987743557293,1.0018575398990688,0.5031914893617021,0.9558486274711206,1.0,14/71,12.92%,DUSP3;GAS6;SQSTM1;ACVR1;HSP90AA1;PITPNM1;NRG3;PTPN1;NCK1;SOCS5;CBL;BANK1;SH2B3;TP53
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.4650174539322759,1.0016223982664305,0.4832474226804124,0.9530874795600119,1.0,4/22,13.21%,DUSP3;DUSP16;DUSP10;DUSP12
prerank,protein kinase activator activity (GO:0030295),0.4183194096277972,1.0005582550232166,0.4844919786096257,0.9525376750814591,1.0,16/60,18.52%,RGCC;GAS6;ABI1;STK11;PAK2;TAOK1;MAP2K2;CALM1;STK3;IQGAP1;MAP2K1;NCKAP1L;DDX3X;STK4;ALS2;CAB39
prerank,histone demethylase activity (GO:0032452),0.4484148508565616,1.0004828448630554,0.48695652173913045,0.9493175418469182,1.0,6/27,11.95%,KDM5A;KDM3A;KDM5B;JMJD1C;KDM4B;KDM4C
prerank,Tat protein binding (GO:0030957),0.5290356194501967,0.999772897118789,0.4937888198757764,0.9478213636659654,1.0,4/10,17.34%,SMARCA4;CTDP1;NPM1;MDFIC
prerank,vinculin binding (GO:0017166),0.5176982847555738,0.9970281798391666,0.47449768160741884,0.9519004563479692,1.0,5/11,17.50%,CTNNA1;PXN;DAG1;UTRN;RTCB
prerank,voltage-gated potassium channel activity (GO:0005249),0.40384729573772266,0.9970163797037493,0.49113660062565173,0.9485516111231861,1.0,5/80,6.34%,HCN3;KCNJ6;KCNH8;KCNH7;KCNK2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.5255202603315131,0.9963160027002482,0.5078864353312302,0.9471511930898733,1.0,3/10,10.29%,PRKAR2A;PKIB;PKIA
prerank,cation channel activity (GO:0005261),0.4017121361755725,0.996194128841452,0.4973821989528796,0.9440873343294853,1.0,15/94,13.91%,SLC24A5;TRPC5;TMEM175;CACNA1D;HVCN1;TMEM63B;TMEM38B;PIEZO2;TRPM4;ANXA2;SEC61A1;MCOLN1;TRPV2;KCNK10;PKD2
prerank,AMP binding (GO:0016208),-0.43245523993217466,-0.9953746602444504,0.4835820895522388,0.742804625450954,1.0,8/11,36.91%,MPPED2;PRKAG1;ACSS2;PFKL;PYGL;PRKAG2;APRT;PFKM
prerank,potassium channel activity (GO:0005267),0.4020447301500814,0.9916499262492797,0.5327102803738317,0.9530896489395326,1.0,17/89,17.25%,HCN3;TMEM175;KCNH8;KCNH7;KCNK2;TMEM38B;KCNK13;KCNK10;PKD2;KCNMB2;KCNMB3;KCNQ5;HCN1;KCND2;KCNA1;KCNA5;KCNB2
prerank,signaling receptor complex adaptor activity (GO:0030159),0.4372089809836111,0.9913768669528402,0.49071925754060325,0.9505398489381904,1.0,10/38,15.70%,LRRK2;LDLRAP1;IRS1;G3BP2;RGS14;NCK1;FRS2;SH2B3;SH2B2;PIK3R1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.5276116434061046,0.9898958149097898,0.49849397590361444,0.9511915501693528,1.0,3/10,13.26%,DSE;GLCE;RPE
prerank,muscle alpha-actinin binding (GO:0051371),0.48879808885697323,0.9858994139051573,0.5055096418732782,0.9584215499600548,1.0,3/15,13.91%,PDLIM2;PALLD;PKD2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.4478230791567786,0.9840345037566955,0.5175332527206772,0.9601981948148502,1.0,5/30,8.86%,UBE2Z;GAS6;TNFAIP8;BIRC3;BIRC6
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.43817503114963696,0.9839421978096451,0.513189448441247,0.9571528002442107,1.0,7/31,16.61%,TMEM175;TMEM38B;SLC12A6;KCNK10;PKD2;HCN1;KCNA1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.3376517727764684,-0.9836118381737213,0.4827586206896552,0.7610863819883588,1.0,7/22,15.78%,ATP6V0A1;ATP6V1A;ATP6V1D;ATP6V0C;ATP2C1;ATP6V0B;ATP6V1C1
prerank,metal ion binding (GO:0046872),0.39291229080674916,0.982877302419699,0.567,0.95688294072473,1.0,67/477,13.95%,PLK1;SCUBE1;CETN2;SNN;SLC25A24;MAN1B1;LRRK2;IGFBP3;PDXK;EYA2;MICU1;TDP2;DYRK2;TPD52;BRAF;ITSN1;LETM1;THBS1;PADI2;S100A6;CEMIP2;WRN;NT5C3A;ACER3;MAP3K20;NUDT5;GLCE;STK11;HPRT1;PITPNM1;GALNT3;CDC42BPB;SYT12;SYT11;PLA2G4A;TRPM4;MAST2;PI4K2A;EXD2;CDH11;CANT1;ANXA2;SRR;TKT;MT1F;MT1M;MT1H;MT1X;MT1A;MT1E;MT1G;MT1B;IDH2;PRNP;EML1;ABL1;ERN1;CDH20;SRPK2;RPE;S100B;COLEC11;CAMKK2;CDH18;PKD2;SPARCL1;ANXA5
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.43156545132864904,0.9800477157106753,0.5045977011494253,0.9610586823092955,1.0,7/33,10.81%,REXO2;EXOSC5;EXOSC7;ERI3;XRN1;EXD2;XRN2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.3915013407438086,-0.9798945095619387,0.5167785234899329,0.7618166537672825,1.0,5/14,16.90%,SLC1A2;SLC25A13;SLC38A7;SLC17A6;SLC1A1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.4972418020269137,0.9797369758571484,0.506079027355623,0.9585901165880315,1.0,4/12,11.95%,KDM3A;JMJD1C;KDM4B;KDM4C
prerank,protein phosphatase activator activity (GO:0072542),0.5059307946198048,0.9788999107621416,0.541374474053296,0.95766689991213,1.0,3/13,14.29%,IGFBP3;PPP2R5C;CALM1
prerank,endoribonuclease activity (GO:0004521),0.44036550684588116,0.9784360062916461,0.5126353790613718,0.9555562077141394,1.0,6/32,12.18%,ZC3H12D;SMG6;AGO2;ZC3H12B;CPSF3;ERN1
prerank,ATPase regulator activity (GO:0060590),0.42652088139306477,0.9756721512442578,0.5300230946882217,0.9594821001432476,1.0,9/38,14.87%,DNAJB1;DNAJC15;BAG3;HSPH1;SIL1;FNIP1;DNAJC1;DNAJB4;TSC1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.4132561324984412,0.975475571846712,0.5126791620727673,0.9567416023318283,1.0,10/51,14.89%,SLCO4C1;SLC35D1;SLCO1B1;SLC35E2B;SLC35E2A;SLC7A8;SLC25A16;SLCO2B1;SLC20A2;SLC25A3
prerank,metalloendopeptidase activity (GO:0004222),0.39648701537225645,0.9743177511017748,0.5286624203821656,0.9564362142031173,1.0,6/76,9.26%,ADAMTS12;NLN;ADAMTS2;ADAMTSL3;NRDC;ADAMTS10
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.38789580407464236,0.9739337257687203,0.604,0.954192105467699,1.0,70/431,13.18%,TUBB4B;PLK1;ATP5F1A;LRRK2;BLM;PDXK;EIF4A3;ARL5A;NRAS;MINK1;RHOF;ARL4A;TARS1;ADSS1;SEPHS1;ARL6;ARF3;NOA1;VPS4A;DYRK2;BMPR1A;RERG;RAP1A;MTG2;ATP7A;BTK;HARS1;MAP3K20;CDK6;ACVR1;ABCD2;STK11;HSP90AA1;CLPX;TUBA1A;HSPA9;RAP1B;CDC42BPB;TAP1;SYN3;RAB6A;RPS6KA5;AARS1;TWF2;MAST2;ARL4C;PI4K2A;KRAS;DAPK1;PIP4K2B;RAB2A;ABCG1;TAOK1;SRR;CDC42;ABCD3;RIT2;ARF1;CHD8;GCK;PFKP;ABL1;ERN1;CDKL5;SRPK2;MYO9B;ABCA1;ABCD1;TGFBR1;ACVR1B
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.43251069866607555,0.9711933872208941,0.5095465393794749,0.9580105235248152,1.0,6/29,13.58%,PRKAR2A;SPRED2;PKIB;PKIA;KAT2B;SPRED1
prerank,cation transmembrane transporter activity (GO:0008324),0.41374333300355665,0.9709767944285834,0.5382932166301969,0.9553740842776385,1.0,8/48,15.51%,SLC66A1;SLC7A2;SLC38A2;SLC7A8;SLC25A2;SLC38A9;SLC15A4;SLC38A6
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4615204906572479,0.9698594559546034,0.5161290322580645,0.9550444528068617,1.0,5/18,12.97%,SMAD6;TGFB2;SMAD3;TGFBR2;TGFBR1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5105154629440724,0.9698444983561396,0.5399698340874811,0.9519115164892157,1.0,1/11,4.27%,AKR1B1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.5046939329045632,0.9671170318958814,0.5130970724191063,0.9557033671371421,1.0,2/10,9.23%,DCLRE1A;EXD2
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.4197304751403902,0.9664828511670025,0.5248554913294797,0.9541303596414321,1.0,9/38,15.30%,WDR45;WDR45B;PLA2G4A;SNX3;KIF16B;SNX20;NCF4;HIP1;SNX13
prerank,phospholipase activity (GO:0004620),0.3983346761921523,0.9661850289361454,0.5516506922257721,0.9518091757790627,1.0,10/67,11.79%,SMPDL3A;SMPD3;SMPD1;PLA2G6;ABHD6;PLA2G4A;ABHD16A;PNPLA6;PLD4;PLCB4
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.3948135381195612,-0.9650674756049002,0.5295857988165681,0.7871161029397149,1.0,4/12,9.28%,PIK3CG;PIK3CA;PIK3C3;PIK3C2B
prerank,ATP binding (GO:0005524),0.38358186489444895,0.9618907079408071,0.6076076076076076,0.9591536295490368,1.0,50/266,14.35%,PLK1;ATP5F1A;BLM;PDXK;EIF4A3;MINK1;TARS1;VPS4A;DYRK2;BMPR1A;ATP7A;BTK;HARS1;MAP3K20;CDK6;ACVR1;ABCD2;STK11;HSP90AA1;CLPX;HSPA9;CDC42BPB;TAP1;SYN3;RPS6KA5;AARS1;TWF2;MAST2;PI4K2A;DAPK1;PIP4K2B;ABCG1;TAOK1;SRR;ABCD3;CHD8;GCK;PFKP;ABL1;ERN1;CDKL5;SRPK2;MYO9B;ABCA1;ABCD1;TGFBR1;ACVR1B;INSR;NVL;MTREX
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.41567481245471494,0.959813930188971,0.5219454329774614,0.9609048826214324,1.0,11/35,16.34%,RELA;SMARCA4;NR3C1;AGO2;UBTF;TAF4;GTF2B;TP53;SNAPC3;NPM1;TAF1B
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.4585879084368514,0.9583388797428163,0.5487804878048781,0.961521318860304,1.0,3/18,10.11%,SOCS4;SOCS7;SOCS5
prerank,iron ion binding (GO:0005506),0.40282946618898363,0.9572482744193437,0.53125,0.9610523493670675,1.0,8/48,8.48%,FECH;FTO;NFU1;EGLN3;EGLN2;KDM3A;EGLN1;ALOX5
prerank,nucleotidyltransferase activity (GO:0016779),-0.34728828595627215,-0.9556787322642801,0.5206611570247934,0.7998155517119592,1.0,7/19,14.17%,TENT2;TENT4B;PAPSS1;MTPAP;PNPT1;TENT4A;CGAS
prerank,SUMO binding (GO:0032183),0.48458376093123906,0.9548379491364715,0.5465753424657535,0.9636894332204139,1.0,1/13,0.61%,HABP4
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.45824914914801684,0.9544075251641412,0.5379213483146067,0.9616429626221875,1.0,5/18,13.18%,BMPR1A;ACVR1;TGFBR2;TGFBR1;ACVR1B
prerank,GTPase activator activity (GO:0005096),0.3790712780406262,0.9533740643313319,0.641,0.9609784850218144,1.0,89/313,17.29%,LRRK2;LLGL2;FGD6;RAPGEF1;FGD3;DOCK8;FGD1;RAB3GAP1;LLGL1;CYTH4;RIN3;ITSN1;SIPA1L3;NF1;TBC1D15;JUN;RAP1A;NRP1;IQGAP2;FARP2;DOCK1;TAGAP;EVI5;DENND6A;VAV3;FARP1;SBF2;ALDH1A1;TBC1D17;ARFGEF1;ARHGAP22;RGS14;EPS8L1;RAPGEF5;RGS3;RIC8B;TBC1D14;RAPGEF4;ADGRB3;ARHGAP1;FNIP1;KALRN;TBC1D10B;RAP1GDS1;GNAQ;STXBP5;ARHGAP35;AKAP13;HPS4;SIPA1L2;ARHGAP39;ARHGEF17;TBC1D4;CYTH1;STXBP5L;OCRL;TBC1D12;VAV2;TBC1D5;TBC1D10A;TBC1D13;RABGAP1;ARHGAP15;ARHGAP32;MYO9B;ARHGAP45;DOCK9;ELMO1;DOCK11;TBC1D22A;TBC1D8;LARS1;ARHGAP31;TBC1D1;VAV1;IQSEC2;IQGAP1;DENND2C;RALGPS1;DNM1L;RP2;ARHGAP17;DOCK10;PREX1;RIN2;TBCK;RALBP1;RAPGEF2;NCKAP1L
prerank,methyltransferase activity (GO:0008168),0.4053556986766529,0.9530784689912384,0.5474285714285714,0.9586284196284665,1.0,6/46,9.78%,EHMT1;SUV39H1;METTL3;NSUN3;AS3MT;NDUFAF7
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.41944934528731304,0.9530751911027888,0.5335689045936396,0.9555817598949559,1.0,8/35,16.43%,NT5C3A;FTO;TARS2;DUS4L;AARS1;GATB;ALKBH1;TRIT1
prerank,protein kinase binding (GO:0019901),0.3797297179694252,0.9478275529410688,0.682,0.9648197535574233,1.0,87/480,13.90%,PLK1;RGCC;ROR2;WDR45;CDK5RAP3;DUSP3;RELA;IRAK4;DVL1;RHOF;PGAM1;GRB2;PRKAR2A;LLGL1;SASH1;MAPRE1;MSN;CEP250;IRS1;NELL1;CADPS;MAP3K11;HDAC9;POLA1;PRKCB;SMAD3;PRKACA;SQSTM1;SPRED2;PTPRJ;ESR1;HDAC5;AP2A1;NR3C1;ACVR1;PDE3B;HSP90AA1;EZR;KIF11;IKBKB;DCTN1;DLG1;MAP2K6;MAPT;DCTN2;PAK2;DUSP16;MAPKAP1;DUSP10;TBC1D14;PTPN1;TWF2;LIMS1;GRK5;CHEK2;FAF1;MAVS;TOM1L2;CEP152;APC;PTPN23;PKIA;TRIM5;MVP;CDC42;TRAF2;IFNAR2;KAT2B;ABL1;NBEAL1;RB1CC1;RPS6;PRKCSH;TCF7L2;BANK1;ADAM10;CYLD;RNF138;SH2B3;MAPKAPK2;TP53;SPRED1;USP37;ADIPOR1;BICD1;NELL2;PRKD2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3748133912384433,0.9412283620255473,0.6112789526686808,0.9769776881895562,1.0,38/147,16.78%,FGD6;RAPGEF1;FGD3;DOCK8;FGD1;RAB3GAP1;CYTH4;RIN3;ITSN1;RAP1A;FARP2;DOCK1;DENND6A;VAV3;FARP1;SBF2;ARFGEF1;EPS8L1;RAPGEF5;RIC8B;RAPGEF4;FNIP1;KALRN;AKAP13;HPS4;ARHGEF17;CYTH1;VAV2;DOCK9;ELMO1;DOCK11;VAV1;IQSEC2;DENND2C;RALGPS1;DOCK10;PREX1;RIN2
prerank,manganese ion binding (GO:0030145),0.402165999277512,0.9406283280617351,0.5675977653631284,0.9753022786859374,1.0,9/48,12.37%,TDP2;DYRK2;GALNT1;WRN;GALNT3;EXD2;B4GALT1;ABL1;XPNPEP1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.48524808740582626,0.9404745876925077,0.5552282768777614,0.9725865966045318,1.0,5/12,15.70%,IRS1;FRS2;SH2B3;SH2B2;PIK3R1
prerank,NAD binding (GO:0051287),0.4343944551520039,0.9400735611446684,0.5669975186104218,0.9703714095138609,1.0,4/26,9.64%,PARP9;HPGD;ALDH1A1;CTBP1
prerank,kinase activity (GO:0016301),0.37775580904717193,0.9394891717486689,0.5905834186284544,0.9685531621080781,1.0,26/109,15.83%,LRRK2;PDXK;SEPHS1;FCSK;PANK1;CHKB;CKB;PI4KA;DGKI;PKN2;LYN;CDK5;NADK2;DGKD;TAOK1;IPMK;GK;MTOR;ABL1;CDKL5;PIK3C2A;CHKA;ETNK1;TRRAP;MAP4K4;DGKZ
prerank,pre-mRNA binding (GO:0036002),-0.3117886120064529,-0.9390748916066111,0.5549738219895288,0.8291705189229229,1.0,14/28,24.36%,HNRNPU;CELF4;TRA2B;ZRSR2;RNPC3;RBM41;HNRNPA1;PRPF8;ERI1;SLU7;SLBP;PTBP1;RBM4;RBM22
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.4638568271890605,0.9355397643834851,0.5484764542936288,0.974827768136916,1.0,1/15,8.02%,PLA2G4A
prerank,glutamate receptor activity (GO:0008066),-0.33670085051455895,-0.9345286355843901,0.5064935064935064,0.8303228534126235,1.0,5/19,13.22%,GRIK1;GRM1;GRIK4;GRM3;GRIK2
prerank,antiporter activity (GO:0015297),0.44340198321364904,0.9329847367594778,0.5862516212710766,0.9777659157574504,1.0,4/20,11.12%,SLC35D1;SLC35E2B;SLC35E2A;SLC25A16
prerank,phosphatidylinositol binding (GO:0035091),0.3849078965949213,0.9328285220338386,0.5966562173458725,0.9751091309718966,1.0,24/91,15.54%,WDR45;ZFYVE9;SNX5;EEA1;RNF34;PITPNM1;SNX10;EPB41;MAPT;WDFY1;TULP3;SNX1;GAP43;AIDA;SNX8;PIGU;ANKFY1;PITPNA;SNX24;MYO1E;HIP1;SNX13;PITPNB;MTM1
prerank,chloride channel activity (GO:0005254),-0.24714212589068077,-0.9308552117792356,0.5972222222222222,0.8306758211713925,1.0,11/59,12.67%,GABRB1;ANO6;GABRA2;TTYH2;ANO3;GABRA3;PACC1;TTYH3;CLCN4;GLRA1;CLCN6
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.47433524901386476,0.9305810761194677,0.5590062111801242,0.9773295183867733,1.0,4/12,12.97%,BMPR1A;ACVR1;TGFBR2;TGFBR1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.41790054964659745,-0.9286638702619264,0.5804597701149425,0.8273478475863596,1.0,6/10,29.89%,GABRA2;GABRA3;GABRA5;GABRA4;GABRG1;GABRA1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.4882483609050082,0.9284090687341825,0.5605095541401274,0.9793324316613838,1.0,3/10,14.79%,CACNA1D;CACNA1A;CACNA1C
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.48621389405187637,0.9282934167873669,0.5657686212361331,0.9765770186671868,1.0,5/10,16.82%,SETD2;SETD3;ASH1L;NSD2;SETD5
prerank,G protein-coupled receptor activity (GO:0004930),0.3697351217337482,0.9270267925139035,0.6803607214428857,0.9764929494570852,1.0,17/239,14.62%,RXFP1;S1PR1;ADGRE1;C5AR1;P2RY14;TAPT1;GPR149;GPR65;CMKLR1;ADGRB3;ADGRE5;MTNR1A;XPR1;CYSLTR1;CALCRL;LPAR6;P2RY12
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.38623802001003454,-0.924139020069424,0.5654761904761905,0.8298377251340858,1.0,5/12,8.37%,PDE4D;PDE8A;PDE4B;PDE8B;PDE1B
prerank,glucuronosyltransferase activity (GO:0015020),0.4403349672908407,0.9232804977230087,0.5805194805194805,0.9820126436052456,1.0,4/19,17.14%,CHSY1;EXT1;LARGE1;EXT2
prerank,ATPase binding (GO:0051117),0.38109331448932415,0.9228115299411879,0.6127659574468085,0.9800645137472211,1.0,14/71,14.20%,WFS1;DNAJB1;UBXN1;AR;ESR1;EZR;SNX10;PTPN3;ATP6V1E1;DERL1;ABCA1;ATXN3;PKD2;ATP6V0A2
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.4396819930068781,0.9213768509142486,0.5958279009126467,0.9772280408473567,1.0,6/21,13.30%,CDK7;CDK2;CDK6;CDK9;CDK5;CDK8
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.4396819930068781,0.9213768509142486,0.5958279009126467,0.9772280408473567,1.0,6/21,13.30%,CDK7;CDK2;CDK6;CDK9;CDK5;CDK8
prerank,phosphatidic acid binding (GO:0070300),0.43841790991147966,0.9202818417681399,0.5997340425531915,0.9765596268175722,1.0,5/19,8.13%,SMPD3;PACSIN2;PITPNM1;GSDMD;MAPKAP1
prerank,ligand-gated calcium channel activity (GO:0099604),-0.3313421954932366,-0.9190397397495673,0.536036036036036,0.8334120441224596,1.0,3/19,4.64%,RYR2;GRIN2B;ITPR1
prerank,amyloid-beta binding (GO:0001540),0.3763875713332135,0.9172026704654317,0.6377870563674322,0.9804049314337319,1.0,15/79,14.85%,CD36;PFDN1;LDLRAP1;TGFB2;EPHB2;APBA1;GRIA4;ITM2B;CACNA1A;CLSTN1;PRNP;SORL1;INSR;GRIN2A;TLR4
prerank,poly(U) RNA binding (GO:0008266),0.4257787580622316,0.9147185036214296,0.5921052631578947,0.9827738625442082,1.0,7/20,16.15%,RBMS3;ATXN1;PABPC4;HNRNPH1;RBMS1;HNRNPC;PATL1
prerank,SH3 domain binding (GO:0017124),0.37706233255950516,0.9139099441314303,0.6141304347826086,0.9814869449319057,1.0,16/62,15.36%,GRB2;ADAM15;SOCS7;ADAM12;WIPF1;ABI1;MAPT;REPS1;CD2AP;CBL;ABL1;WASF2;ELMO1;ZNF106;EVL;SYNJ2
prerank,Toll-like receptor binding (GO:0035325),0.48251981400995103,0.9137898138646214,0.578538102643857,0.9788365495960489,1.0,1/11,1.63%,CD36
prerank,hexosyltransferase activity (GO:0016758),0.3739844569528885,0.9131596706708794,0.646878198567042,0.9771963825126205,1.0,19/101,17.14%,POGLUT3;B4GALT3;GBA2;MTAP;CHSY1;POMT2;GBE1;B4GALT5;B4GALT1;B3GALNT1;B3GNT2;MGAT4B;B3GALNT2;DPY19L1;EXT1;MGAT4A;LARGE1;B3GALT1;EXT2
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.2727627193189093,-0.911723374510421,0.6,0.8415315368244296,1.0,4/34,3.24%,CCNT2;CALM2;CAB39L;CCNT1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3628467671969259,0.9112309108143336,0.82,0.9782714953501176,1.0,88/731,15.19%,POU2F3;ISL1;GLIS1;RORA;ZIC4;SP8;RELA;IRF1;SP1;TFAP4;POU5F2;SOX13;KLF9;ZBTB5;TGIF1;CLOCK;ZEB2;RUNX1;NFATC1;JUN;AR;ZBTB7A;ZNF569;ELK3;WBP2;IRF3;BCL6;SMAD3;TEAD1;ZNF467;ESR1;HDAC5;NR3C1;IKZF1;JUND;PRDM4;MEF2A;WIZ;TFCP2;ZBTB11;NACC1;MAFG;PPARG;NR6A1;TAL1;HBP1;HIVEP1;HOXC4;TCF12;ZNF568;FOXN3;ZSCAN29;NR5A1;NR2C2;SOX11;ZBTB38;BCL11A;ZNF182;PRDM1;HIVEP2;DNMT3A;GMEB2;BACH2;TCF7L2;ZBTB34;ATF6;SOX6;TP53;MAF;NR1D2;KLF13;MYT1L;RXRA;SP4;KCNIP3;RREB1;CARF;CREB1;RFX3;RBPJ;PPARD;DACH2;HIVEP3;CTCF;ARNT;SNAPC3;SMAD4;ZBTB18
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.4144271091994686,0.9111243659572074,0.5945945945945946,0.9756277930842067,1.0,5/25,10.02%,PARP9;PARP8;PARP2;TNKS2;PARP4
prerank,P-type ion transporter activity (GO:0015662),0.4680890572987648,0.9110599571971475,0.5976505139500734,0.9728775169215372,1.0,2/12,9.21%,ATP7A;ATP6V1E1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.37380514201484355,0.9098484377491757,0.6313559322033898,0.9725845088064484,1.0,13/78,10.53%,USP11;CTSC;USP24;USP34;USP29;USP33;USP1;USP48;USP20;USP5;USP46;CTSZ;CAPN2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.47959035145474754,0.9046798207125737,0.6025236593059937,0.9806850202970416,1.0,4/10,17.23%,NAA25;NAA16;NAA15;NAA20
prerank,sequence-specific mRNA binding (GO:1990825),-0.40851005645429417,-0.9043764793537943,0.6253687315634219,0.8495577217957986,1.0,3/10,6.15%,DHX9;SSB;FMR1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.4916640328976568,0.9034446272527603,0.5953488372093023,0.9803968990558084,1.0,4/10,18.99%,ECHS1;HSD17B4;HADHA;AUH
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.4441507262876304,0.9015479350197472,0.6371077762619373,0.9815589132670128,1.0,3/18,6.42%,GAS6;TNFAIP8;BIRC3
prerank,symporter activity (GO:0015293),0.48339715021028185,0.9012571879638983,0.6268174474959612,0.9792238915887013,1.0,10/10,51.69%,SLC28A3;SLC5A8;SLC5A12;SLC5A5;SLC4A4;SLC28A1;MFSD2A;SLC46A2;SLC28A2;SLC5A6
prerank,adenylate cyclase binding (GO:0008179),-0.3962342464405279,-0.8978565532287311,0.6179104477611941,0.856093525110411,1.0,4/10,7.19%,CALM2;CAP1;AKAP6;ADCY2
prerank,ADP binding (GO:0043531),0.4106279666239086,0.8967314704788902,0.6067839195979899,0.9857514776357328,1.0,6/25,12.94%,ATP5F1A;TAP1;ABCG1;ERN1;MYO9B;ABCD1
prerank,nucleotide diphosphatase activity (GO:0004551),0.4518605053607,0.8965893189709666,0.6253602305475504,0.983246887023135,1.0,2/14,4.93%,ENPP5;ENPP4
prerank,single-stranded DNA binding (GO:0003697),0.36864905703330086,0.8962457742258725,0.6742268041237114,0.9812368019582298,1.0,16/93,15.16%,POLR2D;BLM;TDP2;SSBP1;POLA1;BRCA2;RBBP8;MAPT;ERCC4;RAD51B;HMGB1;RNF138;FUBP3;RBMS1;RAD23B;CTC1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.29448702747810673,-0.894762095449509,0.5829383886255924,0.8549536011448982,1.0,9/28,21.52%,MADD;RIPK1;FEM1B;TRAP1;TRAF3;TRAF6;EDA;TMBIM1;BID
prerank,nucleosomal DNA binding (GO:0031492),-0.3172471061601754,-0.894570448860237,0.5535714285714286,0.8477594146981398,1.0,7/21,9.32%,SMARCC1;RBBP4;H3-3A;HDAC1;CHD4;SMARCE1;SMARCB1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3560588653294312,0.8938795485544958,0.886,0.9834618743858269,1.0,104/830,15.19%,POU2F3;GLIS1;RORA;ZIC4;SP8;ZBTB8A;RELA;IRF1;SP1;ZFP90;CASZ1;TFAP4;POU5F2;SOX13;KLF9;ZBTB5;TGIF1;CLOCK;ZEB2;BBX;RUNX1;MAX;NFATC1;JUN;AR;ZBTB7A;ZNF569;ELK3;WBP2;IRF3;BCL6;TRPS1;SMAD3;TEAD1;RBAK;ZNF467;ESR1;HDAC5;NR3C1;IKZF1;JUND;PRDM4;MEF2A;WIZ;TFCP2;CUX1;DRGX;ZBTB11;NACC1;MAFG;PPARG;NR6A1;TAL1;ENO1;CDC5L;DEAF1;HBP1;HIVEP1;ACTN4;HOXC4;ZBTB46;TCF12;ZNF568;GTF2B;ZSCAN29;NR5A1;NR2C2;SOX11;ZBTB38;BCL11A;ZNF182;PRDM1;HIVEP2;DNMT3A;GMEB2;ZFP69;BACH2;TCF7L2;ZBTB34;ATF6;SOX6;TP53;MAF;NR1D2;KLF13;MYT1L;RXRA;NFX1;SP4;KCNIP3;RREB1;CARF;CREB1;RFX3;RBPJ;PPARD;DACH2;HIVEP3;CTCF;ARNT;SNAPC3;NPAS3;SMAD4;ZBTB18
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.36449908963673655,0.891657668379624,0.6638023630504833,0.9850443325177275,1.0,4/73,13.85%,RXFP1;SORCS3;CYSLTR1;CALCRL
prerank,acetylcholine receptor activity (GO:0015464),-0.30278038352267544,-0.8914792899946907,0.5757575757575758,0.8462924729093918,1.0,3/22,25.69%,CHRM3;CHRNA7;CHRFAM7A
prerank,poly-pyrimidine tract binding (GO:0008187),0.40266697279355057,0.8904924339267993,0.6273525721455459,0.9845334791409429,1.0,8/23,16.15%,RBMS3;ATXN1;PABPC4;U2AF2;HNRNPH1;RBMS1;HNRNPC;PATL1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.3754651283233854,0.8902487624622348,0.620137299771167,0.9821746526032745,1.0,7/40,13.56%,SUV39H1;METTL8;TARBP1;SETD3;AS3MT;DNMT3A;DPH5
prerank,adenyl ribonucleotide binding (GO:0032559),0.3535115381891417,0.8898212628466254,0.787,0.9802184817394147,1.0,64/291,17.18%,PLK1;ATP5F1A;BLM;PDXK;EIF4A3;MINK1;TARS1;VPS4A;DYRK2;BMPR1A;ATP7A;BTK;HARS1;MAP3K20;CDK6;ACVR1;ABCD2;STK11;HSP90AA1;CLPX;HSPA9;CDC42BPB;TAP1;SYN3;RPS6KA5;AARS1;RAPGEF4;TWF2;MAST2;PI4K2A;DAPK1;PIP4K2B;ABCG1;TAOK1;SRR;ABCD3;CHD8;GCK;PFKP;ABL1;ERN1;CDKL5;SRPK2;MYO9B;ABCA1;ABCD1;TGFBR1;ACVR1B;INSR;NVL;MTREX;MKNK1;HCN1;NEK6;STK3;MAP4K4;UBA2;ABCE1;PPIP5K2;PRKACB;TBCK;MYO1B;HSPA5;RAPGEF2
prerank,kinase binding (GO:0019900),0.3550702223629127,0.8867595293793992,0.838,0.9837834481446776,1.0,79/435,15.55%,PLK1;RGCC;WDR45;CDK5RAP3;DUSP3;RELA;IRAK4;DVL1;RHOF;EIF4ENIF1;PGAM1;GRB2;LLGL1;SASH1;MAPRE1;MSN;POLR2A;CEP250;UBQLN1;FLNA;CADPS;POLA1;SMAD3;PRKACA;SQSTM1;SPRED2;PTPRJ;ESR1;AP2A1;NR3C1;KIF11;IKBKB;DCTN1;DLG1;MAP2K6;MAPT;DCTN2;PAK2;MAPKAP1;TBC1D14;PTPN1;LIMS1;CHEK2;FAF1;CNOT9;MAVS;TOM1L2;CEP152;APC;PTPN23;DGKD;TRIM5;MVP;CDC42;TRAF2;IFNAR2;KAT2B;NBEAL1;RB1CC1;RPS6;TCF7L2;ADAM10;CYLD;RNF138;TP53;SPRED1;TTC28;USP37;ADIPOR1;BICD1;CALM1;TPCN2;CLTC;DNAJC3;BECN1;NPM1;LRBA;NEK6;NBEA
prerank,alpha-tubulin binding (GO:0043014),0.3907297643220076,0.8849602979425103,0.618531889290012,0.9846632020856719,1.0,8/31,15.14%,BBS4;SETD2;ARL4C;DIP2B;TAOK1;EML4;FYN;ARL8A
prerank,voltage-gated cation channel activity (GO:0022843),0.3577272512835968,0.8844363497165858,0.6904024767801857,0.9828581553156793,1.0,17/97,17.25%,HCN3;CACNG7;CACNA1D;KCNH8;KCNH7;HVCN1;CACNA1A;PKD2;GRIN2A;TPCN2;CACNA1C;KCNQ5;HCN1;KCND2;KCNA1;KCNA5;KCNB2
prerank,lipid phosphatase activity (GO:0042577),0.4387575995413706,0.883802934540199,0.6058823529411764,0.9812986093413518,1.0,2/14,5.74%,SGPP1;SGPP2
prerank,cysteine-type peptidase activity (GO:0008234),0.36303313440549384,0.8833042147275945,0.6888888888888889,0.9794937141487687,1.0,17/73,15.49%,USP11;CTSC;USP24;USP34;USP29;USP33;USP1;USP48;USP20;USP5;USP46;CTSZ;CAPN2;ATG4C;USP37;OTULINL;PDIA3
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.4421453073737102,0.88139125471299,0.6394849785407726,0.9805325843083091,1.0,4/13,15.90%,PDGFB;PTPRJ;ERN1;PDGFC
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.32600640582804746,-0.8810205960995156,0.6264591439688716,0.8614294924427844,1.0,14/18,67.42%,HSD17B8;HSD17B7;DHRS11;HSD17B10;HSD17B2;HSD17B1;HSD11B1;HSD3B7;DHRS9;SRD5A2;HSD3B2;HSD17B14;AKR1C1;HSD17B3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.3687761759825941,0.880845168230404,0.656554712892741,0.9789156008968811,1.0,11/54,16.00%,SIRT7;HDAC9;ACER3;HDAC11;HDAC5;ASRGL1;ASAH1;MIER3;HDAC2;GLS;GLS2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.37456698276295974,0.8772314448053427,0.6506159014557671,0.9833297392914427,1.0,5/49,10.14%,CPNE5;SYT12;SYT11;PLA2G4A;ANXA2
prerank,ATPase activator activity (GO:0001671),0.4102045693640651,0.8770261748009026,0.6185567010309279,0.9809711232894069,1.0,2/20,2.29%,DNAJB1;DNAJC15
prerank,channel activity (GO:0015267),0.37367240711893823,0.8765843073616942,0.6561085972850679,0.979121179994991,1.0,4/41,13.04%,TMEM266;TMEM120B;TRPV2;BCL2
prerank,exoribonuclease activity (GO:0004532),0.4515140958731003,0.8756944881224814,0.6316568047337278,0.9780201589429612,1.0,2/12,6.57%,EXOSC5;EXOSC7
prerank,neuropeptide receptor binding (GO:0071855),-0.35371718885770154,-0.875460780470219,0.6329113924050633,0.8648863478692707,1.0,4/14,35.71%,AGRP;PPY;SHANK1;NMU
prerank,aspartic-type peptidase activity (GO:0070001),-0.3832368808302136,-0.8753488453875663,0.6432748538011696,0.8575556805347891,1.0,3/10,22.24%,CTSD;CTSE;BACE1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.34830686598062743,0.874125140602357,0.903,0.9783471753155206,1.0,88/730,15.19%,POU2F3;GLIS1;RORA;ZIC4;SP8;RELA;IRF1;SP1;TFAP4;POU5F2;SOX13;KLF9;ZBTB5;TGIF1;CLOCK;ZEB2;RUNX1;MAX;NFATC1;JUN;AR;ZBTB7A;ZNF569;ELK3;WBP2;IRF3;BCL6;SMAD3;TEAD1;ZNF467;ESR1;HDAC5;NR3C1;IKZF1;JUND;PRDM4;MEF2A;WIZ;TFCP2;ZBTB11;NACC1;MAFG;PPARG;NR6A1;TAL1;HBP1;HIVEP1;HOXC4;TCF12;ZNF568;ZSCAN29;NR5A1;CREB3L2;NR2C2;SOX11;ZBTB38;BCL11A;ZNF182;PRDM1;HIVEP2;DNMT3A;GMEB2;BACH2;TCF7L2;ZBTB34;ATF6;SOX6;TP53;MAF;NR1D2;KLF13;MYT1L;RXRA;SP4;KCNIP3;RREB1;CARF;CREB1;RFX3;RBPJ;PPARD;DACH2;HIVEP3;CTCF;ARNT;SNAPC3;SMAD4;ZBTB18
prerank,GDP binding (GO:0019003),0.36522453200632393,0.8725196392527795,0.6666666666666666,0.9787588424535273,1.0,12/63,12.49%,NRAS;RAB8B;RAB12;RERG;RAP1A;RAB5B;RAP1B;KRAS;RAB2A;RIT2;RAB18;GNAI3
prerank,ubiquitin-specific protease binding (GO:1990381),-0.31615640908490295,-0.8724314963784744,0.6113207547169811,0.8557916841362586,1.0,6/19,11.84%,PRKN;VCP;CHMP3;AMFR;SUMO1;DERL2
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3669386753570798,0.8721698214191759,0.6747519294377067,0.976716890685306,1.0,15/49,16.68%,UBXN1;RAD18;UBQLN1;SQSTM1;BABAM2;ZFAND6;TAB3;RNF169;MINDY2;EPS15;OPTN;RAD23B;OTUD7A;UIMC1;ZBTB1
prerank,CoA hydrolase activity (GO:0016289),0.42826925992152587,0.8712497745053037,0.6316526610644257,0.9758385445766252,1.0,3/16,12.94%,ACOT9;ACOT13;ABCD1
prerank,mRNA methyltransferase activity (GO:0008174),0.44606657216620194,0.8695765582714992,0.6403508771929824,0.9763393982789236,1.0,2/12,6.37%,METTL8;METTL3
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.30975830496903645,-0.8685266497512195,0.6936170212765957,0.8568171573257828,1.0,3/21,17.46%,P2RX7;GRIK2;P2RX4
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.3777097448122708,-0.8670330318418882,0.6225895316804407,0.8525145388014209,1.0,5/10,33.54%,SIRPA;JUP;CD200;CXADR;PKP2
prerank,C-C chemokine binding (GO:0019957),-0.30102349218216856,-0.8652209919685164,0.6532258064516129,0.8491418243315348,1.0,15/22,66.53%,CCR2;CXCR4;ZFP36;CCR1;CCR6;CCR9;CCRL2;ACKR3;ACKR1;CXCR5;CXCR6;XCR1;CXCR3;CXCR2;CCR7
prerank,hormone receptor binding (GO:0051427),-0.3305024616265131,-0.8636431724838817,0.624561403508772,0.8451337078637438,1.0,4/14,34.83%,JAK2;JAK1;SOCS2;ADCYAP1
prerank,lysophospholipase activity (GO:0004622),0.4051959022422955,0.8635980695098575,0.6318607764390897,0.9847172061367638,1.0,4/20,10.21%,PLA2G6;PLA2G4A;ABHD16A;PNPLA6
prerank,pentosyltransferase activity (GO:0016763),0.37838256021595673,0.8627412318714207,0.6540229885057471,0.9836032220110166,1.0,6/36,10.02%,PARP9;PARP8;LACC1;PARP2;TNKS2;PARP4
prerank,lipase activator activity (GO:0060229),0.45685996172251825,0.8626774498838693,0.6517857142857143,0.9810388556873113,1.0,2/10,13.79%,BTK;FYN
prerank,protease binding (GO:0002020),0.3499443630421639,0.8621164882911099,0.7267144319344934,0.9794265117170655,1.0,18/99,14.92%,POLG;TYSND1;RIOK3;BRCA2;RHBDD2;BFAR;F3;ANXA2;FURIN;PRNP;DERL1;TP53;BCL2;LCOR;FN1;CLTC;PTEN;NFRKB
prerank,nuclear localization sequence binding (GO:0008139),0.4114193922675086,0.8616302365860277,0.6653061224489796,0.9776641858985715,1.0,4/18,9.84%,KPNB1;RANBP6;KPNA6;IPO5
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.3484036000708134,0.8611862339393358,0.6898002103049422,0.9758084414591884,1.0,14/74,14.61%,PDXK;FCSK;PANK1;NT5C3A;CHKB;PI4KA;DGKI;NADK2;DGKD;IPMK;GK;PIK3C2A;CHKA;ETNK1
prerank,ATP hydrolysis activity (GO:0140603),0.3669619647880205,0.8602698789020411,0.6426940639269406,0.974822362018312,1.0,9/41,13.62%,KIF20B;ABCD2;HSP90AA1;CLPX;VWA8;SMCHD1;VPS4B;ABCD1;MYO1E
prerank,metalloaminopeptidase activity (GO:0070006),-0.3291421071212169,-0.857617185965544,0.6545454545454545,0.8498799742116021,1.0,7/16,21.05%,MMP16;TRHDE;XPNPEP3;LTA4H;RNPEPL1;MMP14;ANPEP
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.38815287913513746,0.8541656985932322,0.664572864321608,0.9828231143299722,1.0,5/26,16.81%,CHSY1;B3GALNT1;B3GNT2;B3GALNT2;B3GALT1
prerank,DNA replication origin binding (GO:0003688),0.394769915641797,0.8537307142189836,0.662007623888183,0.9809893734834765,1.0,3/23,9.38%,ORC4;POLA1;ORC2
prerank,ligand-gated anion channel activity (GO:0099095),-0.32662730178004806,-0.8531500708236459,0.6612903225806451,0.8509205453654402,1.0,10/17,29.89%,GABRB1;GABRA2;GABRA3;GLRA1;GABRA5;GLRA2;GABRA4;GABRB3;GABRG1;GABRA1
prerank,CoA-ligase activity (GO:0016405),0.4253222720677615,0.8526354808310779,0.6722222222222223,0.9803574061123213,1.0,1/14,2.58%,ACSBG1
prerank,neuropeptide hormone activity (GO:0005184),-0.30623782900935986,-0.8509355669019487,0.6752577319587629,0.8481158256166401,1.0,18/22,69.40%,AGRP;PPY;ADCYAP1;PENK;CCK;PNOC;GRP;NPFF;NPY;CRH;GAL;NMB;VIP;SPX;CORT;NPPA;GHRH;CALCB
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.3663654030971416,-0.8493623692919855,0.6569767441860465,0.8444752394465688,1.0,5/11,22.55%,MAP3K4;MAP3K13;TAOK2;MAP3K1;EGFR
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.439488049654556,0.8487369269496681,0.6715758468335787,0.9845158234159643,1.0,6/12,17.23%,AGO2;CYFIP2;DCPS;EIF4E2;CYFIP1;EIF4E
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.3299922619578216,-0.8482158942785424,0.6496598639455783,0.8397163453220474,1.0,5/15,9.28%,PIK3CG;PI4KB;PIK3CA;PIK3C3;PIK3C2B
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.4029147699939626,0.8457824843917875,0.6544715447154471,0.9871370288560628,1.0,1/16,1.94%,CD38
prerank,histone acetyltransferase binding (GO:0035035),0.3962922702660124,0.8443807767722475,0.6589446589446589,0.9869960111902474,1.0,5/21,12.92%,ZBTB7A;KANSL1L;MEF2A;ECD;TP53
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.34907920867682535,0.8442803713536728,0.7057546145494028,0.9845996879644665,1.0,17/60,18.10%,LRRK2;LRRK1;CTDSPL2;CTDNEP1;PHLPP1;SSU72;PPM1A;RPAP2;PPP4C;CTDP1;CAMK2G;PTEN;ILKAP;PPP1CB;PPP3CA;PPP6C;PHLPP2
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.3605237650660953,-0.8439047444568637,0.6336088154269972,0.8410384494039863,1.0,1/11,8.30%,KCND3
prerank,organic cation transmembrane transporter activity (GO:0015101),0.4145154382342094,0.843824760623465,0.6734972677595629,0.9827513544009088,1.0,3/16,15.17%,SLC7A8;SLC25A26;SLC44A1
prerank,phosphotyrosine residue binding (GO:0001784),0.3615142651939737,0.8411208266177649,0.6892052194543298,0.9847464590845894,1.0,10/37,15.70%,LDLRAP1;GRB2;IRS1;YES1;PTPN3;ABL1;VAV2;SYK;VAV1;PIK3R1
prerank,methyl-CpG binding (GO:0008327),-0.30084958995901867,-0.8403828247705154,0.6911764705882353,0.841073663065131,1.0,14/22,34.11%,ZBTB4;CHTOP;MBD1;TET1;CXXC4;ERH;ZCWPW1;MBD2;ZBTB21;PRMT1;WDR77;PRMT5;MBD3;LRWD1
prerank,protein kinase regulator activity (GO:0019887),0.34125234818479383,0.8402465011317837,0.7266187050359713,0.9836654438249718,1.0,9/95,9.63%,RGCC;GMFB;PRKAR2A;ANKRD54;ELP3;STK11;NCK1;FAF1;APC
prerank,sodium channel activity (GO:0005272),0.36403110380903025,0.8376054944782179,0.7151162790697675,0.9854613898278599,1.0,1/37,0.39%,HCN3
prerank,calcium ion binding (GO:0005509),0.3365438340205793,0.8371792991080118,0.8898898898898899,0.9835967661119844,1.0,38/323,14.65%,SCUBE1;CETN2;SLC25A24;MAN1B1;MICU1;TPD52;BRAF;ITSN1;LETM1;THBS1;PADI2;S100A6;CEMIP2;ACER3;GLCE;PITPNM1;GALNT3;SYT12;SYT11;PLA2G4A;TRPM4;CDH11;CANT1;ANXA2;SRR;TKT;PRNP;EML1;CDH20;S100B;COLEC11;CAMKK2;CDH18;PKD2;SPARCL1;ANXA5;CALM1;AIF1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.4109131168248099,0.8349480903608131,0.6757532281205165,0.9848651952214978,1.0,1/15,2.01%,P2RY14
prerank,signal sequence binding (GO:0005048),0.3632184957618239,0.8345474149356833,0.6773809523809524,0.983062361441776,1.0,7/35,10.34%,KPNB1;RANBP6;KDELR2;KPNA6;BABAM2;IPO5;SEC61A1
prerank,MAP-kinase scaffold activity (GO:0005078),-0.36320012714502975,-0.8332046979836193,0.7113095238095238,0.8473059192452455,1.0,3/11,6.01%,SPAG9;MAPK8IP3;KSR1
prerank,chemorepellent activity (GO:0045499),0.3704946329994553,0.831911154194229,0.6883273164861613,0.9848996318088393,1.0,4/25,10.93%,SEMA6D;NRG3;SEMA3D;SEMA6A
prerank,adenylyltransferase activity (GO:0070566),-0.2931359468943467,-0.8316237556396864,0.6981981981981982,0.843634689510432,1.0,7/21,14.64%,TENT2;TENT4B;MTPAP;NMNAT2;TENT4A;PAPOLG;GPHN
prerank,gamma-tubulin binding (GO:0043015),0.3817579354094678,0.831473574587819,0.6840731070496083,0.9830680780193617,1.0,8/22,18.25%,TUBGCP6;DIXDC1;BRCA2;TUBGCP2;NDRG1;PAK1;CDK5RAP2;DDX3X
prerank,single-stranded DNA helicase activity (GO:0017116),0.3909539778751412,0.8314140473846393,0.6799468791500664,0.9806697722172173,1.0,1/19,1.53%,RFC2
prerank,store-operated calcium channel activity (GO:0015279),0.43450877048052355,0.8305405940714642,0.680365296803653,0.979638617948757,1.0,1/10,2.08%,TRPC5
prerank,protein tyrosine phosphatase activity (GO:0004725),0.33778052045103407,0.8296983533410075,0.7353255069370331,0.9784625128178956,1.0,15/71,14.87%,EYA2;DUSP3;PTPRJ;PTPN1;PTPRT;PTPN3;PTP4A3;PTPN23;PTPDC1;PALD1;PTPRU;PTPRO;PTEN;PTPN9;PTPN18
prerank,lipoprotein particle receptor binding (GO:0070325),0.380048387493459,0.8295304519414394,0.6950444726810674,0.9762512885227018,1.0,4/27,14.68%,LDLRAP1;AP2A1;RELN;CLTC
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.4083987339134667,0.8277658915176764,0.6762589928057554,0.9767904855549303,1.0,1/14,10.20%,DHRS3
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.37353229065627025,0.8272919790712524,0.6837606837606838,0.9750715018457818,1.0,3/28,8.04%,RNASEH2A;POP1;AGO2
prerank,C-C chemokine receptor activity (GO:0016493),-0.2965771026299621,-0.826639069636111,0.7100840336134454,0.8461542142370203,1.0,14/21,66.53%,CCR2;CXCR4;CCR1;CCR6;GPR75;CCR9;CCRL2;ACKR3;CXCR5;CXCR6;XCR1;CXCR3;CXCR2;CCR7
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.43256903522103113,0.8239650806834056,0.7015151515151515,0.9779623601095703,1.0,3/10,13.77%,DESI2;CYLD;ATXN3
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.38578624733553457,0.8217657708370947,0.6985769728331177,0.9789208186750502,1.0,2/22,6.32%,LDLRAP1;AP2A1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.32692308066299264,0.8197254954098111,0.8496993987975952,0.9796723328198712,1.0,26/173,15.19%,RELA;ZFP90;SOX13;ZBTB5;TGIF1;ZEB2;MAX;JUN;ELK3;BCL6;TRPS1;NR3C1;NACC1;PPARG;ENO1;DEAF1;BCL11A;PRDM1;ZFP69;ZBTB34;MYT1L;NFX1;KCNIP3;PPARD;CTCF;ZBTB18
prerank,calcium-release channel activity (GO:0015278),-0.3134052456642392,-0.8176478007893716,0.716,0.8549461704123507,1.0,3/17,4.64%,RYR2;ITPR2;ITPR1
prerank,5'-nucleotidase activity (GO:0008253),0.41674227584844914,0.8168732332107753,0.6873156342182891,0.9818760034580708,1.0,1/13,5.29%,NT5C3A
prerank,phosphatase activity (GO:0016791),0.3339780562950475,0.816202497772948,0.7621052631578947,0.9805459708825979,1.0,9/73,13.55%,MDP1;DUSP3;PTPRJ;DUSP16;DUSP10;MINPP1;OCRL;DUSP12;PTPRO
prerank,palmitoyltransferase activity (GO:0016409),0.36634122828790683,0.8141644046434372,0.7111959287531806,0.9812340454457112,1.0,5/28,14.15%,ZDHHC24;ZDHHC5;ZDHHC1;ZDHHC6;ZDHHC20
prerank,WW domain binding (GO:0050699),0.3723199408583795,0.8128669269748915,0.7049576783555018,0.9806420446910692,1.0,2/26,6.00%,PMEPA1;KIF20B
prerank,mRNA 5'-UTR binding (GO:0048027),0.37585649858940223,0.8105702990356564,0.7271604938271605,0.9816235695959115,1.0,2/24,3.31%,RPL41;SYNCRIP
prerank,chemokine receptor activity (GO:0004950),0.37742979074949407,0.8092370002097276,0.7051282051282052,0.9814246012086063,1.0,1/24,5.58%,CMKLR1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.3963878394472398,0.8069859309381942,0.7031900138696255,0.9824866288908602,1.0,3/15,11.40%,NDST3;HS6ST2;HS3ST4
prerank,methylated histone binding (GO:0035064),0.3349721997890766,0.8068008805204031,0.7505399568034558,0.9803044255938922,1.0,11/62,12.96%,THAP7;ZMYND8;KDM5A;DPF2;KMT2E;NCAPD3;ING3;GLYR1;CHD8;ZMYND11;ATRX
prerank,beta-tubulin binding (GO:0048487),-0.2479490241245321,-0.8050421374981338,0.8058823529411765,0.8694451358325435,1.0,5/31,5.75%,BCAS3;TBCD;ARL8B;APPL1;SMC3
prerank,microtubule motor activity (GO:0003777),0.33989768226124095,0.8044757374050089,0.7648351648351648,0.981339891821803,1.0,12/51,16.86%,KIF13A;KIF20B;KIF11;KIF26B;KIF16B;KIF3A;STARD9;APPBP2;KIF21A;DYNC1I2;KIF1B;KIF2A
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3325400302427079,0.8015619372168591,0.7613997879109226,0.9833060314818192,1.0,12/70,17.14%,POGLUT3;CHSY1;B4GALT1;B3GALNT1;B3GNT2;MGAT4B;B3GALNT2;EXT1;MGAT4A;LARGE1;B3GALT1;EXT2
prerank,phosphatidylcholine transporter activity (GO:0008525),0.39224334485388634,0.7984695856656894,0.7333333333333333,0.9855121842792164,1.0,6/17,15.46%,PITPNM1;ABCA7;ABCG1;PITPNA;ABCA1;PITPNB
prerank,SUMO transferase activity (GO:0019789),-0.2937782670144065,-0.7979895437403536,0.7125984251968503,0.8745471754346804,1.0,7/16,29.60%,PIAS2;PIAS4;TOPORS;RANBP2;CBX4;TRIM28;HDAC4
prerank,phosphatase binding (GO:0019902),0.3206681642745458,0.7970148629636089,0.8123711340206186,0.9852612090982836,1.0,27/105,17.61%,CTSC;CARHSP1;SYTL2;SMAD3;MAPK1;DLG1;SNX3;PTPRT;MAST2;STX17;TRPC4AP;MVP;TRAF2;PXN;RCAN3;KIF3A;MAPK14;TP53;SPRED1;SHOC2;PPME1;PIK3R1;IQGAP1;TBK1;STAT6;CHCHD3;CTNNB1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.41417774057015366,0.7944176840199922,0.7194570135746606,0.986642449785517,1.0,4/11,17.23%,NAA25;NAA16;NAA15;NAA20
prerank,semaphorin receptor binding (GO:0030215),0.36108274142135194,0.7902160767581529,0.7531486146095718,0.9904445414923205,1.0,4/23,10.93%,SEMA6D;SEMA3D;RIT2;SEMA6A
prerank,methylation-dependent protein binding (GO:0140034),0.32844891179595304,0.7891536673710653,0.7651515151515151,0.9896749446637171,1.0,10/57,12.96%,THAP7;ZMYND8;KDM5A;KMT2E;NCAPD3;ING3;GLYR1;CHD8;ZMYND11;ATRX
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.40174659873366436,0.7865244510034973,0.7216642754662841,0.9910095848573983,1.0,3/13,10.29%,PRKAR2A;EZR;PKIA
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.4083593342816905,0.7858797895683244,0.7234678624813154,0.9895280439882682,1.0,3/11,9.78%,FBXO11;PRMT9;NDUFAF7
prerank,calcium channel activity (GO:0005262),0.32059247115004,0.784500604518091,0.8047767393561787,0.9888911983902221,1.0,13/84,14.79%,SLC24A5;TRPC5;CACNG7;CACNA1D;TRPM4;CACNA1A;ANXA2;SEC61A1;MCOLN1;TRPV2;PKD2;TPCN2;CACNA1C
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.34184039281405326,0.7832312211717001,0.7591324200913242,0.9882432620809319,1.0,6/34,10.81%,REXO2;EXOSC5;EXOSC7;ERI3;EXD2;XRN2
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.4076907664908642,0.7829062223184668,0.7507507507507507,0.9863162354866845,1.0,1/11,1.88%,PTDSS2
prerank,peptidase activator activity (GO:0016504),-0.2648837631307114,-0.7817067855480057,0.8051282051282052,0.8933916250413967,1.0,4/22,7.00%,PSMD14;VCP;MAL;VSIR
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.3267625086320548,-0.7756023910425435,0.7474048442906575,0.8962938288625732,1.0,9/12,67.34%,ELOVL4;OPN3;GPR88;RRH;GPR52;OPN1MW3;OPN1MW;OPN5;OPN4
prerank,glutamate receptor binding (GO:0035254),0.3698263107085437,0.7705809903185732,0.7458791208791209,1.0,1.0,2/17,5.53%,HOMER2;SQSTM1
prerank,GTPase inhibitor activity (GO:0005095),0.3928568288072759,0.7695049566179252,0.7342857142857143,0.9998899005412197,1.0,5/13,16.53%,IQGAP2;IPO5;PDE6D;IQGAP1;CPEB2
prerank,U6 snRNA binding (GO:0017070),0.38417623959343583,0.765212583900691,0.7375886524822695,1.0,1.0,1/14,2.30%,LSM7
prerank,ankyrin binding (GO:0030506),0.3622509421267582,0.7650130601036663,0.7493368700265252,1.0,1.0,2/19,8.18%,CACNA1D;SPTBN1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3536991511671425,0.7644629140644382,0.7718832891246684,0.9996017512662454,1.0,4/24,14.15%,ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC20
prerank,MHC class II protein complex binding (GO:0023026),0.4046486751082238,0.7639297083348447,0.7462462462462462,0.9979785055079102,1.0,2/11,6.93%,YWHAE;HSP90AA1
prerank,fibroblast growth factor binding (GO:0017134),0.3612503146215632,0.7609853979357292,0.7741514360313316,0.9995527990122632,1.0,2/21,7.11%,THBS1;API5
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.31196251767872757,0.7605109876695234,0.8247311827956989,0.9977574837313867,1.0,5/57,8.91%,UQCRH;UQCRC1;NDUFS1;NDUFA9;NDUFV2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.38857958712247875,0.7599857415878548,0.7595307917888563,0.9961544502244842,1.0,1/12,3.19%,VEGFC
prerank,snoRNA binding (GO:0030515),0.3338782303750613,0.7580422033497308,0.7812113720642769,0.9964328972920279,1.0,5/30,12.08%,PRKDC;NUDT5;UTP6;HEATR1;NOP56
prerank,I-SMAD binding (GO:0070411),0.3816270871015262,0.7568867666008396,0.7619718309859155,0.9955406321631298,1.0,4/13,15.19%,SMAD6;SMAD3;TGFBR1;SMAD4
prerank,calcium activated cation channel activity (GO:0005227),-0.29115313770185036,-0.7544573498830737,0.8156028368794326,0.92067507075806,1.0,5/17,14.79%,ANO6;KCNN2;TMEM63A;ANO10;KCNMA1
prerank,tau protein binding (GO:0048156),0.3263877517766492,0.7510538975168607,0.8109965635738832,1.0,1.0,9/40,14.30%,MAP1A;EP300;HSP90AA1;DCTN1;CDK5;TAOK1;S100B;FYN;ROCK2
prerank,myosin binding (GO:0017022),0.31626451098229463,0.7489571014851403,0.8178844056706652,1.0,1.0,8/55,13.05%,LLGL2;LLGL1;ARFGEF1;GIPC1;RAB6A;STXBP5;STXBP5L;RAB3C
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.365659656236877,0.7469005400203264,0.7782426778242678,1.0,1.0,2/15,8.17%,PLA2G4A;SNX3
prerank,aspartic-type endopeptidase activity (GO:0004190),0.3803866990608931,0.7399487225906571,0.7817638266068759,1.0,1.0,5/12,19.42%,SPPL3;NAPSA;PSEN1;SPPL2A;DDI2
prerank,transaminase activity (GO:0008483),-0.30692010739788345,-0.7363855243062025,0.7855072463768116,0.9390329512142574,1.0,4/11,18.53%,GOT1;ABAT;GOT2;BCAT1
prerank,phospholipid transfer activity (GO:0120014),-0.2567209852239109,-0.7341134501284342,0.8533333333333334,0.9351235957733701,1.0,7/21,15.33%,CERT1;ABCA3;PITPNC1;PLEKHA8;PLEKHA3;GLTP;PLTP
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.33775863126803124,0.7323195689197037,0.8032378580323786,1.0,1.0,4/25,9.54%,DAPP1;MAPKAP1;MYO1G;KIF16B
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.32510985561833017,-0.73090911679685,0.8085106382978723,0.9327893357062158,1.0,7/11,67.49%,CHRNA7;CHRNA4;CHRNB2;CHRNA5;CHRNA3;CHRNA9;CHRNB4
prerank,Wnt-activated receptor activity (GO:0042813),0.3546693368915686,0.72893396069665,0.7745664739884393,1.0,1.0,3/15,14.51%,LRP5;FZD9;FZD3
prerank,sulfotransferase activity (GO:0008146),0.3190776019820394,0.7280949043626864,0.8151162790697675,1.0,1.0,1/33,1.12%,UST
prerank,outward rectifier potassium channel activity (GO:0015271),0.38471240281592894,0.7271944055949916,0.802731411229135,1.0,1.0,4/11,16.88%,KCNK2;PKD2;KCND2;KCNA5
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.38202619181172526,0.7260377704008384,0.7910906298003072,1.0,1.0,1/11,2.08%,TRPC5
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.30472110898693244,0.7251927026434287,0.8413566739606126,1.0,1.0,7/55,13.91%,SLC24A5;TRPC5;CACNA1D;ANXA2;SEC61A1;TRPV2;PKD2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.3852929766229012,0.7226635338460892,0.8064516129032258,1.0,1.0,1/11,7.44%,SLC25A20
prerank,nuclear export signal receptor activity (GO:0005049),0.3792758789117505,0.7226503690013452,0.8055964653902798,1.0,1.0,2/11,8.27%,EIF4ENIF1;CSE1L
prerank,translation initiation factor activity (GO:0003743),0.3149581459953987,0.7218840479667917,0.8214702450408401,1.0,1.0,10/36,18.07%,EIF3C;EIF3E;AGO2;EIF1;EIF3A;EIF2S1;EIF4E2;EIF4E;EIF3H;EIF2S2
prerank,phospholipase activator activity (GO:0016004),0.38615008431980813,0.7203938518455819,0.8036253776435045,1.0,1.0,2/10,13.79%,BTK;FYN
prerank,mannosyltransferase activity (GO:0000030),0.34525323123540175,0.7203005616465931,0.8130489335006273,1.0,1.0,2/21,4.72%,ALG3;POMT2
prerank,tumor necrosis factor receptor binding (GO:0005164),0.36402689712885306,0.7190707030435066,0.8051750380517504,1.0,1.0,2/12,10.87%,BABAM2;TRAF2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.33209797360597665,0.7190545233038653,0.7902187902187903,1.0,1.0,8/22,16.68%,SQSTM1;TAB3;RNF169;MINDY2;OPTN;OTUD7A;UIMC1;ZBTB1
prerank,titin binding (GO:0031432),-0.29146984536765486,-0.7173898142196992,0.8285714285714286,0.9425262741755128,1.0,2/13,7.55%,CALM2;CAPN3
prerank,cholesterol binding (GO:0015485),0.3089979110012978,0.7164378257654682,0.8618346545866364,1.0,1.0,11/47,16.25%,SOAT1;SIDT1;STARD5;ABCG1;ABCA1;OSBPL1A;SCARB2;GRAMD1B;ERLIN1;CD81;OSBPL2
prerank,motor activity (GO:0003774),0.29996805916424,0.714907689999913,0.8616216216216216,1.0,1.0,13/60,16.86%,KIF13A;KIF20B;KIF11;KIF26B;KIF16B;KIF3A;STARD9;APPBP2;MYO1E;KIF21A;DYNC1I2;KIF1B;KIF2A
prerank,platelet-derived growth factor binding (GO:0048407),0.3687951624790533,0.714434445610581,0.7880986937590712,1.0,1.0,1/11,5.17%,PDGFB
prerank,Notch binding (GO:0005112),-0.24769605753474935,-0.7104540021816675,0.8691588785046729,0.9438138218758512,1.0,13/22,46.90%,MEGF10;CUL3;SNW1;SNED1;HIF1AN;JAG1;KCTD10;AAK1;TCIM;JAG2;ADAM17;DLK2;NOTCH4
prerank,sulfate transmembrane transporter activity (GO:0015116),0.360237689772535,0.7058464240823229,0.8333333333333334,1.0,1.0,1/14,6.52%,SLC26A11
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.3666586804769423,0.69946402963777,0.812960235640648,1.0,1.0,2/11,11.98%,NUDT5;DCPS
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.2942341642739651,0.6975370318155868,0.8868335146898803,1.0,1.0,7/55,15.51%,SLC7A2;SLC38A2;SLC7A8;SLC25A32;SLC38A9;SLC16A6;SLC38A6
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.30657209214738557,-0.696967805812091,0.8547945205479452,0.9520331711878568,1.0,8/10,69.36%,SLC6A1;SLC6A11;SLC10A1;SLC10A6;SLC10A3;SLC6A12;SLC6A13;SLC10A2
prerank,ribonuclease P RNA binding (GO:0033204),0.36156817386975326,0.6923878967785392,0.812206572769953,1.0,1.0,1/10,7.52%,POP1
prerank,MAP kinase activity (GO:0004707),0.3419608622455302,0.692121737499006,0.8141210374639769,1.0,1.0,4/14,16.31%,MAPK1;MAPK8;MAPK14;MAPK6
prerank,amino acid binding (GO:0016597),0.3091199315755125,0.6917991068953298,0.8651960784313726,1.0,1.0,5/31,12.33%,AARS1;GLRB;SRR;GRM7;GLRA3
prerank,telomerase RNA binding (GO:0070034),0.3225029547229009,0.689170906007269,0.8558897243107769,1.0,1.0,3/22,9.48%,SMG6;XRN1;SNRPD3
prerank,insulin-like growth factor receptor binding (GO:0005159),0.3527796409331606,0.6883696501837373,0.8299418604651163,1.0,1.0,3/12,15.70%,IRS1;INSR;PIK3R1
prerank,RNA stem-loop binding (GO:0035613),0.34097519541492516,0.6872641134040327,0.8397058823529412,1.0,1.0,2/12,6.03%,CSDE1;RC3H2
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.29830097941800304,-0.683075744264225,0.8803418803418803,0.9600339723696288,1.0,7/10,32.27%,NSF;IGSF11;DLG4;SHANK2;GNAS;SHANK1;SHANK3
prerank,voltage-gated calcium channel activity (GO:0005245),0.2990787836548036,0.6807424727223412,0.8521939953810623,1.0,1.0,6/37,14.79%,CACNG7;CACNA1D;CACNA1A;PKD2;TPCN2;CACNA1C
prerank,protein heterodimerization activity (GO:0046982),0.2707954178164046,0.6783183825205673,0.9597989949748744,1.0,1.0,35/178,17.25%,ADCY8;MICU1;PEF1;YWHAE;TPM1;PDGFB;SDCBP;METTL3;MEF2A;IKBKB;TENM4;ADD1;IRAK2;FXR2;ABCG1;DGKD;SNX1;ATF6;TP53;BCL2;MIGA1;FZD9;TLR4;ARNT;NPAS3;HIP1;EXT1;UBA2;MEF2C;VAPB;ZBTB1;TOP2B;SAE1;EXT2;KCNB2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.32891073809626326,0.6766857485633736,0.8738127544097694,1.0,1.0,3/17,11.29%,DECR1;TECR;PTGR2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.34057444551059846,0.6753621204697209,0.8357348703170029,1.0,1.0,3/13,13.10%,PIP4K2A;PIP4K2B;PIK3C2A
prerank,tRNA binding (GO:0000049),0.2864951865088373,0.675111492809488,0.8683035714285714,1.0,1.0,4/43,8.31%,NSUN6;PTCD1;TRNAU1AP;AARS1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.2211354657555788,-0.6744543260208482,0.9560439560439561,0.9616459451715484,1.0,7/25,29.44%,CYP27A1;POR;MSMO1;MICAL1;CH25H;FMO5;MTRR
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.3411665102941616,0.674371386352128,0.8480825958702065,1.0,1.0,2/12,10.90%,RELA;GTF2B
prerank,phospholipase inhibitor activity (GO:0004859),0.35780076472430106,0.6739631132401595,0.8428571428571429,1.0,1.0,2/10,13.95%,ANXA2;ANXA5
prerank,N-acetyltransferase activity (GO:0008080),0.32002620606425797,0.6734861244001081,0.8308921438082557,1.0,1.0,3/19,11.99%,EP300;KAT2B;ESCO1
prerank,diacylglycerol kinase activity (GO:0004143),0.3434253395783179,0.6678499507478031,0.8567164179104477,1.0,1.0,4/11,17.83%,DGKI;DGKD;DGKZ;DGKH
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.3425891928574958,0.6663683397255187,0.8512898330804249,1.0,1.0,1/11,6.53%,PPP1R8
prerank,nucleotidase activity (GO:0008252),0.3329434542380382,0.6658301830996307,0.8704225352112676,1.0,1.0,1/15,5.29%,NT5C3A
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.29737815571009446,0.6641258839219951,0.8841463414634146,1.0,1.0,4/30,12.50%,SLC39A11;ATP7A;SLC31A1;SLC39A10
prerank,H4 histone acetyltransferase activity (GO:0010485),0.3592688123390144,0.6618479502147497,0.8501529051987767,1.0,1.0,2/10,6.78%,EP300;BRCA2
prerank,chloride channel inhibitor activity (GO:0019869),0.3508851635598589,0.6590462253965396,0.8734567901234568,1.0,1.0,1/10,4.76%,STX7
prerank,inward rectifier potassium channel activity (GO:0005242),0.30306809140310165,0.6553767568747441,0.8852459016393442,1.0,1.0,1/24,3.02%,KCNJ6
prerank,hexosaminidase activity (GO:0015929),0.33446285620996447,0.6527987099059697,0.8774583963691377,1.0,1.0,1/12,4.89%,CEMIP2
prerank,TBP-class protein binding (GO:0017025),0.30805121425955867,0.6526326341242095,0.8786346396965866,1.0,1.0,4/21,12.00%,ESR1;PSMC5;GTF2B;YEATS2
prerank,nuclear receptor coactivator activity (GO:0030374),0.2733498658724576,0.6522886367215888,0.9019823788546255,1.0,1.0,7/52,10.26%,BRD8;PRKCB;BUD31;NCOA1;NCOA3;CNOT9;ACTN4
prerank,ribosomal small subunit binding (GO:0043024),0.3178677228531116,0.650102789427821,0.876358695652174,1.0,1.0,6/17,18.25%,EIF4B;EIF1;NPM1;ABCE1;CPEB2;DDX3X
prerank,cAMP response element binding (GO:0035497),0.34684827789524664,0.6485684094183793,0.8673946957878315,1.0,1.0,3/10,14.01%,JUN;CREB3L2;CREB1
prerank,RNA cap binding (GO:0000339),0.31803828459660755,0.6478154190700098,0.8657534246575342,1.0,1.0,6/16,17.23%,AGO2;CYFIP2;DCPS;EIF4E2;CYFIP1;EIF4E
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.3134657630258947,0.646390283734771,0.8810160427807486,1.0,1.0,2/17,10.08%,EPHB2;EPHA5
prerank,ephrin receptor activity (GO:0005003),0.3134657630258947,0.646390283734771,0.8810160427807486,1.0,1.0,2/17,10.08%,EPHB2;EPHA5
prerank,kinase inhibitor activity (GO:0019210),0.28789937384840214,0.6457055020037343,0.8848837209302326,1.0,1.0,6/33,16.50%,GMFB;NCK1;LRP6;DNAJC3;NPM1;YWHAB
prerank,pyrophosphatase activity (GO:0016462),0.2748831652590587,0.6441427490871169,0.9166666666666666,0.9992462209183882,1.0,6/50,11.98%,PRUNE2;NUDT5;NUDT9;ENTPD1;RNGTT;DCPS
prerank,phosphatidylglycerol binding (GO:1901611),-0.25540735589341196,-0.6436769579685689,0.9243421052631579,0.9798577675355772,1.0,7/13,32.74%,OPA1;PITPNC1;PLTP;PLEKHN1;MME;GSDME;STOML2
prerank,protein phosphatase binding (GO:0019903),0.25885420067176546,0.6431414472817473,0.9460834181078331,0.9980571495254595,1.0,26/117,17.95%,ADCY8;SLC9A1;IGBP1;BOD1L1;MAPT;SNX3;PTPRT;STX17;MVP;TRAF2;PXN;KIF3A;MAPK14;TP53;PPP1R16B;SHOC2;ENSA;PPME1;PIK3R1;PPP1R9B;IQGAP1;TBK1;STAT6;MFHAS1;CTNNB1;SMG7
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.31929129874229867,0.6423667248628678,0.8652777777777778,0.9967615277265188,1.0,2/15,7.97%,SETD1A;SETD3
prerank,cytokine receptor activity (GO:0004896),0.26618596749325235,0.6411839220026391,0.948905109489051,0.9957886184288718,1.0,8/83,11.88%,LIFR;IL10RB;CMKLR1;IL1RAP;CD44;F3;IFNAR2;IL17RA
prerank,glycine binding (GO:0016594),0.331693007953255,0.6393208453527394,0.8669724770642202,0.9954229472595277,1.0,3/11,12.33%,GLRB;SRR;GLRA3
prerank,cation:chloride symporter activity (GO:0015377),-0.28194988103625485,-0.6365811395934757,0.9169054441260746,0.9785643165577881,1.0,6/10,37.85%,SLC12A9;SLC12A2;SLC6A1;SLC12A7;SLC12A5;SLC12A4
prerank,amino acid:sodium symporter activity (GO:0005283),0.3333199670000302,0.6355571045856527,0.8746268656716418,0.9965990979984334,1.0,1/11,5.63%,SLC38A2
prerank,phospholipase binding (GO:0043274),0.32139283053601325,0.6341138405699271,0.871866295264624,0.9957429689823735,1.0,3/13,13.79%,BTK;SYK;FYN
prerank,retinoic acid binding (GO:0001972),0.32487915123359895,0.6320018623600226,0.8768115942028986,0.9955400426308825,1.0,12/12,67.54%,RXRA;CYP26A1;UGT1A10;UGT1A4;UGT1A6;UGT1A7;UGT1A8;UGT1A1;CYP26C1;CYP26B1;NR2F2;RARA
prerank,aminopeptidase activity (GO:0004177),0.2877166017897519,0.6312847110872558,0.9079601990049752,0.9941691911119821,1.0,4/26,12.65%,METAP1;LNPEP;XPNPEP1;ERAP1
prerank,NADPH binding (GO:0070402),-0.25602150866937107,-0.6237550895417383,0.9260450160771704,0.9810444752153089,1.0,7/13,30.72%,KCNAB1;QDPR;HMGCR;LBR;DUS2;MTRR;CBR4
prerank,anion channel activity (GO:0005253),0.26191039142761285,0.6215388481365339,0.9344790547798066,1.0,1.0,7/61,12.33%,CLIC1;LRRC8B;CLCN7;CLCN5;GLRB;GABRG2;GLRA3
prerank,chloride transmembrane transporter activity (GO:0015108),0.308044944231931,0.6214309005909445,0.907967032967033,0.9981472327484694,1.0,1/16,6.35%,CLCN7
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.26792651954494917,0.6207510911138195,0.9307511737089202,0.9947262297440858,1.0,4/34,12.65%,NDUFS1;NDUFA9;NDUFV2;NDUFA10
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.26792651954494917,0.6207510911138195,0.9307511737089202,0.9947262297440858,1.0,4/34,12.65%,NDUFS1;NDUFA9;NDUFV2;NDUFA10
prerank,ion channel inhibitor activity (GO:0008200),0.27050956484581035,0.6190399316051914,0.9075144508670521,0.994052286760543,1.0,7/35,15.78%,STX7;NEDD4;CAMK2D;CALM1;KCNMB2;ENSA;STX8
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.23986187289059993,-0.6081653123145359,0.9477351916376306,0.9840724262435115,1.0,7/14,26.50%,MAL;PYCARD;BCL2L13;RACK1;NOD1;CASP1;EBAG9
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.28594340217324843,0.6050591227028125,0.9146981627296588,1.0,1.0,2/20,12.50%,SLC39A11;SLC39A10
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.2540779575974933,0.6050381885058258,0.9335585585585585,1.0,1.0,6/48,13.91%,PIEZO2;TRPM4;MCOLN1;SLC12A6;TRPV2;PKD2
prerank,GTPase activity (GO:0003924),0.23958306136786206,0.6010696626879515,0.987987987987988,1.0,1.0,27/192,15.26%,LRRK2;NRAS;RHOF;GPN1;RAB8B;RERG;RAP1A;MTG2;RAB5B;RAP1B;RAB6A;KRAS;RAB2A;GNAQ;CDC42;RIT2;RAB18;GNAI3;SRPRA;RAB3C;TBC1D24;SAR1B;GNB1;RAB7A;ARHGDIB;ARL8A;ATL2
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.29905105629588324,0.6010125245890485,0.9138686131386862,0.9994240515111672,1.0,3/13,13.00%,LCLAT1;AGPAT4;AGPAT5
prerank,nucleoside-triphosphatase activity (GO:0017111),0.23912332173095124,0.600279824687319,0.994994994994995,0.997927536825561,1.0,36/248,15.26%,LRRK2;NRAS;RHOF;GPN1;RAB8B;RERG;RAP1A;MTG2;KIF20B;ABCD2;HSP90AA1;RAB5B;CLPX;RAP1B;RAB6A;VWA8;KRAS;RAB2A;GNAQ;SMCHD1;CDC42;RIT2;VPS4B;RAB18;GNAI3;SRPRA;ABCD1;RAB3C;TBC1D24;MYO1E;SAR1B;GNB1;RAB7A;ARHGDIB;ARL8A;ATL2
prerank,ion channel activity (GO:0005216),0.24502145994926827,0.5993957852235533,0.9608050847457628,0.996558325490178,1.0,11/80,15.72%,TMC7;TMEM63B;PIEZO2;TRPM4;GRIA4;MCOLN1;TMEM120B;TRPV2;PKD2;GRIN2A;GRID2
prerank,protein kinase inhibitor activity (GO:0004860),0.2610548621310933,0.5977848058834395,0.9252548131370328,0.9957025186063236,1.0,7/42,16.50%,GMFB;SPRED2;NCK1;SPRED1;DNAJC3;NPM1;YWHAB
prerank,transferrin receptor binding (GO:1990459),0.31286231207267134,0.5963494029476145,0.9032258064516129,0.9946063422099086,1.0,3/10,16.20%,IKBKB;SNX1;CD81
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.29749810838074764,0.5960593142378605,0.9162929745889388,0.9928742062444524,1.0,3/13,15.87%,TARBP1;TRMT1L;THUMPD3
prerank,snRNA binding (GO:0017069),0.25370947836463964,0.5920819992368709,0.9472502805836139,0.9935709267491948,1.0,5/42,11.15%,LSM7;CDK9;SNRNP70;SNRPD3;RBM7
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.30141190467707574,0.5829490387594667,0.9288888888888889,0.9975312764587272,1.0,2/12,14.32%,APAF1;CASP8AP2
prerank,ribonuclease P activity (GO:0004526),0.2993205803483321,0.5827924771958481,0.9117199391171994,0.9957010465520457,1.0,1/11,7.52%,POP1
prerank,calcium-activated potassium channel activity (GO:0015269),-0.25140035236901814,-0.5797348789021326,0.9605633802816902,0.9917859726092809,1.0,1/11,1.70%,KCNN2
prerank,actin monomer binding (GO:0003785),0.2710429998528094,0.5790325353225145,0.9374185136897001,0.9959884628497353,1.0,5/22,16.13%,TWF2;TMSB4X;ABL1;LIMA1;MRTFA
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.28960018868205006,0.5675553711546465,0.9342857142857143,1.0,1.0,3/13,12.33%,GLRB;GABRG2;GLRA3
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.2769645595842251,0.5675102695988876,0.9404600811907984,0.9989315023137348,1.0,2/18,10.14%,TMOD3;ANXA2
prerank,PDZ domain binding (GO:0030165),0.23312978488109048,0.5667159688958966,0.9764201500535906,0.9974659887525675,1.0,10/61,15.72%,LLGL2;CRIM1;SRR;SDC2;TBC1D10A;MAP2K2;FZD3;PTEN;SYNJ2;GRID2
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.24773705222313364,-0.5640513873705012,0.9459459459459459,0.9917625714527443,1.0,7/10,36.26%,DPP8;NAALAD2;DPP7;DPP9;DPP10;PRCP;DPP4
prerank,receptor antagonist activity (GO:0048019),0.27110335553688136,0.5610885672306882,0.9492656875834445,0.9986501703626854,1.0,1/17,11.03%,PXDN
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.18718826306351138,-0.5587598064864233,0.9896907216494846,0.9868188365043004,1.0,7/26,31.13%,MPC1;MPC2;SLC6A1;SLC16A2;SLC16A1;SLC16A3;SLC6A11
prerank,carboxy-lyase activity (GO:0016831),0.25799328799408067,0.5555845647348966,0.9514066496163683,0.9997092994440513,1.0,1/23,2.88%,GGCX
prerank,"DNA binding, bending (GO:0008301)",0.27450241727883473,0.5537476677999424,0.9452662721893491,0.9987527219221026,1.0,14/14,72.57%,HMGB1;TERF1;FOXL1;HMGB4;FOXD1;HMGB3;LEF1;FOXC1;TOP2A;HMGA2;SAP30L;TFAM;HMGB2;HHEX
prerank,neuropeptide receptor activity (GO:0008188),0.24596303980809742,0.5516004835853499,0.964329643296433,0.9979484111130339,1.0,1/29,6.75%,SORCS3
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.2682165841944349,0.5506649379455545,0.9527896995708155,0.9965312002386147,1.0,3/15,13.00%,LCLAT1;AGPAT4;AGPAT5
prerank,chemokine binding (GO:0019956),0.249345122163115,0.548810301984153,0.9616810877626699,0.9955501770935618,1.0,2/30,12.01%,ITGA4;HMGB1
prerank,thioesterase binding (GO:0031996),0.28367138372406386,0.5434542268836648,0.9508716323296355,0.9961524505863728,1.0,2/11,10.87%,CDC42;TRAF2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.26365099806204323,0.5368993475840065,0.9636608344549125,0.9971853017112515,1.0,1/16,8.48%,ALOX5
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.22007638130559154,0.533509158976297,0.9853249475890985,0.9967123961603529,1.0,6/75,12.99%,HPGD;UGDH;GLYR1;DHRS3;HSD17B11;HSD17B4
prerank,cardiolipin binding (GO:1901612),0.2805358718205666,0.5242175781402714,0.9571865443425076,0.9986723844670499,1.0,1/10,7.47%,GSDMD
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.23158306405417892,0.5199164511473845,0.9784431137724551,0.9982755105247492,1.0,4/32,15.51%,SLC38A2;SLC7A8;SLC38A9;SLC38A6
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.2706687167574061,0.5165302424865476,0.968,0.997604376420932,1.0,2/10,11.95%,KDM4B;KDM4C
prerank,solute:sodium symporter activity (GO:0015370),-0.16533970439537904,-0.5146259333791521,1.0,0.9930284661653548,1.0,3/27,17.29%,SLC5A3;SLC20A1;SLC4A7
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.26396735718769593,0.5077044265961294,0.9598145285935085,0.9985366937027159,1.0,11/11,73.62%,HCN1;CNGA4;CNGA1;KCNA10;CNGA2;CNGA3;CNGB1;AQP1;CNGB3;HCN4;HCN2
prerank,phosphatase activator activity (GO:0019211),0.255058920715869,0.5016303900116789,0.9748953974895398,0.9986693480000409,1.0,3/14,14.29%,FRS2;PPP2R5C;CALM1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.25776177056297955,0.48815165218130635,0.9724238026124818,1.0,1.0,3/12,16.08%,ARSB;ARSK;GNS
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.25894810785765515,0.4831726199447081,0.9679878048780488,0.9998138031975654,1.0,1/10,11.25%,KAT2B
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.22042767653398315,0.48242595025364066,0.9854014598540146,0.9981611702247817,1.0,2/27,11.18%,SLC26A11;XPR1
prerank,tRNA methyltransferase activity (GO:0008175),0.22869927144961827,0.47242978638757427,0.9887640449438202,0.9985903085198226,1.0,1/16,5.02%,TARBP1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.1990802310784147,-0.4718575976436508,0.9878787878787879,0.9936146280572283,1.0,7/11,41.63%,RPS3;HMCES;APLF;NEIL2;HMGA2;NEIL1;NEIL3
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.21473755076218637,0.4308045615850887,0.9899425287356322,1.0,1.0,1/14,7.52%,POP1
prerank,monocarboxylic acid binding (GO:0033293),0.2048608930477926,0.42443589290471523,0.9932614555256065,1.0,1.0,18/18,79.54%,RXRA;PLA2G1B;CYP26A1;UGT1A10;PSAP;AKR1C1;UGT1A4;UGT1A6;UGT1A7;UGT1A8;UGT1A1;NR1H4;CYP26C1;CYP26B1;NR2F2;RARA;NAPEPLD;PYGL
prerank,delayed rectifier potassium channel activity (GO:0005251),0.16368093531963035,0.375076184548911,1.0,1.0,1.0,32/32,83.66%,KCNQ5;KCNA1;KCNA5;KCNB2;KCNC2;KCNQ3;KCNA7;KCNE1;KCNE5;KCNA10;KCNE2;KCNA3;KCNG3;KCNE4;KCNS1;KCNG4;KCNE3;KCNG1;KCNQ1;KCNQ4;KCNH2;KCNC4;KCNS3;KCNG2;KCNA4;KCNB1;KCNC3;KCNA2;KCNC1;KCNQ2;KCNA6;KCNH1
prerank,protein phosphatase 1 binding (GO:0008157),0.1735247994092833,0.3726682009669947,0.9974651457541192,1.0,1.0,4/21,18.30%,PPP1R16B;SHOC2;PPP1R9B;PHACTR4
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.178688545123466,0.35771467498031645,0.9986072423398329,1.0,1.0,1/14,10.53%,CAPN2
prerank,hormone activity (GO:0005179),0.12622797210567327,0.2988420395302509,1.0,0.9999303005513593,1.0,1/54,7.28%,CCL25
